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1 Abstract 
The essential trace element selenium is an indispensable part of selenoproteins and plays a major role 
in cellular protection against oxidative stress. Both anti-oxidative and pro-oxidative properties have 
been postulated as potential cancer-preventive mechanisms of selenium. However, because of the 
very narrow range between deficiency and toxicity, increased intake of selenium-containing dietary 
supplements could pose a potential oversupply risk for this essential trace element.  
Inorganic, reducible selenocompounds, such as sodium selenite, exert pro-oxidative effects. 
Thiol groups in zinc-binding proteins could be potential molecular targets, e.g. transcription factors 
or DNA repair proteins, which could possibly disturb the maintenance of genomic stability. The 
tumor suppressor protein p53 performs important cellular functions in maintaining genomic stability 
by regulating expression of target genes relevant for control of the cell cycle, DNA repair 
mechanisms and induction of apoptosis. Previous research in our working group has shown that 
sodium selenite-induced cellular responses are mediated by p53. In contrast, effects induced by the 
organic and fully-reduced selenomethionine seemed to be independent of cellular p53 status. 
The underlying carcinogenic mechanisms of cadmium are complex and not yet completely 
understood. Changes in the structure and function of p53 through cadmium compounds have already 
been reported. Concurrent cadmium exposure and dietary selenium supplementation could indeed 
occur, which raises the question of how these different compounds interact within the cell. In this 
work, a possible inhibition by cadmium chloride of sodium selenite-induced p53-mediated effects was 
investigated. Also the organic compound selenomethionine was examined. As a cell model system, 
human colon carcinoma cell lines with different p53 status were chosen. Amongst these cell lines, the 
p53-proficient HCT116 cells possess an intact wild-type p53, while the isogenic p53-deficient 
HCT116 cell line lacks the tumor-suppressive functions from p53.  
In contrast to selenomethinone, pronounced cytotoxic effects over a narrow concentration 
range with sodium selenite were seen in the p53-proficient HCT116 cells, but not in the p53-
deficient cells. Sodium selenite induced oxidative stress by generating superoxide production 
accompanied by depletion of GSH, which subsequently induced pro-apoptotic signaling in a p53-
dependent manner. Even though superoxide and other reactive oxygen species (ROS) are important 
for initiating signals to activate p53, the p53 functional activity may play an important role for 
sustaining sodium selenite-induced ROS generation by activating pro-oxidant genes, leading to an 
acceleration of apoptosis.  
In combination with cadmium, sodium selenite-induced cell death was modulated. Cadmium 
appeared to inactivate p53, which inhibited the sodium selenite-induced GSH-depletion and 
superoxide production and pro-apoptotic signaling of p53. Assuming that the transcription factor p53 
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is unfolded by cadmium exposure, protective cellular mechanisms could be disturbed, resulting in 
accumulation of sodium selenite-induced DNA damage. In the p53-proficient HCT116 cells, 
accumulation of selenium was correlated to the onset of cytotoxicity following exposure to sodium 
selenite. Cell cycle arrest was first induced at comparably high concentrations. Using p53-deficient 
cells or through inhibition of p53 by cadmium made the cells much less sensitive to sodium selenite-
induced apoptosis. The role of p53 as a critical downstream mediator of ROS signaling by sodium 
selenite treatment was supported by the significant attenuation of overall death in the p53-deficient 
cells. Following exposure to the selenocompounds, the obtained gene expression profiles exhibited 
distinct patterns, reflecting their distinct impact on cellular processes. Sodium selenite affected 
expression of genes in manifold pathways in HCT116 cells, mainly mediated via p53. Sodium selenite 
increased oxidative stress response by induction of Nrf2 target genes and by induction of 
metallothioneins (MTs). Induction of genes involved in cell cycle arrest, increased DNA repair and 
induction of apoptosis strongly indicated a p53-mediated response to DNA damage. Cadmium 
attenuated on the other hand the sodium selenite-induced and p53-mediated up-regulation of the 
genes involved in cell cycle arrest, DNA repair and apoptosis. However, the oxidative stress 
response was also highly activated by cadmium alone by induction of MTs and Nrf2 target genes. On 
the contrary, selenomethionine had much less impact on gene expression regulation than sodium 
selenite, demonstrating species-specific effects. Independently of p53, selenomethionine provoked 
cell cycle arrest by decreasing levels of proliferative genes and repressed DNA repair factors. 
Previous observations linked p53 to the cellular uptake of sodium selenite in HCT116 cells, 
but not the uptake of selenomethionine. Increased uptake of sodium selenite in a p53-dependent 
manner was confirmed in this present study. The two types of HCT116 cells exhibited different basal 
extracellular thiol contents, which could influence the thiol-assisted reduction of sodium selenite in 
the extracellular space, and thus the bioavailability of sodium selenite. The reduced cytotoxic effects 
of sodium selenite observed following co-exposure to cadmium was hypothesized to be explained by 
a potential inhibition of the cellular uptake of sodium selenite, which could not be confirmed in this 
work. Unexpectedly, cadmium chloride improved dramatically the uptake of sodium selenite, but not 
selenomethionine, independent on the cellular p53 status.  
To sum up, the inhibiting effect of cadmium on sodium selenite-induced apoptosis has not 
been described previously in literature, to the best of our knowledge. The data obtained with 
HCT116 colon cancer cells may help to explain sodium selenite and cadmium interaction when 
present in the human gastrointestinal tract.  
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2 Zusammenfassung 
Das essentielle Spurenelement Selen ist Bestandteil verschiedener Selenoproteine, die eine wichtige 
Rolle beim zellulären Schutz vor oxidativem Stress spielen. Hinsichtlich der anti-kanzerogenen 
Wirkung von Selen werden anti-oxidative sowie pro-oxidative Eigenschaften diskutiert. Trotzdem ist 
eine gesteigerte Zufuhr von Selen, insbesondere durch selenhaltige Nahrungsergänzungsmittel, 
kritisch anzusehen, da es so möglicherweise zu einer Überversorgung kommt.  
Anorganische, reduzierbare Selenverbindungen z.B. Natriumselenit besitzen pro-oxidative 
Eigenschaften. Dadurch ist es ihnen möglich, Thiolgruppen in zinkbindenden Proteinen wie z.B. 
Transkriptionsfaktoren oder DNA-Reparaturproteinen, anzugreifen, was möglicherweise die 
genomische Stabilität der Zelle gefährdet. Das Tumorsuppressorprotein p53 übernimmt wichtige 
Funktionen innerhalb der Zelle, unter anderem die Regulation der Transkription von Zellzyklus-
Genen, der DNA-Reparatur und der Apoptose. Unser Arbeitskreis konnte bereits in einer früheren 
Arbeit zeigen, dass  p53 die durch Natriumselenit induzierte zelluläre Antwort vermittelt. Im 
Gegensatz dazu war die zelluläre Antwort auf die Behandlung mit vollständig reduziertem 
Selenomethionin vom p53-Status unabhängig. Die zu Grunde liegende karzinogene Wirkung von 
Cadmium beruht auf komplexen Mechanismen und ist bisher noch nicht vollständig 
aufgeklärt. Bereits bekannt ist, dass Cadmiumverbindungen an p53 strukturelle und somit funktionelle 
Änderung auslösen. Hier stellt sich die Frage, inwieweit die o.g. Selenverbindungen innerhalb der 
Zelle mit Cadmium in Wechselwirkung treten können. Diese Arbeit untersucht, ob und inwieweit 
die durch p53 vermittelte Antwort der Zelle auf die Behandlung mit Natriumselenit bzw. 
Selenomethionin durch Cadmium inhibiert wird. Als Modell dienten Zellen mit unterschiedlichem 
Tumorsuppressorprotein p53-Status aus der humanen Kolonkarzinomzelllinie HCT116. 
Im Gegensatz zu Selenomethionin wirkte Natriumselenit innerhalb eines engen 
Konzentrationsbereiches stark zytotoxisch auf p53-profizienten HCT116-Zellen, nicht jedoch auf die 
p53-defizienten Zellen. Aufgrund einer gesteigerten Superoxidproduktion und einer Abnahme von 
GSH induzierte die anorganische Selenverbindung oxidativen Stress in den p53-profizienten Zellen. 
Hierdurch kam es in Abhängigkeit von p53 zu einer Aktivierung pro-apoptotischer Signalwege. Da 
p53 bekanntlich selbst wird u.a. durch reaktive Sauerstoffspezie (ROS) aktiviert wird, vermuten wir, 
dass die funktionelle Aktivität von p53 eine Rolle beim Ausmaß der Natriumselenit-induzierten ROS-
Generierung spielt, indem pro-oxidative Gene von p53 aktiviert werden.  
Bei Co-Inkubation der p53-profizienten Zellen mit Cadmium kam es zu einer Hemmung des 
durch Natriumselenit induzierten Zelltods. Zudem wurden in Anwesenheit von Cadmium in den 
p53-profizienten Zellen die durch Natriumselenit ausgelöste GSH-Depletion, die vermehrte 
Superoxidproduktion sowie die pro-apoptotische Signalwirkung von p53 stark abgeschwächt. Unsere 
Untersuchungen weisen darauf hin, dass Cadmium zur Inaktivierung von p53 führt. Es wird vermutet, 
dass das p53 von Cadmium entfaltet wird und so wichtige protektive Mechanismen innerhalb der 
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Zelle gestört werden. Eine mögliche Folge ist eine Akkumulation von Natriumselenit-induzierten 
DNA-Schäden.  
Bei p53-profizienten HCT116-Zellen korrelierte die Aufnahme von Selen mit dem Beginn der 
Zytotoxizität nach Exposition mit Natriumselenit. Ein Zellzyklusarrest wurde erst bei Behandlung der 
Zellen mit hohen Konzentrationen an Natriumselenit induziert. Bei Verwendung von p53-defizienten 
HCT116-Zellen oder durch die Hemmung von p53 durch Cadmium nahm die Empfindlichkeit der 
Zellen gegenüber Natriumselenit ab, was sich in einer geringeren Apoptoserate äußerte. Das 
Tumorsuppressorprotein p53 gilt als sogenannter „Downstream“-Mediator der ROS-Signalwirkung. 
Dies wurde durch die signifikante Abnahme toter Zellen der p53-defizienten Zelllinie nach 
Behandlung mit Natriumselenit bestätigt. Nach Exposition der Zellen mit den verschiedenen 
Selenverbindungen zeigten sich deutliche Muster in den Genexpressionsprofilen, was die 
unterschiedliche Beeinflussung zellulärer Prozesse widerspiegelt. Der Einfluss von Natriumselenit auf 
die Expression von Genen verschiedener Signalwege in HCT116-Zellen ist vom p53-Status der 
jeweiligen Zelle abhängig. Durch Aktivierung von Nrf2 und Metallothioneinen (MT) verstärkte 
Natriumselenit die oxidative Stressantwort. Zellzyklus-Arrest, verstärkte DNA-Reparatur und 
Apoptose-Induktion wiesen stark auf eine p53-vermittelte Zellantwort auf DNA-Schäden hin. 
Cadmium wiederum hemmte die durch Natriumselenit induzierte und durch p53-vermittelte 
Hochregulierung derjenigen Gene, die an Zellzyklus, DNA-Reparatur und Apoptose beteiligt sind. 
Jedoch aktivierte Cadmium selbst bereits die oxidative Stressantwort deutlich, u.a. auch über die 
Induktion von MT- und Nrf2-Zielgenen. Der Einfluss von Selenomethionin auf die Genexpression war 
im Vergleich zu Natriumselenit allerdings deutlich schwächer. Festgestellt wurde jedoch, dass 
Selenomethionin durch die Herunterregulierung von proliferativen Genen sowie durch die 
Unterdrückung von DNA-Reparaturgenen und unabhängig vom p53-Status einen Zellzyklusarrest 
bewirkte.  
Vorherige Untersuchungen an HCT116-Zellen weisen auf einen Zusammenhang zwischen 
p53 und der zellulären Aufnahme von Natriumselenit, nicht jedoch von Selenomethionin, hin. Diese 
Arbeit bestätigt eine gesteigerte, p53-abhängige Aufnahme von Natriumselenit in die Zelle. Zudem 
wurde gezeigt, dass die p53-profizienten Zellen im Vergleich zu den p53-defizienten Zellen einen 
höheren basalen extrazellulären Thiolgehalt aufwiesen. Die extrazelluläre thiolassistierte Reduktion 
von Natriumselenit wird somit als weiterer Grund für dessen gesteigerte Bioverfügbarkeit diskutiert. 
Die Hypothese, dass die geringere zytotoxische Wirkung von Natriumselenit bei Co-Inkubation mit 
Cadmium auf einer verminderten Aufnahme von Natriumselenit in die Zellen beruht, bestätigte sich 
allerdings nicht. Hingegen wurde unerwarteterweise festgestellt, dass Cadmium die Bioverfügbarkeit 
von Natriumselenit in beiden Zelllinien verbesserte. Die Bioverfügbarkeit von Selenomethionin 
wurde hingegen durch Cadmium nicht beeinflusst. Nach unserem besten Wissen wurde die 
inhibierende Wirkung von Cadmium auf die Natriumselenit-induzierte Apoptose in der Literatur 
bisher nicht beschrieben. Die erhaltenen Daten aus dem verwendeten Zellmodell der HCT116-
Kolonkarzinomzellen können möglicherweise zu einem besseren Verständnis der Wechselwirkungen 
zwischen Natriumselenit und Cadmium im Magen-Darm-Trakt des Menschen beitragen. 
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3 Introduction 
3.1 Selenium 
3.1.1  Occurrence, sources and exposure to selenium 
Selenium was discovered in 1817 by the Swedish chemist Jöns Jakob Berzelius. As a metalloid with 
the atomic number 34, it belongs to the group 16 of the oxygen family, the chalcogens. 
Consequently, selenium shares some of the physico-chemical properties of oxygen and sulfur (Jacob 
et al. 2003). It was originally recognized as a toxic element due to its toxicity in occupationally 
exposed people, while its essentiality in higher organisms was discovered only in 1957 through its 
role in selenoproteins. The industrial uses of selenium include, for instance, electrical components, 
photocopier manufacture, glass manufacture, metal alloys, as well as anti-dandruff shampoo (Johnson 
et al. 2010). While the range between deficient, essential and toxic doses of selenium is very narrow, 
it is indeed required in trace levels in the diet, providing crucial importance to human health (Rana 
2008; Rayman 2000; Rayman 2012).   
The content and species of this essential trace element in plant foods as well as animal foods depend 
on environmental factors, especially the quantity and species of selenium to which the animal or plant 
is exposed (Fairweather-Tait et al. 2010). Globally, selenium concentrations in soils range from 
0.4 mg/kg up to 1200 mg/kg, whereby higher concentrations derive from seleniferous materials, such 
as sand stones and lime stones. Such seleniferous soils are widespread in parts of the United States, 
Canada, South America, China and Russia, while European soils as well as some parts of China are 
generally of low selenium concentration. Significant inputs of selenium to soils occur also from 
natural (e.g. volcanoes) and anthropogenic (e.g. agricultural fertilizers) sources (Fairweather-Tait et al. 
2011; Johnson et al. 2010). Therefore, given the wide range of selenium content in soils, the intake of 
selenium varies hugely worldwide, ranging from deficient to toxic concentrations. Dietary intakes 
range from 7 µg per day to 4990 µg per day with the mean values of 40 µg per day in Europe and 93-
134 µg per day in the USA (Rayman 2012). Selenium-containing supplements add to these intakes, 
especially in the USA where an estimated 50 % of the population take dietary supplements (Rayman 
2012). The main food groups providing selenium are bread and cereals, meat, fish, eggs and dairy 
products. The amount of selenium in plant foods is generally low, except from Brazil nuts and certain 
vegetables which are considered to be selenium-accumulating plants, including onions, garlic, leeks, 
shallots, and chives (Allium family), and broccoli, cabbage, Brussel sprouts and cauliflower (Brassica 
family) (Fairweather-Tait et al. 2010).  
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There is an ongoing discussion whether people are sufficiently supplied with selenium or whether 
supplementation is recommended (Rayman 2012; Schrauzer 2001). Selenomethionine is the 
predominant species of selenium in most natural and non-enriched food. However, the only 
permitted selenium species added to foods for special nutritional use, such as baby formula milk and 
total parenteral nutrition products, are inorganic forms such as selenate and selenite. Worldwide, 
there are many different supplements with varying doses and forms of selenium, and selenium is 
often included in multivitamin-mineral supplements. The selenium amount in supplements analyzed in 
the U.S. shows that they provide between 10 and 200 µg per day (Schrauzer 2001). The German 
Federal Institute for risk assessment (in German, Bundesinstitut für Risikobewertung, (BfR)) 
recommends that selenium intake from dietary supplements should not exceed more than 30 µg 
daily. The BfR also concludes that previous studies have not shown that organic selenium compounds 
for use in dietary supplements are advantageous over selenite-containing supplements. A Cochrane 
review on antioxidant supplements concluded that consuming additional selenium from non-food 
sources provides no clear benefits (Bjelakovic et al. 2008). European populations are generally of low 
selenium status compared to the US population due to low concentrations in crops grown in Europe 
relative to North America, resulting in a more than tenfold difference in selenium concentrations 
between UK and US wheat (Johnson et al. 2010). Finland has since 1985 supplemented their soil 
nationwide with multi-nutrient fertilizers including selenium in the form of sodium selenate due to 
extremely low selenium intake in the 1970’s. Monitoring the nationwide fertilization during 27 years 
has been shown to be effective and safe in improving animal health, increasing selenium levels in milk, 
eggs and the whole food chain, and thus increasing the selenium intake of the whole population. As a 
consequence, the average individual selenium intake in Finland has increased from about 30 µg per 
day to 100 µg per day (Alfthan et al. 2014). In a study from New Zealand, daily consumption of Brazil 
nuts has shown to effectively increase selenium status to the level of 100 µg selenium as 
selenomethionine. The inclusion of this high-selenium food in the diet could avoid the need for 
fortification or supplements to improve the selenium status (Thomson et al. 2008). However, since 
the selenium content of the nuts is highly dependent on the amount of selenium present in the soil, 
daily consumption of Brazil nuts should be limited to avoid toxicity (Dumont et al. 2006).  
3.1.2 Absorption, metabolism and properties of selenium  
Selenium absorption pathways are not yet completely characterized. Inorganic forms, e.g. selenate 
and selenite, seem to be well-absorbed, but not as well-retained in the body as organic forms, 
e.g. selenocysteine and selenomethionine (Fairweather-Tait et al. 2010). Most forms of selenium are 
absorbed efficiently, but the identification of responsible transport proteins for uptake of dietary 
selenium remains uncertain (Fairweather-Tait et al. 2011). Organic selenoamino acids appear to be 
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effectively transported by various intestinal amino acid transporters (Nickel et al. 2009), while 
multifunctional anion exchangers of the SLC26 family have been proposed as candidates for uptake of 
selenate (Fairweather-Tait et al. 2011). The selenite transporter remains to be identified. However, 
studies utilizing anion channel blockers to investigate the mechanism of selenite uptake have 
suggested that selenite uptake is an active process mediated by an anion transporter (Ganyc and Self 
2008) or partly mediated by phosphate transporters in plants (Li et al. 2008). Figure 3.1 shows the 
chemical structures of the two investigated selenocompounds, sodium selenite and 
selenomethionine.  
Figure 3.1: Chemical structures of sodium selenite and selenomethionine.  
Absorbed dietary selenium is released from enterocytes into the portal circulation and is used for 
biosynthesis of intestinal selenoproteins. The further selenium metabolism depends highly on the 
form in which they are present in plasma. Figure 3.2 provides an overview of the metabolism of 
selenomethionine and sodium selenite. Hydrogen selenide (H2Se) is the central metabolite of both 
organic and inorganic forms. Selenomethionine, selenocysteine, selenate and selenite enter the 
selenide pool by different pathways, and from this point used for synthesis of selenoproteins or 
excreted in the urine as selenosugars. Selenomethionine is converted via transsulfuration to 
selenocysteine or directly through the γ-lyase reaction into methylselenol (CH3SeH). This is followed 
by a demethylation reaction and the resulting metabolite is directed into the selenide pool by 
selenocysteine lyase. In comparison to selenomethionine, selenite is first reduced to 
selenodiglutathione (GSSeSG) and then metabolized to hydrogen selenide by glutathione reductase 
or thioredoxin reductase under the consumption of NADPH. H2Se can react with O2 to form 
elementary selenium and superoxide (O2•−), which has been proposed to be responsible for the 
induction of apoptosis by multiple selenocompounds (Brigelius-Flohe 2008). Hydrogen selenide is 
also phosphorylated to selenophosphate, a substrate for selenoprotein biosynthesis. Through this 
reductive pathway, selenocysteine, as the 21st amino acid, can finally be incorporated within the 
active sites of selenoproteins in response to a UGA codon in the respective mRNA (Brigelius-Flohe 
2008; Brozmanova et al. 2010). 
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Figure 3.2: Metabolism of selenomethionine and sodium selenite. GSH: glutathione, GSSG: glutathione 
disulfide, GSSeSG: selenodiglutathione, CH3SeH: methylselenol, H2Se: hydrogen selenide, O2•−: superoxide. 
Modified from (Brigelius-Flohe 2008; Fairweather-Tait et al. 2010; Letavayova et al. 2006). 
Selenium plays a unique role among the essential trace elements since it is genetically encoded for 
incorporation into proteins, as the constitutive part of the 21st amino acid, selenocysteine. There are 
25 known selenoprotein genes, and all identified selenoproteins have their selenocysteine residue in 
the functional catalytic site (Lu and Holmgren 2009). Two main groups of selenoproteins exist 
according to the location of the selenocysteine within the protein. The first group contains 
selenocysteine close to the C-terminal region, e.g. thioredoxin reductase (TrxRs), while 
selenocysteine is found close to the N terminal region in the second group, e.g. glutathione 
peroxidases (GPxs) (Lu and Holmgren 2009). Because the selenol is fully ionized at normal 
physiological pH, it is more reactive than thiol groups (Behne and Kyriakopoulos 2001). Although 
several selenoenzyme families, including GPxs, TrxRs and deiodinases (DIOs), are well-described 
(Jacob et al. 2003), the exact function of many selenoproteins is still unknown (Arner 2010; 
Brozmanova et al. 2010).  
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From a biochemical point of view, selenium substitutes for sulfur in defined cysteines present in 
selenoproteins. Selenium differs from sulfur by its redox potentials and stabilities of oxidation states, 
providing multiple catalytic potentials. Thus, it can function both as a reductant and as an oxidant. A 
remarkable feature of selenium consists of its ability to oxidize thiols under reducing conditions that 
are present in the cytosol (Jacob et al. 2003; Zeng and Combs, Jr. 2008). Unlike the organic forms 
selenomethionine and selenocysteine, in which selenium is present in the reduced state (selenide: Se 
2-), the inorganic salts frequently provided as dietary supplements contain selenium in oxidized forms 
(selenite: Se 4+; selenate: Se 6+) (Finley 2006). Cellular effects induced by different species deserve 
special attention. As part of GPxs, selenium is considered as an antioxidant, but it may also exert 
pro-oxidative properties, depending at least in part on the selenium species under investigation. 
A moderate genotoxic activity of selenium compounds has been found in several in vitro systems 
(Kramer and Ames 1988), the extent varying between different selenium species investigated in our 
laboratory (Hall 2008; Klaus 2009). However, not only damage induction but also the cellular 
response to damage, for example the involvement of p53, depends on the chemical form of selenium. 
Zhao and co-workers showed that selenite induced apoptosis by producing superoxide, which 
activated p53. In turn, activation of p53 then synergistically enhanced superoxide production and 
apoptosis induced by selenite (Zhao et al. 2006).   
3.1.3 Selenium in human health 
Despite its very low level in humans, the micronutrient selenium is unique among the metal trace 
elements due to its genetically encoded incorporation via selenocysteine into selenoenzymes and 
position at their active catalytic center. Selenium status and the redox-protective effects of 
selenoproteins have potential consequences for health. While most selenoproteins participate in 
general antioxidant defense and redox state regulation, namely GPxs respectively TrxRs, other 
selenoproteins play more specific essential roles. For example, the DIOs are crucially involved in 
thyroid hormone metabolism, and GPx4 is essential for spermatogenesis and selenophosphate 
synthetase 2 (SPS2) participates in selenoenzyme biosynthesis (Roman et al. 2014). The immune 
response is affected by selenium as well, but the underlying mechanisms are poorly understood 
(Hoffmann and Berry 2008). A decrease in ROS from oxidative stress and the modulation of 
inflammatory signaling pathways via the antioxidants and redox functions of selenoproteins have been 
postulated (Fairweather-Tait et al. 2011). Selenium exhibits anti-inflammatory properties by inhibiting 
the NF-κB cascade that induces the production of pro-inflammatory interleukins and tumor necrosis 
factor-α (TNF-α) (Duntas 2009).  
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The range of intake between selenium deficiency and toxicity is very narrow (Fairweather-Tait et al. 
2011). An intake of about 20 µg per day for adults is generally accepted as the minimum needed to 
prevent onset of Keshan disease. At low dietary intake, selenium satisfies the dietary need for 
selenoprotein biosynthesis, which is recommended to be 30-40 µg per day by the World Health 
Organization (WHO) or 55 µg of selenium per day for healthy adults recommended by the US 
Institute of Medicine (Dennert et al. 2011). In order to prevent selenosis, the US Institute of 
Medicine has set an upper limit of 350-400 µg per day (Dennert et al. 2011). However, some studies 
have observed selenium intake levels of 750-850 µg per day with no signs of selenium toxicity 
(Ramoutar and Brumaghim 2010).  
Selenium deficiency can results in diseases such as hypothyroidism, weakened immune defense and 
cardiovascular diseases (Ramoutar and Brumaghim 2010). Keshan disease is an endemic 
cardiomyopathy observed in selenium-deficient areas of China, where the main clinical features are 
acute or chronic episodes of a heart disorder characterized by cardiogenic shock or congestive heart 
failure. A preventive effect of selenium supplementation against Keshan disease was identified in the 
1970’s in inhabitants with low selenium status (Fairweather-Tait et al. 2011). A disease also present in 
selenium-deficient areas is the Kashin-Beck disease, an endemic, chronic degenerative 
osteoarthropathy. The etiology of the disease is not known, but the risk factors appear to involve 
mycotoxins and organic substances in portable water, Coxsackie B3 virus infection and deficiency in 
certain trace elements, mainly iodine and selenium. Selenium supplementation seems to be effective 
at preventing an exacerbation of the disease and in promoting healing (Fairweather-Tait et al. 2011).  
Selenium toxicity is much less common than deficiency, but may occur as a result of over-
supplementation or through high levels in food. Acute toxic symptoms are associated with extremely 
high intakes of selenium (3200-7600 µg per day) (Roman et al. 2014). There are reports on 
miscalculated dietary supplements entering the market posing a health risk to users (MacFarquhar et 
al. 2010). However, only limited data regarding selenium toxicity for humans are available, which 
make the establishment of sound upper limit recommendations for selenium intake difficult. Clinical 
signs of chronic selenosis include garlic odor of the breath and skin, teeth deformation, skin lesions, 
brittle hair, thickened and stratified nails and loss of hair and nails in the case of dietary intake of 
5 mg per day (Fairweather-Tait et al. 2011; Ramoutar and Brumaghim 2010).  
Cancer  
During the last decades, there has been an ongoing discussion on potential cancer preventive effects 
of higher than dietary levels of selenium and beneficial roles of dietary selenium supplementation. The 
landmark cancer study, Nutritional Prevention of Cancer (NPC) Trial, a randomized, double-blind, 
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placebo-controlled study, introduced the rationale for the use of selenium as a chemopreventive 
agent (Clark et al. 1996). Secondary results from this skin cancer prevention trial showed a significant 
reduction in the overall incidence of prostate cancer by selenium supplementation. Nevertheless, 
even though some studies point towards a reduction of, for instance, prostate tumors by selenium, 
the pre-terminated Selenium and Vitamin E Cancer Prevention Trial (SELECT) did not support this 
assumption (Lippman et al. 2009). The SELECT-study was the largest cancer prevention trial ever 
performed, randomizing more than 35 000 healthy, middle-aged men into four groups, where 
supplementation with selenium and vitamin E were tested separately or in combination. The primary 
endpoint was biopsy-confirmed prostate cancer, and the planned duration of the trial was 12 years. 
However, the trial was terminated after 7 years due to no observed effect on prostate cancer risk in 
neither of the groups. Instead, a small, non-significant increase in diabetes type 2 was indicated 
(Lippman et al. 2009). However, based on secondary findings to the SELECT follow-up, it would be 
more correct to report no effect in type 2 Diabetes risk (Klein et al. 2011). In addition, diabetes was 
also a secondary outcome on follow-up of the parent NPC trial (Stranges et al. 2007). Both studies 
had obvious flaws, and have met several counterarguments (Muecke et al. 2010; Rayman and Stranges 
2013; Steinbrenner et al. 2013). The SELECT study results may be attributed to the relative high 
selenium status within the study population and to the use of selenomethionine, which may not be 
the most effective anti-carcinogenic form of selenium since selenomethionine is incorporated non-
specifically into non-selenoenzymes due to its similarity to methionine. Therefore, choosing sodium 
selenite as a supplement might represent a better alternative because the effects of the 
supplementation can be verified by increased serum selenium or circulating selenoprotein 
concentrations (Fairweather-Tait et al. 2011; Muecke et al. 2010). 
The mechanisms behind potential anti-cancerogenic effects of selenium are still unclear (Zhao et al. 
2006). Postulated underlying mechanisms for effects of selenium on cancer may include regulation of 
cell cycle and apoptosis, antioxidant activity of selenoproteins resulting in the protection of DNA, 
proteins and membrane lipids, as well as immune system modulation (Fairweather-Tait et al. 2011). 
However, pro-oxidative properties of selenium, and not anti-oxidative, may best account for 
observed anti-cancer effects (Drake 2006). One possible mechanism might be zinc release from 
metallothionein via oxidation of thiol groups (Chen and Maret 2001). Nevertheless, other zinc-
binding proteins could be also potential molecular targets, e.g. transcription factors, DNA repair 
proteins or tumor suppressors, which could possibly disturb the maintenance of genomic stability 
(Blessing et al. 2004). Increasing attention has been drawn towards polymorphisms within 
selenoprotein genes and their association with enhanced cancer risk (Zhuo and Diamond 2009). The 
effectiveness of dietary selenium supplementation depends on many factors, such as baseline 
selenium status, age, gender, genetic background of an individual, type of cancer, and time point of 
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intervention, in addition to metabolic conversion and dose of the applied selenocompound. The 
outcomes of human studies on cancer prevention by selenium have been, however, so far 
inconsistent and disappointing (Steinbrenner et al. 2013). Experimental human studies indicate overall 
that selenium does not reduce cancer risk. No convincing evidence has so far been provided that 
individuals with so-called low selenium intake, that is, in the order of 20-70 µg per day, may reduce 
cancer risk by increasing their selenium exposure (Vinceti et al. 2013). Vinceti and co-workers (2014) 
updated a Cochrane review on selenium in cancer prevention from 2011, which included 63 studies 
with more than one million participants. They reported that individuals with higher selenium levels or 
intake had a lower incidence of certain cancer types (e.g. prostate cancer), but no effect on other 
cancers (e.g. breast cancer) was observed. It was, however, not possible to determine whether 
selenium levels or intake were really the reason for the lower risk of cancer from these studies. A 
healthier lifestyle as well as healthier nutritional intake and overall better living conditions are 
important factors influencing cancer risk. Taken together, in addition to the fact that the two 
randomized controlled trials, NPC and SELECT, failed to provide evidence on cancer prevention by 
selenium supplementation in men, the authors recommended further evaluation of the effects of 
selenium supplements in populations according to their nutritional status as the effects may differ 
between low-supplied and well-supplied individuals. Currently, there is no convincing evidence that 
regular intake of selenium supplements is beneficial in individuals with regard to their cancer risk 
(Vinceti et al. 2014). 
Type 2 Diabetes Mellitus  
Epidemiological data suggests potential pro-diabetic effects of high selenium intake in humans.  In 
well-nourished populations, high selenium exposure may be associated with type 2 diabetes or insulin 
resistance (Rayman and Stranges 2013). Results from in vitro and in vivo studies suggest that inorganic 
selenium can enhance insulin sensitivity by mediating insulin-like actions, but little information is 
known about insulin-like actions for selenocompounds such as selenomethionine (Stranges et al. 
2010). Selenoproteins and selenocompounds may interfere at different stages with insulin-induced 
signal transduction, eventually leading to a dysregulated carbohydrate metabolism (Steinbrenner et al. 
2011; Steinbrenner 2013). Selenium status and GPx1 expression have been reported to affect the 
activity of insulin-antagonistic phosphatases that are regulated by hydrogen peroxide-mediated 
reversible oxidation of catalytic cysteine residues. GPx1 and selenoprotein P (Sepp1) inhibited 
phosphorylation (activation) of key mediators in energy metabolism, such as protein kinase B (Akt) 
and AMP activated protein kinase (AMPK) in liver and skeletal muscle (Steinbrenner 2013). The 
regulation of Sepp1 as a gluconeogenic enzyme provides a likely explanation for reported cross-
sectional associations of high plasma selenium/Sepp1 levels in hyperglycemia and type 2 Diabetes 
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(Steinbrenner 2013). However, increased plasma selenium levels might be both a consequence and a 
cause of diabetes. A dysregulated carbohydrate metabolism in diabetes might affect plasma selenium 
and Sepp1 levels, as the hepatic biosynthesis of Sepp1 is suppressed by insulin and stimulated under 
hyperglycemic conditions (Steinbrenner 2013). 
More information is needed to identify the optimal range of selenium intake and status in order to 
minimize adverse effects in glucose metabolism while optimizing type 2 Diabetes prevention 
(Stranges et al. 2010). A post-hoc analysis of the NPC trial showed a significantly increased risk of 
type 2 Diabetes in those supplemented with selenium (200 µg per day as selenium yeast) and 
followed for a mean of 7.7 years (Stranges et al. 2007). In the SELECT study, selenium 
supplementation had no effect on risk of type 2 Diabetes after a median follow-up of 5.5 years (Klein 
et al. 2011). Importantly, the data from the SELECT study were not adjusted to the general increase 
of diabetes in the US (Muecke et al. 2010) seen in the context that Diabetes mellitus affected over 
170 million people worldwide in 2000, and is estimated to reach 366 million people in 2030, with 
more than 90 % of patients suffering from type 2 Diabetes (Wild et al. 2004). Due to the 
experimental design of the SELECT trial, the study is neither adequate to prove the ineffectiveness of 
selenium in prevention of prostate cancer nor to estimate the risk of selenium triggering the onset of 
diabetes (Muecke et al. 2010). While a link between certain selenoproteins and glucose metabolism 
or insulin resistance is clear, the relationship between selenium and type 2 Diabetes is undoubtedly 
complex. It is possible that the relationship is U-shaped, with harm occurring both below and above 
the physiological range for optimal activity of some or all selenoproteins (Rayman and Stranges 
2013). 
3.2 Cadmium 
3.2.1 Occurrence, sources and exposure to cadmium  
In 1817 cadmium was discovered concurrently by the German researchers Friedrich Strohmeyer and 
Karl Samuel Hermann as an impurity of zinc carbonate. This chemical element with the atomic 
number 48 belongs to the transition metals in group 12 of the Periodic table, chemically similar to 
zinc and mercury. Cadmium and its compounds occur predominantly in oxidation state 2+, like zinc. 
It appears as a white silvery bright metal, naturally and frequently bound to zinc in zinc ores, as well 
as to lead and phosphate. Industrially, cadmium is primarily used in the production of nickel-cadmium 
batteries, alloys, in pigments such as inorganic coloring agents as well as in stabilizers for synthetic 
materials (Pinot et al. 2000). Furthermore, cadmium is present in phosphate minerals and sludge used 
as agricultural fertilizers. The agricultural as well as the industrial utilization of cadmium are supposed 
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to be the main causes of the dispersal of cadmium in the environment and in food (Satarug et al. 
2003). 
Cadmium is a heavy metal with no known biological function in humans (Pinot et al. 2000). Present in 
food and tobacco smoke it is a widespread environmental pollutant. The major sources of human 
exposure to cadmium are tobacco smoke and diet, as well as occupational exposure. Cadmium is 
taken up in the body by inhalation and ingestion, and exhibits a very long biological half-life (10-
30 years) (CONTAM 2009; Waalkes 2003). The International Agency for Research on Cancer 
(IARC) classified cadmium in group 1 as a human carcinogen based on data from human occupational 
exposure delivering sufficient evidence for lung cancer and limited evidence for kidney, liver and 
prostate cancer (IARC 1993; WHO 2011). 
Plants are known to accumulate cadmium from the soil due to a ready uptake of cadmium by the 
root system in plants. High consumption of cereals and vegetables is recommended due to a variety 
of health reasons. However, these foods are the main contributors of dietary cadmium intake and 
found to be most significant sources of cadmium for the non-smoking population (Satarug et al. 
2003). Meat is also a dietary source of cadmium, but to a lower degree. Organ meats such as kidneys 
and liver could contain higher levels of cadmium due to its accumulation in these organs. Fish is 
thought to contain lower levels of cadmium, while shellfish and mollusks may accumulate larger 
amounts. It seems likely that vegetarians or individuals high consumption of seafood may have more 
cadmium accumulation than the general population (Nawrot et al. 2010; Satarug et al. 2003). Tobacco 
plants are known to accumulate cadmium in their leaves (Scherer and Barkemeyer 1983), which 
makes tobacco smoke a major exposure source to cadmium. Each cigarette is estimated to contain 
1 to 2 µg cadmium, and smoking one cigarette results in a net inhalation of 0.1 to 0.2 µg cadmium 
(Pinot et al. 2000). During the burning process, cadmium oxide is formed and readily absorbed. Up to 
50 % of the inhaled cadmium enters the systemic circulation of smokers (Satarug et al. 2003).  
Gastrointestinal absorption of cadmium varies greatly between individuals, genders and foods 
(Satarug et al. 2003), however, gastrointestinal cadmium absorption is generally lower than its 
respiratory absorption (Nawrot et al. 2010). The amount of absorbed cadmium in the gastrointestinal 
tract is proportional to the concentration of cadmium in the food product (Nawrot et al. 2010). The 
absorption fractions are estimated to be between 5 % and 8 % (Flanagan et al. 1978). The uptake of 
cadmium is increased if the nutritional status of calcium, iron or zinc is low (Nawrot et al. 2010). Iron 
deficiency is considered to be one of the main nutritional deficiency disorders affecting large fractions 
of the European population (Nawrot et al. 2010). Iron status can significantly influence the uptake of 
cadmium (Flanagan et al. 1978; Vahter et al. 1996). High absorption rates of cadmium occurred during 
iron deficiency and iron overload due to up-regulation of the duodenal iron transporter divalent 
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metal transporter 1 (DMT1). Despite equal or even lower exposure levels, women absorb and 
accumulate cadmium to a higher extent than men (Akesson et al. 2002). Due to a higher prevalence 
of iron depletion in women than in men, low iron status is probably the main reason why cadmium is 
more accumulated in women (Vahter et al. 1996).  
In 2009, the EFSA Panel on Contaminants in the Food Chain (CONTAM) established a tolerable 
weekly intake (TWI) for cadmium of 2.5 µg per kg body weight (CONTAM 2009). The mean 
exposure for European adults is close to the TWI, while subgroups such as vegetarians, children, 
smokers and people living in highly contaminated areas may exceed the TWI by about twofold. 
Although the risk for adverse effects in kidney function at an individual level is very low, the 
CONTAM Panel concluded that the current cadmium exposure at the population level should be 
reduced. The TWI from 2009 was reaffirmed in 2011 in order to ensure a high level of protection to 
consumers (CONTAM 2011). Moreover, in 2010 the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) concluded that daily ingestion of cadmium in food has a small or negligible effect 
on overall exposure, in spite of the long half-life of cadmium. Health risks due to cadmium exposure 
should be assessed over months. The Committee established therefore a monthly value of tolerable 
intake as provisional tolerable monthly intake (PTMI), which was set to 25 µg per kg body weight. 
The estimates of cadmium exposure through the diet in all age groups, including consumers with high 
exposure and with special dietary habits (e.g. vegetarians) were below the PTMI (FAO/WHO 2010). 
However, taking non-dietary exposure into account, it is anticipated that the total exposure of some 
subgroups of the population could exceed the JECFA PTMI as well as the CONTAM TWI 
(CONTAM 2011). 
There are some prevention strategies to reduce exposure to a toxic metal like cadmium in order to 
reduce adverse health effects. Reduction of cadmium pollution must be enforced by further proper 
legislation. To reduce the transfer of cadmium from soil to plants, the soil cadmium bioavailability 
should be reduced by maintaining agricultural and garden soil close to neutral. Smoking cessation is 
effective in reducing the self-induced cadmium exposure, while a balanced iron intake is effective in 
reducing the bioavailability of cadmium present in the intestine by reducing its absorption (Nawrot et 
al. 2010). 
3.2.2 Cadmium in human health  
As a chemical element, cadmium cannot be degraded. Approximately 50 % of the body burden of 
cadmium can be found in the kidneys, whereas 15 % and 20 % are in the liver and the muscles, 
respectively (Nawrot et al. 2010). Cadmium can cross cell membranes via different mechanisms 
e.g. metal transporters, and once inside the cell, it binds to ligands with exceptional affinity 
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e.g. metallothioneins (MTs) (CONTAM 2009). Cadmium is not easily cleared by the cells, and the 
poor efficiency of cellular export systems explains the long storage time of cadmium in storage 
tissues such as the kidneys, the liver and the intestine. Because cadmium exposure induces the 
synthesis of MTs in several tissues, it is suggested that MT binding decreases cadmium toxicity. The 
ability of the liver to synthesize MT appears to be sufficient to bind all the accumulated cadmium 
(CONTAM 2009). Cadmium binds to albumin in the blood, and is to a large extent taken up by the 
liver, where it induces the synthesis of MTs. Cadmium is excreted in bile mainly bound to glutathione 
or released into the plasma bound to MT. The cadmium-MT complex is filtered through the renal 
glomeruli and then reabsorbed by proximal tubular cells until the critical concentration is reached. 
The critical concentration of cadmium is reached when the tubular cells are not capable of enough 
MT synthesis to neutralize free cadmium ions produced by lysosomal degradation of cadmium-MT 
complex. When the critical concentration is exceeded, tubular damage results in increased 
enzymuria, low molecular weight proteinuria and increased excretion of cadmium either in complex 
with MT or free ion (CONTAM 2009). Chronic exposure to cadmium results not only in its 
accumulation in the kidneys and liver, but also in the endothelium of blood vessels and vascular 
smooth muscle cells (Nawrot et al. 2010).  
Cadmium has for decades been recognized as both carcinogenic and toxic. Increasing epidemiological 
evidence suggests that chronic low dose exposure to cadmium appears to be associated with 
negative effects on human health, more than previously assumed (Nawrot et al. 2010). Direct 
interactions between cadmium and DNA appear to be of minor importance. The genotoxicity of 
cadmium could instead be explained by indirect mechanisms (Hartwig 2010). Frequently discussed 
underlying mechanisms have been demonstrated in diverse experimental systems, such as generation 
of reactive oxygen species (ROS), inhibition of DNA repair enzymes and deregulation of cell 
proliferation (Hartwig 2010), but also aberrant gene expression (Joseph 2009). With respect to DNA 
repair processes, cadmium has been shown to disturb nucleotide excision repair (NER), base 
excision repair (BER) and mismatch repair (MMR). Consequences are increased susceptibility 
towards other DNA-damaging agents and endogenous mutagens. Furthermore, cadmium induces cell 
proliferation and inactivates negative growth stimuli (Giaginis et al. 2006; Hartwig 2010). The 
physicochemical properties of the divalent cadmium ion may help to explain observed biological 
effects. The ion easily substitutes for the calcium ion in biological systems because of equal charge 
and radius. In the case of the zinc ion, the radius of the cadmium ion is larger, but cadmium is still 
able to substitute for divalent zinc ions in many enzymes and transcription factors (Beyersmann and 
Hartwig 2008). In particular, cadmium interferes with the structure and function of the tumor 
suppressor protein p53. Zinc plays a crucial role in the structure of p53 and thereby its function by 
ensuring correct folding of the DNA binding domain of p53, which is essential for DNA binding and 
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transcriptional activity. Cadmium has been demonstrated to alter the zinc binding of p53, leading to 
an accumulation of p53 in cells consisting mainly of unfolded and consequently inactive p53 (Hainaut 
and Mann 2001; Meplan et al. 1999; Schwerdtle et al. 2010). The impairment of DNA repair by 
cadmium may be especially harmful in cells adapted to cadmium. Cadmium induces several genes 
responsible for cadmium and ROS tolerance such as those coding for metallothionein, glutathione 
synthesis and function, catalase and superoxide dismutase. Prolonged cell survival in combination 
with a tolerance of cadmium toxicity may increase the chance for accumulation of critical mutations 
(Beyersmann and Hartwig 2008). 
3.3 Oxidative stress 
Cells are able to balance the production of oxidants and antioxidants under normal physiological 
conditions. Oxidative stress arises when cells are subjected to either excess levels of ROS or 
antioxidant depletion, disturbing the cellular redox balance in favor of the pro-oxidants. Oxidative 
stress overwhelms antioxidant protection, which subsequently could lead to oxidative damage of 
cellular macromolecules. ROS are natural by-products of metabolic pathways under normal 
conditions, and increased ROS levels provide a major relevant function in signal transduction 
(Thevenod 2009). However, because ROS are highly reactive chemical species, they can cause 
substantial damage to tissue and cellular macromolecules. Oxidative stress may result in the 
accumulation of dysfunctional proteins, lipid peroxidation, damaged DNA and apoptosis caused by 
exogenous and endogenous sources (Ercegovac et al. 2010). Exogenous factors, such as ozone, 
UV radiation, chemicals, and also life style-related risk factors e.g. eating habits, smoking, alcohol 
consumption and physical activity could increase cellular oxidative stress (Willcox et al. 2004). During 
mitochondrial reduction of oxygen to water, 1-2 % of the oxygen is released, escaping general 
metabolism and forming superoxide anions, hydrogen peroxide and hydroxyl radicals. While 
hydrogen peroxide and superoxide anions cannot react with DNA, hydroxyl radicals and singlet 
oxygen can directly damage DNA when they are formed in close proximity to DNA (Pryor 1986). 
Figure 3.3 shows the major cellular forms of ROS, how they are formed and subsequently 
metabolized. Superoxide anion radicals can spontaneously convert to hydrogen peroxide or be 
converted by superoxide dismutase (SOD) to oxygen and hydrogen peroxide. From hydrogen 
peroxide, reactive hydroxyl radicals can be formed via catalytic effects of transition metal ions, 
especially Fe2+. Where iron ions are present, hydroxyl radicals can form via the Fenton reaction, as 
hydrogen peroxide could reach all cell compartments (Halliwell and Gutteridge 1990). Hydroxyl 
radicals possess the ability to induce numerous types of DNA damage, such as DNA strand breaks, 
oxidative base modification and AP sites, while singlet oxygen reacts specifically with guanine bases 
and forms thereby more oxidative DNA base modifications than DNA strand breaks (Halliwell and 
Introduction 
 
18 
 
Aruoma 1991; Pflaum et al. 1994). Oxidative DNA damage could arise by direct formation of ROS, 
through inactivation of cellular detoxifying systems, such as GSH depletion, inhibition of anti-
oxidative enzymes, or inhibition of DNA repair proteins.  
 
Figure 3.3: The major cellular forms of reactive oxygen species (ROS), their generation and cellular 
metabolism. GSH: glutathione, GSSG: glutathione disulfide, G-6-P dehydrogenase: glucose-6-phosphate 
dehydrogenase. Modified from (Goel and Khanduja 1998). 
The sulfhydryl (-SH)-containing tripeptide glutathione (GSH) is ubiquitous in all organisms, acting as a 
major cellular antioxidant to maintain the cellular redox balance. The non-protein thiol consisting of 
γ-glutamyl-cysteinyl-glycine is synthesized from two consecutive ATP-dependent reactions following 
a peptide bond between glutamate and cysteine that is catalyzed by γ-glutamylcysteine synthetase. 
Glutathione synthetase catalyzes the condensation of the carboxyl group of cysteine with the amino 
group of glycine. The first reaction represents the rate-limiting synthesis step, which is inhibited by 
regenerated GSH and amino acid availability (Conrad and Sato 2012). When GSH is oxidized, 
glutathione disulfide (GSSG) is generated due to disulfide bridge formation. The glutathione reductase 
reduces GSSG back to GSH by consuming NADPH, representing the most important cellular redox 
buffer system. GSH is present in millimolar concentrations in the cell. As an electron donator, GSH is 
oxidized to GSSG in the enzymatic reduction of peroxides catalyzed by glutathione peroxidases, 
thereby protecting cells by removing hydrogen peroxides. In xenobiotic metabolism, conjugation of 
GSH with non-polar and electrophile xenobiotics occurs. This detoxifying reaction is catalyzed by the 
glutathione-S-transferase family to detoxify xenobiotics.  
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An important transcription factor for genes involved in the antioxidant defense and xenobiotic 
metabolism is the nuclear factor E2-related factor 2 (Nrf2) that binds to antioxidant responsive 
elements (ARE) in the promotor regions of its target genes. Activation of Nrf2 induces transcription 
of antioxidative and xenobiotic genes, thereby protecting cells against oxidative stress-induced cell 
death. Keap1 acts as a sensor of oxidative stress, functioning as a negative regulator of Nrf2. Keap1 
complexes with Nrf2, which holds Nrf2 in the cytosol and ensures ubiquitination of Nrf2 and 
resulting in proteasomal degradation. Ubiquitin is an 8 kDa protein, which binds covalently to lysine 
residues of proteins in a multistep enzymatic process. A chain of poly-ubiquitin provides a signal for 
the proteasomal degradation of the modified protein (Haglund and Dikic 2005). The BTB (broad-
complex C, Tramtrack, and Bric-a-brac), a conserved 100-residue protein motif at the N-terminal, 
functions as the dimerization site for Keap1 proteins. BTB binds to Cullin3, which plays an essential 
role for ubiquitination of Nrf2. The numerous cysteine residues in Keap1 function as optimal targets 
for electrophiles and oxidants. Formation of disulfide bonds through oxidation of the thiol groups 
changes the conformation of Keap1 and its activity. Due to the conformational change of Keap1, 
Keap1 can no longer bind to Nrf2, resulting in the dissociation of the two proteins, thereby Nrf2 can 
translocate to the nucleus. The Nrf2 signaling pathway is thus activated upon oxidative stress. The 
formation of heterodimers in nuclei with bZip family proteins, e.g. Maf, ensures Nrf2-regulated gene 
transcription (Kansanen et al. 2012). Figure 3.4 shows the activation of the Nrf2-Keap1 signaling 
pathway. 
Figure 3.4: Activation of Nrf2-Keap1 pathway. Keap1 and Nrf2 associate in a complex in the cytosol, which 
influence the degradation of Nrf2. The stress-sensor Keap1 changes confirmation upon various stress factors, 
leading to the dissociation from Nrf2; thus, Nrf2 is stabilized. Nrf2 translocates to the nucleus and binds to 
antioxidant response elements (ARE) in promotor regions and induces numerous cytoprotective target genes. 
Modified from (Mitsuishi et al. 2012). 
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3.4 Tumor suppressor protein p53 
The tumor suppressor protein p53 is of great importance in maintaining the genomic stability in cells 
and functions as a stress-responsive transcription factor. Described as the “guardian of the genome”, 
the gene coding for the protein is frequently observed to be mutated in human cancers (Lane 1992). 
The observation that 50 % of all human tumors possess a mutation in the p53 gene clearly exhibits 
the tumor suppressive properties of the p53 protein, whereby most mutations are point mutations 
and occur in the region of the DNA binding domain (Martin et al. 2002). Consequently, when cells 
contain mutant p53, p53-dependent cell cycle arrest upon damaged DNA will not occur, resulting in 
an increased likelihood of mutations and cancer formation. 
p53 is a transcription factor with a molecular weight of 53 kDa and is composed of 393 amino acids. 
The protein sequence can be divided into three distinct functional domains: the N-terminal 
transactivation domain, the DNA binding domain and the regulatory C-terminal domain. The C-
terminal domain contains three functional motifs with a nuclear localization signal, a nuclear export 
signal regulating subcellular localization, in addition to a tetramerisation domain, responsible for the 
formation of the transcriptionally active tetrameric form of p53 (Hainaut and Mann 2001). In normal, 
non-stressed cells, p53 is maintained at low steady-state levels with a half-life of approximately 
20 minutes. This short half-life is due to rapid, ubiquitin-dependent degradation of the protein shortly 
after its synthesis. The most important p53 regulatory protein is the E3 ubiquitin ligase MDM2, which 
participates in the degradation of p53. Various stress factors, such as DNA damage, could however 
lead to phosphorylation of the N-terminal region of p53, inhibiting binding of MDM2, and thereby 
leading to stabilize p53 due to increased half-life, provoking an accumulation of p53. Not only the 
stability of the protein itself may be altered; acetylation in the C-terminal range enhances the 
sequence-specific DNA-binding ability to p53-responsive elements in the promoter region of its 
target genes, mediating the gene expression in a multitude of genes involved in cell cycle control, 
apoptosis or DNA repair (Stewart and Pietenpol 2001). Figure 3.5 shows the structure of p53.  
At least 3 % of all identified genes in the human genome encode for proteins with zinc-binding 
structures (Maret 2003). The p53 protein features also a zinc-binding protein motif, but it does not 
represent a classical zinc finger structure, like those in other transcription factors. Instead, one zinc 
ion is coordinated by three cysteine residues and one histidine residue. The zinc binding stabilizes the 
tertiary structure of p53 and enables the protein binding to the DNA minor grooves. The binding of 
p53 to specific DNA sequences is mediated through the conformation-specific structure in this 
central binding domain (Hainaut and Milner 1993). p53 itself is redox-sensitive because of the 
presence of conserved cysteine residues containing redox-sensitive thiol groups which function as 
cellular redox sensors. The redox status of reactive sulfhydryl residues of nuclear p53 determines its 
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DNA binding activity (Hainaut and Milner 1993; Kim et al. 2011). Human p53 contains 10 cysteine 
residues in the DNA binding domain and the orientation of each cysteine residue plays an important 
role in the redox regulation of p53 (Kim et al. 2011). Zinc finger structures have been shown to be 
sensitive targets for toxic metal compounds (Hartwig 2001). By destabilizing the conformation of 
these zinc-binding structures, the sequence-specific DNA binding capacity of p53 is abolished 
(Hainaut and Milner 1993; Meplan et al. 2000). Subsequently, the expression of genes involved in cell 
cycle regulation as well as apoptosis is affected (Chan et al. 2004). Exposure to cadmium has been 
shown to change the conformation of p53 and thereby its tumor-suppressive functions, causing p53 
to function as a „mutant”-like form, meaning that p53 is not activated upon damaged DNA (Meplan 
et al. 1999; Schwerdtle et al. 2010). 
 
Figure 3.5: The transcription factor p53 contains several domains, including the amino (N)-terminal 
transactivation domain, a central sequence-specific DNA binding domain and a carboxy (C)-terminal domain 
that contains oligomerization sequences and nuclear-localization signals. Nuclear export of p53 is regulated by 
signals at both termini. Interactions with proteins e.g. MDM2 or p300/CBP with the N terminal region can lead 
to modifications such as ubiquitylation or acetylation in the C terminal region. Three cysteine residues and one 
histidine residue coordinate one zinc ion and stabilize the conformation of the DNA binding domain. In this 
domain, most mutations are observed. Modified from (Vousden and Lu 2002). 
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3.5 Cell cycle control and apoptosis 
The cell cycle represents a series of tightly integrated controlled events allowing the cell to grow and 
proliferate. It is composed of interphase and mitosis (M) phases. The interphase includes the several 
gap (G) phases; the resting phase G0, the G1- and G2 phases, where the synthesis of mRNA and 
proteins occur, and the synthesis (S)-phase, where the DNA is replicated. This complex, interacting 
network is regulated by cyclins, cyclin dependent kinases (CDK) and CDK-inhibitors (CDKI) 
(Stewart and Pietenpol 2001) (see Figure 3.6). Eight different cyclins that are involved in the cell cycle 
are known, while at least 11 different CDKs are identified. Most cyclins exhibit major changes in 
mRNA and protein expression levels during the cell cycle course. CDKs are activated by various 
cyclins and provide a function in transcriptional regulation as well. Cyclin-CDK complexes are 
heterodimers acting as serine/threonine protein kinases, whereby their activity is regulated by 
phosphorylation and dephosphorylation. Active cyclin-CDK complexes phosphorylate a range of 
substrates, governing the course of the cell cycle. The proteins of the inhibitor of CDK4 (INK4)-
family and the protein of the CDK-interacting protein/kinase inhibitor protein (CIP/KIP)-family 
belong to the CDKIs (Harper and Brooks 2005; Malumbres and Barbacid 2009). The retinoblastoma 
tumor suppressor protein (pRb) is a transcriptional master regulator, critical for G1 to S phase 
transition in the cell cycle (Chan et al. 2001). It interacts with the E2F transcription factor family to 
repress gene transcription required for this transition (Harbour and Dean 2000). E2F activity is 
regulated in a cell cycle-dependent manner, principally through its temporal association with pocket-
protein family members, the prototype being pRb. Pocket proteins are, in turn, regulated through 
phosphorylation by CDKs, which are subject to the negative control by CDK inhibitors (CDI) 
(Stevens and La Thangue 2004). Deregulated cyclin activity in transformed cells contributes to 
accelerated cell cycle progression (Golias et al. 2004). Cyclin A can activate two different CDKs and 
function in both S phase and mitosis.  
Cells are subject to permanent damage through endogenous and exogenous influences. Following 
DNA damage, the cell cycle can be delayed or stopped at certain checkpoints that exist at the G1-S 
transition and at the G2-M transition. These checkpoints sustain genomic integrity by inhibiting 
replication of damaged DNA and disturbances during mitosis (Iliakis et al. 2003). Before incorrect 
replication leads to mutations, different repair mechanisms can eliminate DNA damage during cell 
cycle arrest, allowing enough time for the damage to be repaired. If the damage is too severe, 
programmed cell death, known as apoptosis, will be induced.  
The role of p53 in cell cycle arrest at the G1-S transition is well understood. In the event of DNA 
damage, the effector protein p53 is activated via a complex of signal cascades (Abraham 2001; Niida 
and Nakanishi 2006). Activation of p53 results in an increased expression of p21. p21 is the CDKI of 
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the CIP/KIP family that binds and inhibits the cyclin D-CDK4 complex. As a result, the 
phosphorylation of the tumor suppressor protein pRb is prevented, leaving it bound to transcription 
factors in the E2F family, and thereby inhibiting the expression of genes necessary for entering the S-
phase (Harper and Brooks 2005). p21 can also inhibit replication and modulate repair by binding to 
proliferating cell nuclear antigen (PCNA) (Waga et al. 1994). The level of DNA damage is decisive for 
the fate of the cell. With low levels of damage, p53 induces p21 gene expression in order to put the 
cell in cell cycle arrest, which gives the cell time to repair the damage. If the level of DNA damage is 
too high, p53 induces expression of pro-apoptotic genes, e.g Bcl-2-associated X protein (Bax), leading 
the cell into apoptosis due to the irreparable damage. Accumulation of the p53 protein causes a 
transient arrest of the cell cycle in the G1 phase, prior to DNA replication, or in the G2 phase, just 
before mitosis (Soussi 2000). This arrest in cell division in response to DNA damage enables the cell 
to activate enzymatic DNA repair processes to repair the lesions, acting as a “stop light”. In cells 
expressing mutated p53, cell division is not arrested upon DNA damage. Mutations in the p53 gene 
can change the conformation of the resulting protein, making it more resistant against degradation. 
Regardless of the location of mutation, most p53 mutants have half-lives of 5-10 hours, and the 
protein accumulates in tumor cell nuclei. Cells containing a mutant p53 gene can no longer maintain 
the integrity of the genome since the cell does not receives the signal for a cell cycle arrest, which 
again can give rise to clones with greater malignant potential (Soussi 2000). 
  
Figure 3.6: Cell cycle machinery. Schematic presentation of various factors involved in cell cycle progression 
and control. Modified from (Golias et al. 2004).  
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There are many different forms of cell death, including the well-known apoptosis and necrosis. 
Compared to necrosis, apoptosis is an active, ATP-consuming, genetically-controlled process which 
results in characteristic morphological changes such as cell shrinking, membrane blebbing, chromatin 
condensation and DNA fragmentation (Wang 2001). 
Apoptosis can be induced via extrinsic (e.g. hypoxia) or intrinsic (e.g. DNA damage) signals. In the 
extrinsic pathway, the binding of a ligand to membrane-bound death receptors results in signaling 
cascades where initiator-caspases (cysteinyl-aspartate specific proteases) and subsequently, effector-
caspases, are activated (Fan et al. 2005). Caspases are proteolytic enzymes with various functions 
such as deactivating anti-apoptotic proteins, activating apoptotic proteins (e.g. DNases) and degrading 
structural proteins (e.g. actin). The intrinsic pathway is a mitochondrial pathway. The membrane 
potential of the mitochondria is determined by the ratio of anti-apoptotic (e.g. Bcl-2) and pro-
apoptotic (e.g. Bax) proteins of the Bcl-2 family. Reduction of the mitochondrial membrane potential 
accompanied by an increase of pro-apoptotic proteins makes the membrane permeable for 
cytochrome C, which is then released from the inner membrane into the cytosol. In the cytosol, 
cytochrome C forms the apoptosome together with Apaf-1 and caspase 9, which then activates the 
caspase cascade and the induction of apoptosis (Huerta et al. 2007). The intrinsic pathway also occurs 
independent from caspase activation through participation of the apoptosis inducing factor (AIF). AIF 
is released into the cytosol and translocated to the cell nuclei as DNase, where the DNase induces 
DNA fragmentation (Huerta et al. 2007). In the case of DNA damage, the p53 protein is 
phosphorylated and stabilized. It blocks proliferation by up-regulation of p21, which finally triggers 
cell cycle arrest in G1 phase. When accumulated above a certain threshold level, p53 can activate 
pro-apoptotic genes such as Bax, PUMA (p53 up-regulated modulator of apoptosis) and the FAS 
receptor (Roos and Kaina 2006).  
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4 Hypothesis  
The intake of the essential trace element selenium varies widely around the globe, ranging from 
deficient to toxic concentrations. Because of the ongoing discussion regarding potential cancer-
preventive properties of higher selenium intake levels and the beneficial roles of dietary selenium 
supplementation in the last decades, dietary supplements containing selenocompounds such as 
sodium selenite and selenomethionine add to these intakes, especially in the USA, where an 
estimated 50 % of the population take dietary supplements (Rayman 2012). However, at least in well-
nourished populations, high selenium exposure may be associated with type 2 Diabetes or insulin 
resistance (Rayman and Stranges 2013).  Because the range of intake between selenium deficiency 
and toxicity is very narrow, increased intake of selenium-containing dietary supplements could pose a 
potential oversupply risk for this essential trace element.  
In the case of inorganic, reducible selenocompounds, like sodium selenite, pro-oxidative effects such 
as zinc release from metallothionein via oxidation of thiol groups are plausible (Chen and Maret 
2001). Other zinc-binding proteins could also be potential molecular targets, e.g. transcription 
factors, DNA repair proteins or tumor suppressors, which could possibly disturb the maintenance of 
genomic stability (Blessing et al. 2004). The tumor suppressor protein p53 performs important 
cellular functions in order to maintain genomic stability. It acts as a redox-sensitive transcription 
factor, regulating expression of target genes relevant for control of the cell cycle, DNA repair 
mechanisms and induction of apoptosis. The native and intact conformation of p53 and thereby its 
function as a transcription factor is essentially coordinated by its zinc ion. Previous research in our 
working group has shown that sodium selenite-induced cellular effects are mediated by p53 (Klaus 
2009). In contrast, effects induced by the organic and fully-reduced selenomethionine seemed to be 
independent of p53 status.  
Cadmium is a classified carcinogen, but the underlying carcinogenic mechanisms are complex and not 
yet completely understood. Changes in the structure and function of p53 through cadmium 
compounds have already been reported (Meplan et al. 1999; Schwerdtle et al. 2010). Concurrent 
cadmium exposure and dietary selenium supplementation could indeed occur, which raises the 
question of how these compounds interact within the cell. In this work, a possible inhibition of p53-
mediated effects induced by sodium selenite after co-exposure to cadmium chloride was investigated. 
As a cell model, human colon carcinoma cell lines with different p53 status were chosen. The p53-
proficient HCT116 cells possess an intact wild-type p53, while the isogenic p53-deficient HCT116 
cell line lacks the tumor-suppressive functions from p53. This present work aimed to determine 
sodium selenite-induced effects in the presence and absence of cadmium in these cell models, while 
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concurrently comparing with selenomethionine to elucidate specific selenium-species effects. The 
chosen endpoints were the determination of cytotoxicity, analysis of gene expression profiles, 
induction of oxidative stress, induction of cell cycle changes and apoptosis, and cellular uptake of the 
selenocompounds. We hypothesized that due to different chemical structures, and thereby different 
cellular metabolism of the two examined selenocompounds, varying cytotoxic effects and gene 
expression profiles were to be expected. One suggested mechanism in cadmium-induced 
carcinogenicity might involve deregulation of gene expression. It was asked whether we could 
observe specific selenium-species differences in the presence and absence of cadmium on the 
regulation of gene expression. Induction of oxidative stress by GSH depletion or by inhibition of ROS 
scavenging antioxidant enzymes following cadmium exposure is often reported as a mechanism in 
cadmium-induced cytotoxicity. The toxicity of sodium selenite is described to involve GSH in the 
reduction of sodium selenite, which could lead to GSH depletion and disturbance of the redox 
homeostasis. The questions whether cadmium could deplete GSH content in our HCT116 cells, and 
how the GSH content is affected by simultaneous exposure to sodium selenite and cadmium 
chloride, were raised. Potential targets of cadmium may be selenium-dependent enzymes, like 
glutathione peroxidase and thioredoxin reductase, as well as selenium-independent enzymes, such as 
glutathione reductase, superoxide dismutase and catalase. We asked if the selenol group in 
selenoproteins could be a sensitive target in cadmium-induced carcinogenicity by the specific binding 
of cadmium to selenol group in these antioxidant enzymes. Additionally, we asked whether the 
enzyme activities of antioxidant enzymes are affected by simultaneous exposure to sodium selenite 
and cadmium chloride. 
As reported in literature, sodium selenite-induced oxidative stress could lead to DNA damage and 
activation of p53 (Zhao et al. 2006). Recognition of DNA damage provokes a DNA damage response, 
including cell cycle arrest, induction of DNA repair proteins or induction of apoptosis to maintain 
genomic stability. Determination of flow cytometric parameters, including superoxide generation, cell 
cycle distribution and apoptosis aimed to clarify the cellular impact of cadmium and sodium selenite 
in HCT116 cells, and thereby elucidate the impact of p53 status with regard to cellular response to 
damage. Because of a possible inhibition of p53-mediated, sodium selenite-induced cellular effects by 
cadmium could compromise genomic stability, and due to earlier observations in the working group 
regarding a possible involvement of p53 in the cellular uptake of sodium selenite, but not 
selenomethionine (Klaus 2009), the bioavailability of the selenocompounds in the absence and 
presence of cadmium was examined in order to possibly explain the impact of cadmium on induced 
cellular effects by selenocompounds. Determination of extracellular thiol content under the same 
conditions was also conducted. 
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5 Results and discussion 
Various examinations helped elucidate the cellular effects following sodium selenite exposure. 
Possible interactions between sodium selenite and cadmium co-exposure were highlighted, as well as 
elucidating p53-mediated cellular effects in response to sodium selenite exposure and investigating 
selenium species specificity. Gene expression profiles were obtained in order to examine the impact 
of sodium selenite in combination with cadmium chloride and in comparison to selenomethionine. 
Other parameters such as oxidative stress markers (superoxide production, GSH content, enzymatic 
activity of antioxidative enzymes), as well as cell cycle distribution and apoptosis parameters 
(cell viability, mitochondrial membrane potential, subG1 fraction, nuclear translocation of AIF) were 
additionally examined after simultaneous exposure to sodium selenite and cadmium chloride. The 
cellular uptake of selenium after exposure to the two selenocompounds in combination with 
cadmium chloride was also investigated. In this chapter, the results of these investigations are 
presented and discussed.  
5.1 Cytotoxicity 
Alterations in the cytotoxicity of the two investigated selenocompounds were examined by 
performing colony-forming ability. The cell number provides a measure for acute cytotoxicity, while 
the colony number predicts the colony-forming ability of single cells, and is thereby reflecting the 
long-term growth inhibition and the proliferative potential after exposure to a certain compound. 
5.1.1 Impact of sodium selenite and selenomethionine on the viability 
of HCT116 cells 
Figure 5.1 and Figure 5.2 show the concentration-dependent influence on both parameters after 24 h 
incubation with sodium selenite or selenomethionine, respectively, in p53-proficient and p53-
deficient HCT116 cells. Sodium selenite decreased both the cell number (Figure 5.1A) and the 
colony-forming ability (Figure 5.1B) in p53-proficient HCT116 cells, but not in p53-deficient 
HCT116 cells. Comparing the cell number (39 %) at the highest tested concentration (8 µM) in the 
wild-type cells to the colony number (8 %), the long-term proliferative potential was strongly 
reduced. In the p53-deficient cells, 24 h incubation with 8 µM sodium selenite caused no significant 
cytotoxic effect determined as cell number (87 %) or colony number (91 %), implying that the cells 
were not able to respond to the possible cellular damage caused by sodium selenite exposure. These 
results suggest that cytotoxic effects observed in sodium selenite-induced cell death might be 
mediated by p53.  
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Figure 5.1: Cytotoxicity of sodium selenite in p53-proficient and p53-deficient HCT116 cells after 
24 h incubations. Cytotoxicity was determined by cell number (A) and colony number (B). Mean values ± SD 
of three independent experiments are shown. Statistically significant differences between the cell lines tested by 
independent sample t-test (Mann-Whitney U test): *** = p < 0.001. 
 
In the case of the reduced selenocompound, selenomethionine, we tested concentrations 100-fold 
higher than those of sodium selenite in the same cell models (Figure 5.2). We observed comparable 
effects on the cell number and colony number with increasing concentrations of selenomethionine. 
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Also, no significant differences in the cytotoxicity in regard to the p53-status of the cells were 
detected. These results imply that selenomethionine-induced cytotoxic effects are not mediated by 
the tumor-suppressive actions from p53, suggesting that p53 is important in selenium species 
specificity. Overall, sodium selenite is far more cytotoxic than selenomethionine. 
 
 
Figure 5.2: Cytotoxicity of selenomethinonine in p53-proficient and p53-deficient HCT116 cells 
after 24 h incubation. Cytotoxicity was determined by cell number (A) and colony number (B). Mean values 
± SD of three independent experiments are shown. No statistically significant differences between the cell lines 
tested by independent sample t-test (Mann-Whitney U test). 
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Selenium is a cellular growth inhibitor in several mammalian tumor cells. Inhibition of cell 
proliferation and induction of cell death is induced by all forms of selenium (Lu et al. 1995). Kralova 
and co-workers showed in the same cell model that p53 sensitizes the cells towards sodium selenite. 
In the study by Kralova, they used proliferation tests, such as DNA synthesis measurements (BrdU-
ELISA), total protein content (Coomassie Brilliant Blue Assay) or integrity of the respiratory chain 
(WST-1, water soluble tetrazolium) (Kralova et al. 2009). The WST-1 test system was insensitive in 
comparison to the other methods, and the differences between the cell lines were relatively low. The 
choice of cytotoxicity test system is decisive since different cytotoxicity tests in general provide 
varying results, probably due to different mechanisms of action (Schroterova et al. 2009). Tests that 
consider clonal survival are recommended (Komissarova et al. 2005). Goel et al. found no impact of 
the p53-status on the cytotoxicity after 24 h exposure to selenomethionine when using MTT test in 
the same cell model as in this present study. They showed that after longer incubation times, the 
cells became more sensitive (e.g. 100 µM selenomethionine after 72 h compared to untreated 
controls) (Goel et al. 2006).  
A comparable cytotoxicity of selenomethionine and sodium selenite in different colon cancer cell 
lines is shown in only one study (Schroterova et al. 2009). Both selenium compounds were shown to 
be cytotoxic already at concentration of 1 µM in HT29 and SW480 cells, and at a concentration of 
16 µM in SW620 cells. A clear difference between the compounds is however more plausible. On 
the one hand, the reducible sodium selenite possesses direct pro-oxidative features. These 
differences play a role in the metabolism. The strong accumulation of selenium in the cell after 
incubation with selenomethionine is due to unspecific integration into cellular proteins in exchange of 
methionine. Selenium is not immediately bioavailable in this storage form. Stagnation of accumulation 
at higher concentration may be due to storage capacity. Sodium selenite has been shown to be taken 
up via a passive anion transporter in keratinocyte models, while organic selenoamino acids such as 
selenomethionine appear to be efficiently transported by various intestinal amino acid transporters 
(Nickel et al. 2009). The uptake of sodium selenite would then greatly increase after extracellular 
reduction to hydrogen selenide via an active, ATP-dependent mechanism in an anion transporter 
(Ganyc and Self 2008). Sodium selenite cytotoxicity is determined by selenium uptake, which again is 
dependent on the extracellular redox state (Olm et al. 2009). A major part of the extracellular thiols 
is cysteine. Extracellular thiol production and consequently, selenium uptake and cytotoxicity, are 
dependent on cystine uptake through the xc--cystine antiporter. Xc--antiporter expression with 
concomitant secretion of cysteine (via MRPs) is associated with selenite sensitivity mediated via a 
high-affinity uptake by a reduced form of selenite (Olm et al. 2009).  
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5.1.2 Impact of sodium selenite and selenomethionine in 
combination with cadmium chloride on the viability of HCT116 cells  
Due to the possible involvement of p53 in sodium selenite-induced cytotoxicity, as shown in Figure 
5.1, we combined a simultaneous exposure to cadmium chloride and sodium selenite. Cadmium 
chloride has been shown to unfold the tumor suppressor protein p53 by displacing its divalent zinc 
ion, thereby causing a conformational change of the protein, which results in loss of functionality 
(Meplan et al. 1999; Schwerdtle et al. 2010). Exposure to 10 µM cadmium chloride without sodium 
selenite caused a reduction in the colony number to about 85 % in the proficient cell line (Figure 
5.3A) and 89 % in the deficient cells (Figure 5.3B). The colony-forming ability after exposure to lower 
concentrations of sodium selenite (up to 3 µM) in combination with cadmium was comparable to 
sodium selenite incubation only. At the tested concentrations of 5 µM and 8 µM sodium selenite, the 
presence of cadmium attenuated the cytotoxicity caused by sodium selenite from 48 % to 65 % and 8 
% to 47 %, respectively, in p53-proficient HCT116 cells (Figure 5.3A). Neither sodium selenite nor 
cadmium chloride co-exposure caused significant changes in the colony number in the p53-deficient 
HCT116 cells after 24 h incubation (Figure 5.3B).  
Unexpectedly, we observed an enhancement of selenomethionine-induced cytotoxicity in 
combination with cadmium chloride in a p53-dependent manner (Figure 5.4A). Selenomethionine 
decreased indeed the colony number in the p53-deficient cells after 24 h treatment, but the presence 
of cadmium showed no further influence (Figure 5.4B). These data suggest an impact of p53-status on 
the increased selenomethionine-induced cell death when cadmium is present. 
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Figure 5.3: Colony-forming ability after 24 h incubation with sodium selenite in combination with 
cadmium chloride. p53-proficient (A) and p53-deficient (B) HCT116 cells were treated with sodium selenite 
(1 µM-8 µM) with or without 10 µM cadmium chloride. Cytotoxicity was determined by colony-forming ability. 
Mean values ± SD of three independent experiments are shown. Statistically significant differences between 
single and combined treatment with cadmium as tested by independent sample t-test (Mann-Whitney U test): 
*** = p < 0.001. 
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Figure 5.4: Colony-forming ability after 24 h incubation with selenomethionine in combination 
with cadmium. p53-proficient (A) and p53-deficient (B) HCT116 cells were treated with selenomethionine 
(10 µM-1000 µM) with or without 10 µM cadmium chloride co-incubation. Cytotoxicity was determined by 
colony-forming ability. Mean values ± SD of three independent experiments are shown. Statistically significant 
differences between single and combined treatment with cadmium as tested by independent sample t-test 
(Mann-Whitney U test): * = p < 0.05, ** = p < 0.01. 
 
Examining the cells after 8 h sodium selenite treatment in p53-proficient HCT116 cells, a strongly 
reduced colony-forming ability at the highest tested concentration could be observed (Figure 5.5A), 
but not, however, in p53-deficient HCT116 cells (data not shown). This implies once again that 
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cytotoxicity following sodium selenite exposure is likely to be mediated by p53. Co-exposure to 
cadmium for 8 h almost completely reversed the outcome of sodium selenite incubation, again 
implying an impact of cadmium on p53-mediated cytotoxicity induced by sodium selenite.  Figure 
5.4B shows that selenomethionine only reduced the colony number to 90 % at the highest tested 
concentration after 8 h treatment in p53-proficient HCT116 cells, showing that the increased 
cytotoxicity of selenomethionine in combination with cadmium chloride seen after 24 h incubation 
could not be observed after 8h. 
 
 
Figure 5.5: Colony-forming ability after 8 h exposure to sodium selenite or selenomethionine in 
combination with cadmium. p53-proficient HCT116 cells were treated with sodium selenite (A) or 
selenomethionine (B) with or without 10 µM cadmium chloride co-incubation. Cytotoxicity was determined by 
colony-forming ability. Mean values ± SD of three independent experiments are shown. Statistically significant 
differences between single and combined treatment with cadmium as tested by independent sample t-test 
(Mann-Whitney U test): *** = p < 0.001.  
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5.2 Gene expression profiling 
Regulation of cellular signaling pathways and modification of gene expression occurs frequently at the 
transcriptional level. Analysis of transcriptional changes following exposure to a certain compound 
could therefore provide new insight into potential intracellular targets of compounds of interest. 
Whether exposure to a compound induces or represses transcription depends both on time and 
concentration as well as the specific compound. Employing a high throughput-RT-qPCR enabled the 
quantitative analysis of 96 x 96 independent PCR reactions in parallel to examine cellular responses 
at the transcriptional level to exposure to different selenocompounds in the combination with 
cadmium chloride. The gene expression profiles of sodium selenite and selenomethionine in the 
presence and absence of cadmium chloride could thereby be recorded, elucidating their influence on 
various signaling pathways. Due to the complexity of the generated data, details on genes and 
signaling pathways were selected and presented, in order to highlight involvement of p53 in sodium 
selenite-induced effects. Additionally, the possible modulation by cadmium chloride co-exposure as 
well as species-specific effects of selenium was examined. By arranging the genes according to highest 
fold change of the relative gene expression induced by sodium selenite (5 µM, 24 h) within each 
category, comparisons between the p53-proficient and p53-deficient HCT116 cells, and effects of co-
exposure to cadmium chloride as well as exposure to selenomethionine could be obtained. More 
than a 2-fold gene up-regulation was considered as significant, while the cut-off for significant gene 
down-regulation was set to <0.5. Complete gene expression profiles of sodium selenite and 
selenomethionine alone and in combination with cadmium chloride, as well as concentration-
dependent cadmium chloride profiles are arranged in the appendix (see Table A4-8). Also to be 
found in the appendix, is a summary of all examined genes together with the respective encoded 
proteins (Table A1-3). Because the genes ADH, ALDH1A1, AXIN, CYP1A1, DDIT3, GADD45A, GPX2, 
and UGT1 were only marginally expressed in the applied cell lines, these genes were not considered 
in the data analysis.  
5.2.1 Impact of sodium selenite exposure in combination with 
cadmium on gene expression and the role of p53 on sodium selenite-
induced gene expression  
In order to examine the impact of sodium selenite exposure and the possible involvement of the 
tumor suppressor protein p53, both p53-proficient and p53-deficient HCT116 cells were treated 
with sodium selenite for 24 h. In addition, p53-proficient HCT116 cells were co-incubated with 
sodium selenite and 10 µM cadmium chloride for 24 h to reveal the possible interaction of cadmium 
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on sodium selenite-induced and p53-mediated effects. Thus, their unique gene expression profiles 
could be analyzed and compared. 
Genes involved in oxidative stress response and inflammation 
Oxidative stress arises when cells are subjected to either excess levels of ROS or antioxidant 
depletion, disturbing the cellular redox balance in favor of the pro-oxidants. Oxidative stress 
overwhelms antioxidant protection, which subsequently could lead to oxidative damage of cellular 
macromolecules. Generated superoxide radicals are not particularly reactive, but other ROS could 
develop from these radicals. Superoxide dismutases convert the superoxide radical anion to 
molecular oxygen and hydrogen peroxide. The latter is converted to highly-reactive hydroxyl radical 
under the catalytic action of Fe2+ via the Fenton reaction (Halliwell 2006). In the case of increased 
ROS production, an enhanced gene expression of numerous cytoprotective antioxidants enzymes, 
such as heme oxygenases, catalase and glutathione peroxidases may take place.  
Figure 5.6 shows the impact of 24 h exposure to sodium selenite (5 µM) on genes associated with 
the oxidative stress response as well as inflammation in p53-proficient- and p53-deficient HCT116 
cells, as well as the impact of 24 h co-exposure to 10 µM cadmium chloride or cadmium alone in 
p53-proficient HCT116 cells. Transcript levels of the GSH redox system-associated genes TXNRD, 
GCLC, GSR and G6PD, as well as the xenobiotic genes NQO1 and EPHX1 were increased after sodium 
selenite exposure in p53-proficient HCT116 cells (Figure 5.6A). These genes are target genes of Nrf2 
and possess ARE sequences in their promoter regions (Baird and Dinkova-Kostova 2011), indicating 
an activation by Nrf2. In the p53-deficient cell line, increased mRNA levels of TXNRD1, GCLC and 
NQO1 were also observed: however, GSR and G6PD levels were only tendentiously induced. EPHX1 
levels were unchanged. The stronger induction of Nrf2 target genes in p53-proficient cells than p53-
deficient cells could imply a partial influence of p53 in the oxidative stress response. The transcript 
level of NFE2L2, which encodes the transcription factor Nrf2, was enhanced 2-fold. The gene KEAP1, 
encoding the protein Keap1 which binds Nrf2 in cytosol leading to the proteasomal degradation of 
Nrf2, was however, not induced. Induction of Keap1 exerts a specific negative feedback mechanism 
which can turn off induced Nrf2 signal cascade (Lee et al. 2007). One of the most frequently induced 
downstream gene following Nrf2 activation is NQO1 (summarized in Baird and Dinkova-Kostava, 
2011). Induction of NQO1 provides a protective mechanism since the oxidoreductase NQO1 
catalyzes the detoxification of quinones to hydroquinones, avoiding potential formation of 
semichinone radical intermediates. In this way, cells are protected from quinone-induced oxidative 
stress. EPHX1 encodes for the epoxide hydrolase 1, which plays an important role both in activation 
and inactivation of xenobiotics. Due to the ARE sequence in its promoter region, EPHX1 activation 
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via Nrf2 is possible. It is difficult to evaluate which impact the induction of EPHX1 exhibits on the 
cellular homeostasis in HCT116 cells since epoxide hydrolases are mainly responsible for 
degradation of toxic epoxides to dihydrodioles, and thereby detoxification. Glucose 6-phosphate 
dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, 
generates reducing equivalents in the form of NADPH, which is used to maintain GSH in its reduced 
form, thereby allowing detoxification reactions (Rahman et al. 1999). Despite Nrf2 activation, 
induction of all selected Nrf2 dependent genes was not observed. No expression changes in CAT, 
GPX1, GSTP1, PRDX1, SOD2, and TXN were seen. Gene expression induction of antioxidant enzymes 
could also be regulated by other less investigated mechanisms. Some studies suggest that among 
others kinases such as protein kinase C (PKC), phosphor-3-kinase (PI3K) and MAP kinases (MAPKs) 
participate in the activation of Nrf2, and thereby selectively modulate signal transduction (Huang et 
al. 2000; Keum et al. 2003).  
Figure 5.6A shows that co-exposure to cadmium chloride also induced these Nrf2 target genes, with 
the exception of EPHX1, similar to the p53-deficient cell line in response to sodium selenite 
exposure. This implies a partial influence of p53 in the oxidative stress response. The transcript level 
of the transcription factor Nrf2 coded by NFE2L2, was enhanced 2-fold by sodium selenite, but co-
exposure to cadmium chloride did not induce NFE2L2 mRNA. Neither sodium selenite incubation 
nor co-incubation with cadmium affected the gene KEAP1 transcript levels, which is known to be a 
negative cytoplasmic regulator of Nrf2 (Lee et al. 2007).  
Exposure to cadmium only (10 µM) induced also TXNRD1 and GSR mRNA levels, but only tended to 
up-regulate GCLC expression levels after 24 h (Figure 5.6A). Moreover, TXNRD1, GSR and GCLC 
mRNA levels were significantly induced already at 8 h exposure (see appendix Table A4). ABCB1 
mRNA levels were also increased following cadmium chloride exposure. ABCB1 encodes an ABC 
transporter, also known as multidrug resistance P-glycoprotein 1 (Mdr1) that can function as 
xenobiotic efflux pump (Sabolic et al. 2008).The simultaneous exposure to sodium selenite and 
cadmium chloride, however, showed a smaller induction of the ABCB1 gene.  
Sodium selenite induced heme oxygenase 1 (HMOX1) transcript levels by 20-fold in the p53-
proficient cell line, while an 8.5-fold increase could be observed in the p53-deficient cells 
(Figure 5.6B). No change in heat shock protein 1A (HSPA1A) was seen in any of the cell lines, 
indicating no activation of the transcription factor heat shock factor HSF-1. In combination with 
cadmium chloride, HMOX1 mRNA was induced over 66-fold after exposure to sodium selenite. A 
20-fold change could be observed after incubation with sodium selenite only, while10 µM cadmium 
for 24 h incubation induced the transcripts of HMOX1 by 44-fold (Figure 5.6B), suggesting an additive 
effect of the co-exposure to sodium selenite and cadmium chloride on HMOX1 expression. The early 
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response gene and stress response gene HMOX1 showed a time- and concentration-dependent rise 
in expression levels following cadmium chloride incubation only, whereby the highest fold change 
(108-fold) was observed at the earliest time point of 8 h (see appendix Table A4). Induction of the 
early response gene HMOX1 represents a general transcriptional response to oxidative stress, which 
can be induced by several transcription factors such as AP-1 (Jun), Nrf2 and HSF-1 (Alam and Cook 
2003). While no change in HSPA1A gene expression was seen after sodium selenite incubation, co-
exposure to cadmium chloride led to 30-fold higher expression levels (Figure 5.6B). The transcript 
levels of HSPA1A after 24 h incubation with 10 µM cadmium chloride were strongly induced by more 
than 200-fold. Like HMOX1, HSPA1A gene expression was also time- and concentration-dependent 
enhanced following cadmium chloride incubation, however, in contrast to HMOX1 gene expression, 
the HSPA1A gene expression was higher after 24 h than 8 h. However, at a shorter incubation time 
(8 h), concomitant exposure to sodium selenite and cadmium chloride abolished the HSPA1A gene 
induction completely, although exposure to 10 µM cadmium chloride alone raised the HSPA1A 
mRNA levels by 59-fold after 8 h incubation (see appendix Table A4). These results would suggest an 
antagonistic effect of sodium selenite on cadmium-induced HSPA1A expression. GSH-depletion has 
been shown to be decrease heat shock protein mRNA levels (Belton et al. 2011). We observed that 
sodium selenite depleted intracellular GSH content (Figure 5.14), while cadmium increased the GSH 
levels (Figure 5.13), which might suggest that GSH-depletion could be involved in the observed 
antagonizing effect of sodium selenite on cadmium-induced HSPA1A up-regulation. Taken together, 
given the present results, it is likely that Nrf2 activation was involved in the cellular response to 
exposure to sodium selenite, as well as to cadmium and also to co-exposure to them. 
Changes in the mRNA levels of MT1X, MT2A and SLC30A1, which encode for two metallothionein 
isoforms (MTs) and zinc transporter 1 (ZnT1), respectively, were only observed in the p53-proficient 
HCT116 cells, which suggest a p53-dependent effect following sodium selenite treatment 
(Figure 5.6C). SLC30A1 is a target gene of metal-response element-binding transcription factor-1 
(MTF-1), known to be activated by metals such as zinc, but also heavy metals like cadmium. A direct 
interaction with MTF1 could lead to activation of the transcription factor and induce the expression 
of MTs via the metal responsive element (MRE). Besides regulation by MRE, the expression of MTs 
can also be modified by the glucocorticoid responsive element (GRE) and ARE (Coyle et al. 2002). 
The activation through MRE occurs primarily via binding of metal to MTs. Since HCT116 cells are not 
hormone sensitive, activation via GRE is of little relevance. Here, we observed that sodium selenite 
also activated this transcription factor, possibly due to oxidative zinc release of MTs (Chen and Maret 
2001). 24 h co-exposure to cadmium chloride increase the MTX1 expression from 3-fold to 14-fold, 
and almost doubled the MT2A expression levels to 6-fold compared to sodium selenite alone (Figure 
5.6C). Cadmium alone raised the MTX1 levels 19-fold after 24 h exposure (Figure 5.6C); however, a 
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38-fold change was seen after 8 h (see appendix Table A4). The MT2A expression was increased 
about 8-fold after 24 h incubation. Additionally, the expression of the ZnT1 gene was 3.3-fold higher 
after 24 h cadmium exposure (Figure 5.6C). The mRNA levels of ZnT1 were increased by 10-fold 
after 8 h cadmium exposure (see appendix Table A4). These observations point out that a strong MT 
expression, including zinc transporter expression, which are target genes of the metal responsive 
transcription factor MTF-1, were early responses to cadmium exposure. In contrast, sodium selenite-
induced MT expression was first observed after 24 h, but not after 8 h incubation. However, a 
tendency in the up-regulation of the ZnT1 gene (1.9-fold induction) was seen after 8 h exposure to 
sodium selenite. The induction of these MTF-1 target genes by sodium selenite was thereby a slower 
response than that seen following cadmium exposure.    
The inflammation marker interleukin-8 (IL8) gene was strongly induced 84-fold and 74-fold in p53-
proficient- and deficient cells, respectively (Figure 5.6B). Cadmium alone (10 µM) increased IL8 gene 
expression levels by 6-fold. Co-exposure to cadmium chloride affected sodium selenite-induced IL8 
gene expression negatively. Sodium selenite induced an 84-fold change in IL8 mRNA levels, while in 
the presence of cadmium chloride only a ~6.5 fold change was observed (Figure 5.6B). While sodium 
selenite induced the IL8 gene by 154-fold after 8 h (see appendix Table A5), simultaneous 8 h 
incubation with cadmium chloride only raised the IL8 mRNA levels by 2.5-fold (see appendix 
Table A4). Concomitantly to the sodium selenite-induced up-regulation of IL8 mRNA levels, the gene 
expression levels of NFKB2 was increased by a factor of 3.7 in the p53-proficient cells, but was 
induced by less than 2-fold in the p53-deficient cells (Figure 5.6D). NFKB2, which encodes the p100 
subunit of the transcription factor NF-κB, was induced also by about 2.4-fold in the presence of 
cadmium. Sodium selenite tended to induce transcript levels of NFKB1A, the NF-κB inhibitor IкBα, 
and NFKB1, the p105 subunit of NF-κB, however, co-exposure to cadmium resulted in no fold change 
of these two genes. The transcriptional induction of IL8, NFKB2, NFKB1 and NFKB1A, is mediated by 
NF-κB. Another target gene of NF-κB is the gene encoding the ferritin heavy chain the intracellular 
iron storage protein, FTH1, which plays an important role in the regulation of iron homeostasis. 
Sodium selenite raised mRNA levels of FTH1 mRNA levels in both cell lines by about 5-fold, 
independent of cadmium chloride (Figure 5.6A). This implies an activation of the transcription factor 
NF-κB since IL-8 and ferritin encoded by FTH-1 are target genes of NF-κB, in addition to the genes 
encoding the inactive precursor subunits of the transcription factor. Another important gene in iron 
homeostasis is TFRC, which encodes for the membrane-bound transferrin receptor. However, the 
expression levels of this gene were not changed after sodium selenite exposure. The change in 
expression of FTH1 is presumably closely associated with the induction of HMOX1. Enhanced activity 
of the stress-responsive heme oxygenase leads to accelerated intracellular heme catabolism, which 
could mobilize divalent iron ions out of protoporphyrin IX ring of the heme molecule. Free iron ions 
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catalyze ROS formation via the Fenton reaction, thereby evoking cytotoxic effects. The ability of 
HMOX-1 to increase heme catabolism represents, however, a cytoprotective effect, which prevents 
sensitizing cells to undergo programmed cell death (Gozzelino et al. 2010). 
Cadmium-induced oxidative stress is related to induction of overexpression of the oncogenes c-fos 
and c-jun, the members of the redox-sensitive AP-1 transcription factor (Joseph et al. 2001; Qu et al. 
2005). Filipic and Hei showed that GSH-depletion by pretreatment with BSO resulted in increased 
mutagenicity of cadmium, indicating indirectly that ROS mediates a genotoxic response in mammalian 
cells exposed to cadmium (Filipic and Hei 2004). Exposure to cadmium consequently up-regulated 
genes encoding for proteins involved in defense and cellular repair including MTs, heme oxygenases, 
heat shock proteins and thioredoxin reductases (Nishitai and Matsuoka 2008; Valbonesi et al. 2008; 
Yamada et al. 2009). Suggested mechanisms are involvement of redox sensitive transcription factors 
such as Nrf2, AP1 and NF-κB. Direct involvement of cadmium on HMOX-1 and heat shock protein 
70 has been shown to be regulated via MRE (Koizumi et al. 1992; Koizumi et al. 2007).  
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Figure 5.6: Impact of sodium selenite (5 µM) in combination with cadmium chloride (10 µM) and 
the role of p53 on the relative gene expression of genes associated with (A, B, C) oxidative stress 
response and (B, D) inflammation in p53-proficient and p53-deficient HCT116 cells after 24 h 
incubation Gene name abbreviations listed in Table A3. Mean values ± SD of at least two independent 
experiments of double or single determinations are shown.  
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Genes associated with cell cycle control 
Relative gene expression of cell cycle control genes in p53-proficient- and p53-deficient 
HCT116 cells after 24 h exposure to 5 µM sodium selenite was also investigated (Figure 5.7). Sodium 
selenite increased mRNA levels of the cyclin-dependent kinase inhibitor CDKN1A1 that encodes p21, 
by 10-fold. p21, which is mainly regulated through p53, is a major cell cycle inhibitor, leading to G1 
cell arrest. In the p53-deficient cells a nearly 3-fold increased transcript amount of p21 was found, 
suggesting a p53-independent induction of p21. Another cyclin-dependent kinase inhibitor CDKN2B, 
known as p15, was also induced by about 3-fold upon sodium selenite treatment, however, only in 
p53-proficient cells. Other target genes of p53 that were only enhanced in the proficient cells were 
protein phosphatase PPM1D and serine/threonine‐protein kinase PLK3, implying a G1/S-and G2/M 
arrest, respectively. The PPM1D acts as a protein phosphatase that down-regulates p38, and thereby 
decreasing the phosphorylation rate of p53 (Li et al. 2006). This feedback mechanism initiates cell 
cycle arrest and represses apoptotic effects. These mentioned p53 target genes were already induced 
after 8 h exposure to sodium selenite (see appendix Table A5). MDM2 is a negative feedback 
regulator of p53, and its gene expression was induced in p53-proficient cells, but not in p53-deficient 
cells, although p53 mRNA levels were increased in both cell lines. The enhanced transcript levels of 
p53 in the p53-deficient cells could possibly form a non-functional p53 protein, but thereby disabled 
to regulate its target genes. The cell cycle inhibitors p21 and p15 were induced in addition to the 
simultaneous up-regulation of TP53 and MDM2, providing a marker for genotoxic stress. p53 is 
subject to a negative and a positive feedback mechanism as other transcription factors (Harris and 
Levine 2005). In this context, it is possible that p53 can induce its own expression as well as the 
expression of MDM2. The cyclin-dependent kinase regulator cyclin D (CCND1) was increased by 
1.65-fold in the p53-proficient cells (data not shown). However, this was not significant. Cyclin D is 
important for the cell cycle progression by complexing with CDK4 and CDK6, which are responsible 
for the G1-S transition. Cyclin D also binds to the Rb protein, which leads to the release of the 
transcription factor E2F1, regulating genes necessary for S phase transition. In both cell lines, 
repressed transcript levels of the transcription factor E2F1 important for cell cycle progression, were 
found, indicating prohibited cell progression and thereby cell cycle arrest. The gene expression 
analysis showed that the transcript levels of EGFR were almost doubled in the p53-proficient cells. 
The EGF receptor (EGFR) is activated by epidermal growth factor (EGF) that can activate, for 
instance, the ERK signaling pathway, leading to increased expression of cyclin D and enhanced cell 
proliferation. Oxidative stress-induced phosphorylation of EGFR is described in literature as an EGF-
independent EGFR activation (Meves et al. 2001). It is therefore possible that the observed 
intracellular oxidative stress could activate the ERK signaling pathway through ROS and thereby 
affect the expression of genes involved in cell proliferation, cell differentiation and apoptosis.   
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An increase of JUN levels, which encodes activator protein AP-1, by sodium selenite was observed in 
both cell lines, suggesting an activated JNK/p38 MAPK signaling pathway. Originally thought to be a 
distinct transcription factor, AP-1 is now synonymous with the large group of homo- and 
heterodimeric Jun and Fos DNA-binding proteins. Jun and Fos regulate multiple cellular processes, 
including proliferation, differentiation, apoptosis, and the adaptive response to stress. A binding site 
for AP-1 is found in the promotor region of HMOX-1 (Alam and Cook 2007).  Decreased GSH levels 
(see Figure 5.20) and increased AP-1 and NF-κB activation seen in the gene expression profile of 
sodium selenite may be associated with an enhanced pro-inflammatory IL-8 release in alveolar 
epithelial cells, suggesting a mechanism for the pro-inflammatory effects of oxidative stress (Rahman 
et al. 2002). Another study demonstrated that NF-κB plays an essential role in the activation of wild-
type p53 tumor suppressor to initiate pro-apoptotic signaling in response to generation of 
superoxide (Fujioka et al. 2004).  
The impact of the simultaneous exposure of sodium selenite and cadmium chloride on the relative 
gene expression in cell cycle control genes in p53-proficient HCT116 cells represented a point of 
interest. mRNA levels of CDKN1A1, better known as p21, were enhanced by 10-fold by sodium 
selenite. However, a significant induced p21 expression was also observed to less extent in the p53-
deficient cells (Figure 5.7). Co-exposure to cadmium abolished the sodium selenite-induced p21 
expression completely. A G1 arrest is normally induced resulting from enhanced p21-expression. 
Cells were unable to raise p21 transcript levels, possibly due to an interaction between cadmium 
chloride and p53, since p21 is mainly regulated through p53. A 3-fold-increased expression of the 
CDK inhibitor p15 (CDKN2B) was induced upon sodium selenite treatment in a p53-dependent 
manner. The presence of cadmium chloride cancelled the p15 up-regulation induced by sodium 
selenite. Sodium selenite-enhanced expression of other target p53 genes as well such as the negative 
feedback regulator of p53 MDM2, the protein phosphatase PPM1D and serine/threonine‐protein 
kinase PLK3 was not induced when cadmium chloride was present, indicating an abolition of p53-
mediated responses to sodium selenite exposure. Interactions with cell cycle checkpoints have 
previously been demonstrated for cadmium. In the presence of cadmium, γ-radiation-induced cell 
cycle arrest in G1 and G2/M phases was suppressed due to impairment of p53 caused by unfolding of 
its conformational structure (Meplan et al. 1999). 
Sodium selenite-induced enhancement of JUN expression levels was observed in both p53-proficient 
and p53-deficient cells, suggesting an activated JNK/p38 MAPK signaling pathway (Figure 5.7). In the 
presence of cadmium chloride, a significant induction of AP1 was also observed, although sodium 
selenite alone induced twice the amount of JUN transcript levels. 24 h exposure to 10 µM cadmium 
chloride enhanced JUN expression by about 4-fold while 8 h exposure to cadmium induced a 13-fold 
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change of JUN (see appendix Table A4), suggesting that JUN might be another early response gene 
induced in the stress response to cadmium exposure. 
 
Figure 5.7: Impact of sodium selenite (5 µM) in combination with cadmium chloride (10 µM) and 
the role of p53 on the relative gene expression of genes associated with cell cycle control genes 
in p53-proficient and p53-deficient HCT116 cells after 24 h incubation. Gene name abbreviations 
listed in Table A3.  Mean values ± SD of at least two independent experiments of double or single 
determinations are shown.  
Genes associated with DNA repair pathways 
Sodium selenite induced several p53-dependent genes involved in DNA damage response. As shown 
in Figure 5.8, we observed increased transcript levels of XPC, DDB2, RRM2B, and ATM, suggesting 
activated DNA repair mechanisms. During activated nucleotide excision repair (NER), p53 binds to 
p53-response elements to up-regulate the expression of the XPC (xeroderma pigmentosum 
complementation group C) and DDB2 (p48/DNA damage‐binding protein 2) genes. XPC and 
p48/DDB2 recognize and bind to specific lesions on the DNA. ERCC1, ERCC4 and ERCC5 encode 
NER specific endonucleases, which bind and cleave the DNA leaving 5′ phosphate and 3′ hydroxyl-
termini to the site of the damage (Sengupta and Harris 2005). Transcripts of ERCC1, ERCC4 and 
ERCC5 tended to increase following sodium selenite treatment. Together with ERCC4, also known as 
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XPF, ERCC1 forms the ERCC1-XPF enzyme complex in NER (Sengupta and Harris 2005). An 
induction of transcript levels of NER genes indicates that sodium selenite exposure causes DNA 
damage. RRM2B is generally associated with DNA repair, however not classified in a specific repair 
pathway due to involvement in NER, BER and MMR. RRM2B encodes the ATM-interacting 
ribonucleotide reductase M2B, and is induced to provide desoxyribonucleotides for DNA repair due 
to induction of other repair genes. Thus, it is essential in the DNA damage response. Marginal 
influence on expression of other DNA repair genes was additionally observed. 
ATM and ATR play central roles in the DNA damage response with respect to cell cycle arrest and 
control of DNA replication. Both are serine/threonine protein kinases responsible for sensing DNA 
damage, activating amongst others the DNA damage checkpoint via activation of numerous targets, 
including p53 and checkpoint kinases (Chk1, Chk2) through phosphorylation, and thereby leading to 
cell cycle arrest. ATM is recruited and activated by DNA double-strand breaks, while ATR is 
activated in response to persistent single-stranded DNA, which may occur at stalled replication 
forks, and acts as an intermediate in NER and homologous recombination repair (HR) (Shiloh 2001; 
Shiloh 2006). Gene expression levels of NER genes were unchanged in p53-deficient HCT116 cells 
upon sodium selenite exposure, indicating strongly a p53-mediated response to DNA damage. 
In the presence of cadmium, vertially no change in expression levels compared to the control in all 
selected genes in the DNA damage response was found (Figure 5.8). An inhibition of induced NER 
gene expression levels in response to sodium selenite exposure by cadmium suggests that sodium 
selenite-induced DNA damage is not being recognized and repaired due to a presumable incapability 
of the tumor suppressor, p53, to enhance expression levels of necessary repair proteins in response 
to damage. Cadmium has been shown to disturb major DNA repair processes, such as NER, BER and 
MMR (Hartwig 2010). There are at least 30 proteins involved in NER. Cadmium inhibits repair of 
UVC- and BaP-induced DNA lesions by impairing assembly and disassembly of the DNA damage 
recognition proteins XPC, XPA and XPG in the DNA repair complex (Fatur et al. 2003; Schwerdtle 
et al. 2010). 
Oxidative DNA damage is repaired by DNA base excision repair (BER). No induction of BER 
associated genes APEX, LIG1, LIG3, OGG1, PARP1 and POLB was observed after exposure to sodium 
selenite (data not shown). Compared to BER, p53 is assumed to affect NER to a greater extent at 
the transcriptional level (Seo and Jung 2004). NER repairs mainly bulky DNA adducts and helix-
distorting lesions, however, NER genes such as XPC, XPA and ERCC4 are shown to be up-regulated 
by oxidative stress (Langie et al. 2007). Components of the NER machinery may therefore also have a 
role in repair of oxidative DNA damage as a back-up mechanism to BER (Slupphaug et al. 2003). The 
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parallel induction of NER genes in addition to ATM and RRM2B represents an indicator of induced 
repair and synthesis of DNA.  
 
Figure 5.8: Impact of sodium selenite (5 µM) in combination with cadmium chloride (10 µM) and 
the role of p53 on the relative gene expression of genes associated with DNA repair in p53-
proficient and p53-deficient HCT116 cells after 24 h incubation. Gene name abbreviations listed in 
Table A3. Mean values ± SD of at least two independent experiments of double or single determinations are 
shown. 
Genes associated with apoptosis 
The pro-apoptotic genes BBC3, TNFRSF10B (DR5), PMAIP1 (Noxa) and BAX were induced by sodium 
selenite, indicating an induction of apoptosis. However, up-regulation of the anti-apoptotic genes 
XIAP and BCL2L1 was also observed (Figure 5.9). In p53-deficient cells, the p53-target gene BAX was 
not up-regulated after sodium selenite exposure, but PUMA, Noxa and DR5 showed increased mRNA 
levels, suggesting a p53-independent response. Induction of PMAIP1 in response to DNA damage can 
occur in a p53-independent manner, possibly as a downstream target of p73 (Ploner et al. 2008). 
Co-exposure to cadmium chloride raised the Noxa gene expression levels 2-fold: however, no 
change in other pro-apoptotic genes was observed (Figure 5.9). Although the apoptotic 
transcriptional response was possibly mediated both in a p53-dependent- and independent manner, 
these results indicate once again that the sodium selenite-increased gene induction is attenuated by 
simultaneous cadmium exposure.  
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Figure 5.9: Impact of sodium selenite (5 µM) in combination with cadmium chloride (10 µM) and 
the role of p53 on the relative gene expression of genes associated with apoptosis in p53-
proficient and p53-deficient HCT116 cells after 24 h incubation. Gene name abbreviations listed in 
Table A3. Mean values ± SD of at least two independent experiments of double or single determinations are 
shown. 
The Bcl-2 family may be divided into three groups according to its Bcl-2 homology (BH) domains, its 
mitochondrial anchorage and its pro- or anti-apoptotic effect (Mohamad et al. 2005). The multi-
domain pro-apoptotic BAX also belongs to this protein family, while the BBC3 gene, also known as 
PUMA (p53 upregulated modulator of apoptosis), is a pro-apoptotic member of the BH3-only 
subgroup of Bcl-2 family proteins. It is a key mediator of p53-dependent and p53-independent 
apoptosis by binding to the inhibitory members such as anti-apoptotic members Bcl-2 and Bcl-XL of 
the Bcl-2 family (Bcl-2-like proteins) via its BH3 domain (Hikisz and Kilianska 2012). PMAIP1, also 
known as Noxa, exerts its pro-apoptotic function mainly by neutralizing the anti-apoptotic Bcl-2 
proteins and facilitating activation of Bax and/or Bak proteins (Ploner et al. 2008). Activation of death 
receptors (DR), which are members of the tumor necrosis factor (TNF) receptor family located at 
the plasma membrane, including Fas, DR4, and DR5, can be regulated by p53 as a part of the extrinsic 
apoptotic pathway (Sheikh et al. 1998; Yu and Zhang 2005). 
APAF-1 is also an apoptosis initiator: however, its mRNA content remained unchanged in both cell 
lines. As APAF-1 harbors p53-responsive elements in the promoter region, it represents another 
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target in DNA damage-induced apoptosis mediated by p53 (Robles et al. 2001). In mitochondria-
mediated apoptosis, cytochrome C is released into the cytosol due to mitochondrial depolarization 
which occurs in response to DNA damage and other stimuli. APAF-1 and cytochrome C form a 
complex leading to the recruitment and activation of pro-caspase-9 to form the apoptosome, the 
first step in the caspase activation cascade that ultimately leads to chromatin degradation (Mohamad 
et al. 2005; Shi 2001).  
5.2.2 Differential impact of sodium selenite and selenomethionine on 
transcriptional regulation 
The differential gene expression profiles of the two investigated selenocompounds, sodium selenite 
and selenomethionine, were obtained in order to examine possible selenium species-dependent 
transcriptional differences following 24 h exposure to 5 µM sodium selenite and 500 µM 
selenomethionine in p53-proficient HCT116 cells cellular exposure. Co-exposure to 
selenomethionine and 10 µM cadmium chloride for 24 h were also investigated to reveal the impact 
of cadmium on selenomethionine-induced effects.  
Genes involved in oxidative stress response and inflammation 
The oxidative stress response, including inflammation markers, was highly induced by sodium selenite 
exposure, partially in a p53-dependent manner (Figure 5.6). Transcript levels of Nrf2 target genes 
remained unaffected in response to selenomethionine, unlike sodium selenite exposure, which 
enhanced several target genes of Nrf2 (Figure 5.10A), indicating an important specific difference 
between the selenium species since sodium selenite exposure enhanced several Nrf2 target genes. 
Figure 5.6 shows that co-exposure to cadmium chloride also induced Nrf2 target genes. However, 
the cadmium chloride-induced enhancement of Nrf2 target genes was less pronounced in the 
presence of selenomethionine (Figure 5.10). The transcript levels of the transcription factor Nrf2 
coded by NFE2L2 were neither enhanced by selenomethionine nor by co-exposure to cadmium 
chloride. ABCB1 mRNA levels were repressed by 45 % after selenomethionine exposure (Figure 
5.10A), but up-regulated more than 3-fold upon cadmium exposure alone (Figure 5.6A). After 
simultaneous exposure to selenomethionine and cadmium chloride, the ABCB1 gene, an 
ABC transporter efflux pump, was more than 3-fold enhanced (Figure 5.10A). Given the present 
results, it is likely that induction of several Nrf2-target genes by cadmium chloride was less 
pronounced in the presence of selenomethionine, although expression of a few xenobiotic 
metabolism genes was enhanced.   
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The p53-dependent effects on the mRNA expression levels of MT1X, MT2A and SLC30A1 following 
sodium selenite treatment occurred possibly due to oxidative zinc release of MTs. Exposure to 
selenomethionine did not affect the gene expression levels of these genes (Figure 5.10C), suggesting 
another differential transcriptional response to the two selenocompounds. 24 h exposure to 
selenomethionine and cadmium chloride increased the MTX1 and MT2A expression by 47-fold and 
11-fold, respectively (Figure 5.10C). Cadmium alone raised the MTX1 levels 19-fold after 24 h 
exposure, while the MT2A expression was 8-fold increased (Figure 5.6C). The expression of the 
ZnT1 gene (SLC30A1) was unchanged upon selenomethionine incubation, but a 4.3 fold change after 
24 h cadmium co-exposure was found (Figure 5.10C). This increase was most likely due to the 
influence of cadmium itself since cadmium alone induced a 3.3-fold change (Figure 5.6C). Target 
genes of the metal responsive transcription factor MTF-1, such as MTs and ZnT1, were thereby also 
induced in the presence of cadmium. 
While sodium selenite induced HMOX1 mRNA levels by 20-fold, a significant, but smaller (2-fold), 
change could be observed upon exposure to selenomethionine. Simultaneous exposure to 
selenomethionine and cadmium chloride led a 159-fold change of HMOX1 gene expression 
(Figure 5.10B), which was much higher than the 44-fold change by 24 h incubation with 10 µM 
cadmium chloride alone (Figure 5.6B). Several transcription factors such as AP-1 (Jun), Nrf2 and HSF-
1 may enhance the expression of the early responsive gene HMOX1 (Alam and Cook 2003). 
Figure 5.11 shows that selenomethionine exposure led to an enhancement of JUN gene expression 
levels by about 3-fold, which indicates an activation of the transcription factor AP-1. HSPA1A mRNA 
levels were unchanged after exposure to selenomethionine, such as in the case of sodium selenite, 
implying no activation of the transcription factor heat shock factor HSF-1. However, co-exposure to 
cadmium chloride induced HSPA1A mRNA levels 139-fold. In comparison to exposure to sodium 
selenite in combination with cadmium chloride, a 30-fold higher HSPA1A gene expression was seen 
(Figure 5.10B). Because 24 h incubation of 10 µM cadmium chloride strongly induced HSPA1A mRNA 
levels by more 200-fold (Figure 5.6B), this could imply that HSPA1A transcript levels are negatively 
affected by co-exposure to sodium selenite, but not by co-exposure to selenomethionine.  
The inflammation marker IL8 was also induced by selenomethionine by 8-fold, which, however, was 
induced over 84-fold by sodium selenite in a p53-independent manner. Co-exposure to cadmium 
chloride led to a 16-fold change of IL8 mRNA (Figure 5.10B). Because cadmium alone (10 µM) 
induced IL8 gene expression by 6-fold, the simultaneous exposure to selenomethionine and cadmium 
chloride seems to act additively on the gene regulation of IL8. When compared to sodium selenite 
and cadmium chloride co-exposure, co-exposure to cadmium chloride affected sodium selenite-
induced IL8 gene negatively, as in seen in Figure 5.6B. The mRNA levels of the p100 subunit of NF-
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κB, NFKB2, the NF-κB inhibitor IкBα NFKB1A or the p105 subunit of NF-κB, NFKB1, did not change 
upon selenomethionine exposure, but negatively affected by co-exposure to cadmium chloride. 
(Figure 5.10D). The NF-κB inhibitor IкBα NFKB1A was repressed by 60 % and the p105 subunit of 
NF-κB, NFKB1 was more than 40 % repressed. FTH-1 mRNA levels were, however, increased by 
treatment with selenomethionine by about 3-fold and by 2-fold following co-exposure to cadmium 
chloride (Figure 5.10A). The change in expression of FTH1 is presumably closely associated with the 
induction of HMOX1. The genes IL-8 and FTH-1 are targets of the transcription factor NF-κB, and 
their induction after selenomethionine exposure suggests a possible activation of NF-κB, although the 
subunits of the NF-κB were not enhanced, and, in the case of co-exposure, repressed.  
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Figure 5.10: Impact of selenomethionine (500 µM) in comparison to sodium selenite (5 µM) and 
the impact of selenomethionine (500 µM) in combination with cadmium chloride (10 µM) 
regarding the relative gene expression on genes associated with oxidative stress response (A, B, 
D)  and inflammation (C, D) in p53-proficient HCT116 cells after 24 h incubation. Gene name 
abbreviations listed in Table A3. Mean values ± SD of at least two independent experiments of double or single 
determinations are shown. 
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Genes associated with cell cycle control 
While sodium selenite increased mRNA levels of the cyclin-dependent kinase inhibitor CDKN1A1 
(p21) by 10-fold, the p21 expression levels did not change either upon selenomethionine exposure 
or co-exposure to cadmium and selenomethionine (Figure 5.11). As p21 also was induced by 3-fold 
by sodium selenite in the p53-deficient cells, a p53-independent induction of p21 was suggested 
(Figure 5.8). The CDK inhibitor CDKN2B, p15, was however increased by about 4-fold upon 
selenomethionine treatment, independent of cadmium (Figure 5.11). p15 was also p53 dependently 
increased after sodium selenite incubation. In other words, p21 gene expression was unaffected by 
selenomethionine exposure and affected by sodium selenite exposure independent from p53, while 
p15 transcript levels were found to be affected by exposure to selenomethionine and 
p53 dependently raised upon exposure to sodium selenite. Another p53 target gene enhanced in 
response to selenomethionine independent of cadmium was the serine/threonine‐protein kinase 
PLK3, indicating a possible G2/M arrest. The expression of the negative feedback regulator of p53, 
MDM2 was not increased, implying no activation by p53. p53 mRNA levels were tendentiously 
increased (1.8-fold). However, the activity of p53 is mainly regulated by post translational 
modifications, and not by transcriptional regulation (Vousden and Lu 2002). Repressed transcript 
levels of the transcription factor E2F1 important for cell cycle progression were found, indicating 
prohibited cell progression and cell cycle arrest, was observed for both selenocompounds, in 
addition to nearly doubled transcript levels of EGFR.  
A more than 50 % repression of the CDK inhibitor CDKN1B (p27) was observed following 
selenomethionine exposure in combination with cadmium chloride. We observed that the gene MYC 
that encodes c-Myc, which is a multifunctional, nuclear phosphoprotein and acts as a proliferative 
transcription factor, was more than 65 % down-regulated after co-exposure to selenomethionine and 
cadmium chloride, in addition to a 55 % repression of the transcription factor E2F1. A tendentious 
down-regulation of cell cycle inhibitor p27 and the transcription factors MYC and E2F1 was found 
after selenomethionine exposure and cadmium exposure alone (Figure 5.7), implying a possible 
additive repression in the simultaneous incubation of selenomethionine and cadmium chloride. 
E2F1 promoter contains c-MYC responsive elements (Oswald et al. 1994). Inhibition of 
E2F1 expression could result in decreased formation of the E2F1-DP1 complex, and, thereby in 
relatively low activation of DNA synthesis genes.  
An activation of the transcription factor AP-1 was assumed due to the selenomethionine-induced 
enhancement of JUN gene expression levels about 3-fold. An 11-fold increase in JUN gene induction 
was observed upon co-exposure to cadmium chloride (Figure 5.11). After 24 h exposure to cadmium 
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alone, a 4-fold change of JUN expression was found (Figure 5.7), suggesting an additive induction of 
JUN gene expression after co-exposure to selenomethionine and cadmium chloride. 
Figure 5.11: Impact of selenomethionine (500 µM) in comparison to sodium selenite (5 µM) and 
the impact of selenomethionine (500 µM) in combination with cadmium chloride (10 µM) 
regarding the relative gene expression on cell cycle control associated genes in p53-proficient 
HCT116 cells after 24 h incubation. Gene name abbreviations listed in Table A3. Mean values ± SD of at 
least two independent experiments of double or single determinations are shown.  
Genes associated with DNA repair pathways and apoptosis 
Sodium selenite induced several p53-dependent genes involved in NER and DNA damage response, 
in a p53-dependent fashion (Figure 5.8). Oxidative DNA damage is repaired by DNA base excision 
repair. Like in the case of sodium selenite, no enhancement of BER associated genes APEX, LIG3, 
OGG1, and POLB was observed after exposure to selenomethionine. However, mRNA levels of PCNA 
and LIG1 were repressed by about 50 %, indicating a possible inhibition of DNA repair processes. 
Repression of LIG1, a gene encoding for a DNA ligase and necessary for the conjunction of two DNA 
strands to one DNA strand, indicates a possible inhibition of DNA ligation. PCNA (proliferating cell 
nuclear antigen) suppresses the activation of DNA polymerase δ (POLD1), thereby playing a role in 
replication inhibition. Overall, it is evident that the two different selenocompounds clearly influence 
DNA damage gene regulatory patterns, and that this effect was selenium species-specific.  
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No significant induction of DNA damage response-associated genes could be found after co-
exposure to selenomethionine and cadmium chloride due to relatively high standard deviations 
(Figure 5.12A). Down-regulation of several repair genes was, however, observed in response to 
treatment, especially to co-treatment of selenomethionine and cadmium chloride.  Selenomethionine 
repressed LIG1 both in the presence and absence of cadmium. LIG1 is a gene encoding for a 
DNA ligase 1, and its repression might result in an inhibition of DNA ligation. The gene expression of 
PCNA, which is the co-factor of DNA polymerase δ by suppressing the activation of the polymerase, 
was even further repressed from 48 % down to 33 % in the presence of cadmium, which could imply 
a possible replication inhibition. The expression of the p53-dependent NER-associated gene 
DDB2 (p48/DNA damage‐binding protein 2) was down-regulated to 40 % in the presence of 
cadmium.  
The APEX gene encodes the major apurinic/apyrimidinic (AP) endonuclease, which is especially 
involved in DNA base excision repair. This gene was also repressed by 60 % upon simultaneous 
treatment of selenomethionine and cadmium chloride. Down-regulation of this important 
AP endonuclease, which initiates repair by cleaving the occurring AP site, could therefore impair the 
repair process. A 60 % down-regulation of the repair gene RAD51 was also found after co-exposure 
to cadmium. The gene product of RAD51 is a recombinase that transiently binds to both single-
stranded and double-stranded DNA during the recombination reaction, being essential in 
homologous recombination (HR) of DNA during double strand break repair. Taken together, 
exposure to selenomethionine alone and in combination with cadmium chloride could possibly inhibit 
DNA repair processes due to down-regulation of several central genes involved in these 
mechanisms. 
While sodium selenite enhanced induction of the pro-apoptotic genes BBC3 (Puma), TNFRSF10B 
(DR5), PMAIP1 (Noxa) and BAX, an indication of apoptosis induction, exposure to selenomethionine 
also led to an activation of DR5 and Noxa, which would suggest an induction of apoptosis 
(Figure 5.12B). This effect occurred also in the presence of cadmium. No significant changes in 
mRNA levels of the pro-apoptotic factors BBC3 (Puma) and BAX were observed. The anti-apoptotic 
gene XIAP, which encodes the X-linked inhibitor of apoptosis protein, doubled its transcript levels in 
response to co-exposure to cadmium and selenomethionine, while the anti-apoptotic BCL2 gene was 
down-regulated by 45 %. In addition, the mRNA content of the apoptosis initiator APAF-1 was 
repressed by about 40 %. The complex formed by APAF-1 and cytochrome C known as the 
apoptosome recruits and activates procaspase-9 initiating the first step in the cascade of caspase 
activation that ultimately leads to chromatin degradation (Mohamad et al. 2005; Shi 2001). Down-
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regulation of APAF1 could therefore lead to decreased formation of the apoptosome, and thus 
apoptosis.  
 
 
Figure 5.12: Impact of selenomethionine (500 µM) in comparison to sodium selenite (5 µM) and 
the impact of selenomethionine (500 µM) in combination with cadmium chloride (10 µM) 
regarding the relative gene expression on (A) DNA repair and (B) apoptosis associated genes in 
p53-proficient HCT116 cells after 24 h incubation. Gene name abbreviations listed in Table A3. Mean 
values ± SD of at least two independent experiments of double or single determinations are shown.  
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5.2.3 Summary of the gene expression profiling 
The oxidative stress response was strongly induced by sodium selenite, partially dependent of p53 
cellular status. Enhanced pro-inflammatory IL-8 levels suggest a mechanism for pro-inflammatory 
effects of sodium selenite-induced oxidative stress. Sodium selenite induced p53 target genes in cell 
cycle control, DNA repair and apoptosis, indicating strongly a p53-mediated response to DNA 
damage. The parallel induction of NER genes in addition to ATM and RRM2B represents an indicator 
of induced DNA repair – and synthesis. PUMA, Noxa and DR5 showed increased mRNA levels in both 
cell lines, suggesting a p53-independent response. Cadmium attenuated the sodium selenite-induced 
and p53-mediated up-regulation of genes involved in cell cycle, DNA repair and apoptosis. Moreover, 
the oxidative stress response was highly activated by cadmium alone. Selenomethionine had to less 
extent impact on gene expression regulation than sodium selenite, demonstrating species-specific 
effects. The DNA damage response, especially BER, was however negatively affected by 
selenomethionine, which was further repressed in the presence of cadmium. Table 5.1 summarizes 
the obtained gene expression profiles.  
Table 5.1: Summary of obtained gene expression profiles of selenocompounds alone or in combination with 
cadmium chloride. Na2SeO3: sodium selenite, SeMet: selenomethionine, CdCl2: cadmium chloride 
 Na2SeO3 
 
(p53+/+) 
Na2SeO3 
 
(p53-/-) 
Na2SeO3  
+ CdCl2 
(p53+/+) 
SeMet 
 
(p53+/+) 
SeMet 
+ CdCl2 
(p53+/+) 
CdCl2 
 
(p53+/+) 
MTs ↑ - ↑↑ - ↑↑↑ ↑↑↑ 
Heat-shock - - ↑ - ↑↑↑ ↑↑↑ 
Oxidative stress 
response  ↑↑ ↑ ↑↑↑ ↑ ↑↑ ↑↑↑ 
Inflammation ↑↑↑ ↑↑↑ ↑ ↑ ↑ ↑ 
Redox-sensitive 
transcription 
factors  
↑↑↑ ↑ ↑ - - ↓↑ 
Cell cycle 
progression  
- - - ↓ ↓ ↑↑ 
Cell cycle arrest ↑↑↑ ↑ - ↑ ↑ - 
DNA damage 
response ↑↑ - - ↓ ↓ - 
NER ↑↑ - - (↓) ↓ - 
BER - - - ↓ ↓↓ - 
Pro-apoptotic 
signaling ↑↑↑ ↑↑ ↑ ↑ ↑ ↑ 
Anti-apoptotic 
signaling ↑ - - - - ↑ 
       
Results and discussion 
 
57 
 
5.3 Oxidative stress 
Potential mechanisms in induction of oxidative stress include GSH-depletion or inhibition of ROS-
scavenging antioxidant enzymes, which are often proposed as mechanisms in cadmium-induced 
cytotoxicity. We investigated the possible depletion of GSH by cadmium in our cell model of 
HCT116 cells. Since the toxicity of sodium selenite may involve GSH in the reduction of sodium 
selenite, which could in turn lead to GSH-depletion and disturbance of the redox homeostasis by the 
production of superoxide, we examined the effect of simultaneous exposure to sodium selenite and 
cadmium chloride on GSH content and superoxide generation. Other potential targets of cadmium 
may be selenium-dependent enzymes like glutathione peroxidase and thioredoxin reductase as well 
as selenium-independent enzymes, such as glutathione reductase, superoxide dismutase and catalase. 
Selenoproteins could be a sensitive target in cadmium-induced carcinogenicity by specific binding to 
selenol group in these antioxidative enzymes. Examinations of enzyme activities of antioxidant 
enzymes after simultaneous exposure to sodium selenite and cadmium chloride were performed. 
5.3.1 Impact of sodium selenite in combination with cadmium 
chloride on GSH content  
GSH is the most prevalent low-molecular-weight thiol in mammalian cells and essential in the 
regulation of disulfide bonds of proteins and the detoxification of electrophiles and oxidants. Thus, it 
belongs to the major components in the cellular antioxidative defense. A reduced content of GSH or 
a shift towards GSSG are associated with intracellular oxidative stress. In non-stressed cells more 
than 99 % of GSH is maintained in its reduced state (Deneke and Fanburg 1989). The quantification 
of total GSH content was determined by Tietze’s enzymatic recycling assay using the thiol reagent 
DTNB (Tietze 1969). 
The intracellular GSH pool following exposure to increasing cadmium chloride concentrations at a 
series of time point was studied (Figure 5.13). At the earliest examined time points (2 h and 4 h), no 
changes in the intracellular GSH were observed after incubation with cadmium chloride in the 
concentration range from 1 µM to 50 µM. The lowest investigated cadmium chloride concentration 
(1 µM) had no influence on intracellular GSH levels at any of the studied time points. Increased 
intracellular GSH levels were, however, seen after 6 h exposure to cadmium chloride at a 
concentration of 5 µM, reaching a peak level after 12 h with 10 µM cadmium chloride. Neither longer 
incubation time (24 h) nor higher cadmium chloride concentration (50 µM) further increased the 
GSH pool. Cells growing under sodium selenite supplementation upon cadmium exposure showed 
similar patterns (data not shown). Buthionine sulfoximine (BSO) was used as a positive control to 
specifically deplete GSH due to its irreversible inhibition of γ-glutamyl-cysteine synthetase and 
B C 
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thereby de novo GSH synthesis. 1h exposure to 100 µM BSO depleted the total GSH level to 4.7 % 
compared to the untreated control, which contained on average 6.7 mM total GSH (data not shown).  
 
Figure 5.13: Impact of cadmium on intracellular GSH content. p53-proficient HCT116 cells were 
treated with increasing cadmium chloride concentrations (1 µM-50 µM) after several incubation time (2 h, 4 h, 
6 h, 8 h, 12 h and 24 h). The total content of GSH was determined after the method of Tietze. Mean values ± 
SD of three independent experiments are shown. Statistically significant differences from the corresponding 
untreated control at each time point were tested by ANOVA with Dunnett’s T3 Post-Hoc test: ** = p < 0.01, 
*** = p < 0.001.  
In p53-proficient HCT116 cells, sodium selenite reduced the cellular GSH level at cytotoxic 
concentrations (8 µM) after 8 h as well as after 24 h to about 65 % and 37.6 %, respectively. 
Increasing concentrations from 1 µM to 5 µM sodium selenite did not result in any significant changes 
in the cellular GSH content (Figure 5.14A). However, with similar conditions in p53-deficient cells, 
8 µM sodium selenite only diminished the GSH pool to 85.7 % of the control after 24 h exposure, 
implying a p53 dependent effect on the GSH-depletion provoked by sodium selenite (Figure 5.14B).  
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Figure 5.14: Impact of sodium selenite in combination with cadmium chloride on intracellular 
GSH content. p53-proficient HCT116 cells (A) or p53-deficient HCT116 cells (B) were treated with sodium 
selenite (1 µM-8 µM) in combination with 10 µM cadmium chloride for 8 h and 24 h incubation The total 
content of GSH was determined after the method of Tietze (Tietze 1969). Mean values ± SD of three 
independent experiments are shown. Statistically significant differences between single and combined 
treatments with cadmium chloride as tested by independent sample t-test (Mann Whitney U test): * = p < 0.05, 
** = p < 0.01. 
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Other studies have shown that cytotoxic effects followed by GSH-depletion are mediated, at least in 
part, through activation of p53 (Du et al. 2008). Incubation with cadmium chloride (10 µM) alone in 
p53-proficient HCT116 cells increased the glutathione content significantly compared to the 
untreated control. Sodium selenite in combination with cadmium chloride remained similar 
compared to cadmium chloride alone (Figure 5.14A). The same could be observed in p53-deficient 
HCT116 cells (Figure 5.14B). Only at 8 µM sodium selenite, the GSH pool in the presence of 
cadmium chloride was dropped to control levels after 8 h and 24 h co-exposure in the p53-proficient 
cells.  
The rapid rise in GSH levels in response to only short exposure to cadmium might be due to the 
induction of newly synthesized GSH. Intensified regeneration of GSSG to GSH could also play a role. 
Based on the gene expression profile following cadmium chloride, increased gene expression levels of 
GSH-synthesizing γ-glutamyl cysteine ligase (GCLC) and the GSSG reducing GR were induced, which 
supports the effect of cadmium chloride on the increased GSH content. These results are in 
agreement with other studies showing that exposure to cadmium results in the induction of GCLC, 
facilitating enhanced GSH synthesis (Bannai et al. 1991; Eneman et al. 2000). GSH might be the 
primary detoxifying mechanism against cadmium for the cell due to the fact that its cysteine thiol 
group, which reduces the heavy metal by generating a stable glutathione-cadmium complex 
(Delalande et al. 2010). Cadmium has a high affinity for thiols, and thus the highly abundant GSH is a 
primary target for free cadmium ions in cells. GSH acts by scavenging cadmium to prevent its 
interaction with critical cellular targets. Reports show that during acute cadmium exposure 
GSH levels undergo a rapid depletion, and cadmium-induced depletion of the GSH pool, thus 
disturbing the redox balance and leading to an oxidative environment (Lopez et al. 2006). Chronic 
exposure to cadmium produces an elevation in tissue GSH content, which in turn decreases 
oxidative damage, which could be explained by the initial cadmium-induced GSH depletion 
counteracted immediately via an increased GSH synthesis (Cuypers et al. 2010). A significant rapid 
increase of GSH levels in the protective response to cadmium exposure through Nrf2 signaling in 
Jurkat T-cells is also reported (Ogasawara et al. 2014). Their findings suggest that cadmium-induced 
activation of GSH synthesis is initiated as an acute response for cadmium detoxification. They found 
that MT expression induced by cadmium occurred much later. The study indicates that the rapid 
increase in GSH is an essential defense response, with the subsequent induction of MT potentially 
chelating the remaining cadmium retained within the cell, and thereby leading to continued 
suppression of cadmium toxicity. 
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5.3.2 Impact of sodium selenite in combination with cadmium 
chloride on superoxide generation  
We determined the induction of superoxide radicals after exposure to increasing concentrations of 
sodium selenite in the presence and absence of 10 µM cadmium chloride for 6 h. The redox cycler 
menadione was used as a positive control to induce superoxide. 15 min incubation of 100 µM 
menadione increased superoxide levels dramatically to 345 % in the p53-proficient HCT116 cells 
compared to the untreated control (Figure 5.15A). The whole concentration range of sodium 
selenite from 3 µM to 9 µM induced significantly the superoxide levels in p53-proficient cells, while 
concomitant exposure to cadmium chloride suppressed sodium selenite-enhanced superoxide 
generation. At the concentration 5 µM sodium selenite, the superoxide induction was increased to 
161 %, while 7 µM and 9 µM sodium selenite caused an increase to 216 % and 238 %, respectively. 
Figure 5.15A shows also that the same concentration range of sodium selenite failed to generate 
significant levels of superoxide in the p53-deficient HCT116 cells, indicating a p53-dependent effect 
on superoxide induction when the cells are exposed to sodium selenite. In contrast, exposure to the 
fully-reduced selenomethionine did not induce superoxide in either set of HCT116 cells (Figure 
5.15B). These results indicate that superoxide generation is presumably p53-mediated due to 
p53 activation upon sodium selenite exposure, which might play an important role in pro-apoptotic 
signaling induced by sodium selenite in HCT116 cells.  
Cadmium did not induce formation of superoxide in HCT116 cells under the given conditions. 
Appearing in its +2 oxidation state, cadmium belongs to the transition metal group, however, 
cadmium is not redox-active, being unable to induce ROS in Fenton or Haber Weiss like reactions 
(Casalino et al. 1997; Eneman et al. 2000). As an exogenous source cadmium is demonstrated to 
indirectly produce ROS in various cell lines (Price and Joshi 1983; Szuster-Ciesielska et al. 2000; 
Watanabe et al. 2003). Production and accumulation of ROS inhibits the electron transfer chain in 
mitochondria (Wang et al. 2004). Cadmium has been shown to generate ROS, producing a 
breakdown of the mitochondrial membrane potential (Lopez et al. 2006).  
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Figure 5.15: Impact of sodium selenite or selenomethionine in combination with cadmium on 
superoxide generation. p53-proficient and p53-deficient HCT116 cells were treated with (A) sodium 
selenite (3 µM-9 µM) or (B) selenomethionine (100 µM-500 µM) in combination with cadmium chloride (10 
µM) for 6 h. 15 min incubation with 100 µM menadione was used as the positive control (PC). The level of 
superoxide was detected by the dye indicator dihydroethidium (DHE) using flow cytometry. Mean values ± SD 
of three independent experiments are shown. Statistically significant differences between single and combined 
treatment with cadmium chloride as tested by independent sample t-test (Mann-Whitney U test): * = p < 0.05, 
** = p < 0.01. Statistically significant differences between untreated control and positive control tested by 
ANOVA with Dunnett’s T3 Post-Hoc test:  *** = p < 0.001.  
0
50
100
150
200
250
300
350
400
450
0 3 5 7 9 PC
D
H
E
 s
ig
n
a
l 
 
(%
 o
f 
c
o
n
tr
o
l)
 
Sodium selenite [µM] 
p53-proficient
p53-proficient + cadmium chloride (10 µM)
p53-deficient
p53-deficient + cadmium chloride (10 µM)
A 
*** 
* 
** 
** 
** 
0
50
100
150
200
250
300
350
400
450
0 100 300 500
D
H
E
-S
ig
n
a
l 
 
(%
 o
f 
c
o
n
tr
o
l)
 
Selenomethionine [µM] 
p53-proficient
p53-proficient + cadmium chloride (10 µM)
p53-deficient
p53-deficient + cadmium chloride (10 µM)
B 
Results and discussion 
 
63 
 
5.3.3 Impact of cadmium chloride on enzymatic activities of isolated 
antioxidant enzymes  
Selenoproteins could be potential targets of cadmium due to their selenol group in the catalytic 
active site. Figure 5.16A shows that the enzyme activity of isolated GPx from bovine erythrocytes is 
strongly reduced after incubation with cadmium. About 50 % of the inhibition occurred already after 
incubation with 5 µM cadmium. At the highest tested concentration (50 µM), the remaining GPx 
activity was about 9 %. The enzyme activity of isolated TrxR from rat liver was concentration- 
dependently inhibited after incubation with cadmium chloride (Figure 5.16B). Furthermore, the 
concentration of TrxR incubated with cadmium chloride was decisive in the observed activity 
inhibition. GR is structurally homologous to TrxR: both are members of pyridine nucleotide-
disulphide oxidoreductase family, but are differentiated by the SeCys in the active catalytic center of 
TrxR and Cys residue of GR (Zhong et al. 2000). We investigated whether cadmium could also 
inhibit GR enzyme activity due to this homology. Figure 5.16C shows that GR activity decreased with 
increasing cadmium concentrations. About 50 % of the inhibition occurred, like in the case with GPx, 
already after incubation with only 5 µM cadmium. These data suggest that cadmium is able to interact 
with both the thiol group in GR and selenol in TrxR and GPx, thus inhibiting their enzyme activity in 
a subcellular context.  
Figure 5.16: Impact of cadmium on enzyme activity. Isolated GPx (100 mU/ml) from bovine 
erythrocytes (A), isolated TrxR (30 or 50 nM) from rat liver (B), and isolated GR (2,5 U/ml) from Baker’s yeast 
(C) were incubated with increasing cadmium chloride concentration for 5 min. Total GPx activity was 
determined indirectly by GR coupled assay with reduction of GSH. Total TrxR activity was determined with 
the DTNB reduction assay. Total GR activity was determined by NADPH consumption in regeneration of 
GSH. Mean values ± SD of at least two experiments are shown. 
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5.3.4 Impact of sodium selenite in combination with cadmium 
chloride on enzymatic activities of antioxidant enzymes  
We determined the impact of our treatments on antioxidant enzyme activities originating from the 
same cell extracts from HCT116 cells. Figure 5.17A shows that sodium selenite increased 
thioredoxin reductase activity, also in the p53-deficient cells as in the presence of cadmium, which 
reflects the results from the gene expression analysis. Only a marginal increase of GR activity to 
130 % was observed after sodium selenite treatment, however, increased GR activity (165 %) in the 
presence of cadmium was seen (Figure 5.17B). No significant change in GPx activity after sodium 
selenite exposure was seen in neither cell lines, regardless of co-exposure to cadmium (Figure 
5.17C). The selenocysteine residue in the active center of the selenoproteins GPx and TrxR seemed 
to be a less sensitive target of cadmium in the cellular context. Complexation of cadmium within the 
cells could be a possible explanation why enzyme activity inhibition could not be shown in cells 
exposed to cadmium, thereby unable to reach the level an intracellular concentration of free 
cadmium required for enzyme activity inhibition. 
These three antioxidant enzymes play important roles in the antioxidative defense. Together with 
thioredoxin (Trx) and NADPH, thioredoxin reductase is an essential part of the thioredoxin system 
which exists in nearly all living cells. Trx is a small redox active protein sustaining a wide range of 
functions in many different organisms. The oxidized Trx possesses an active site disulfide that has to 
be reduced to a dithiol for Trx to exert most of its functions. This reduction is catalyzed by TrxR 
using NADPH. The different functions of Trx are thereby entirely dependent upon the activity of 
TrxR (Arner 2009). Glutathione reductase catalyzes the reduction of glutathione disulfide (GSSG) to 
the sulfhydryl form glutathione (GSH), which is essential in maintaining the reducing environment of 
the cell (Seefeldt et al. 2009). Glutathione peroxidases reduce lipid hydroperoxides to their 
corresponding alcohols by oxidation of the selenol of its selenocysteine residue by hydrogen 
peroxide, and thereby using GSH as substrate free hydrogen peroxide can be reduced to water 
(Brigelius-Flohe 2008). 
Under standard cell culture conditions selenium is deficient in the growth medium (Muller et al. 
2010). We cultivated HCT116 cells also by supplementing the growth medium with 50 nM sodium 
selenite already in freshly thawed cells, providing time for the cells to express and induce 
selenoproteins. Basal GPx activity was more than 200 % higher in selenite supplemented cells, while 
basal TrxR activity was not significantly higher under selenite supplementation (data not shown). We 
further investigated whether Se supplementation could potentially enhance overall cellular 
antioxidative capacity by modulating catalase and SOD enzyme activities. However, sodium selenite 
supplementation did not alter their basal enzyme activities (data not shown).  
Results and discussion 
 
65 
 
Figure 5.17: Impact of sodium selenite in combination with cadmium chloride on (A) TrxR 
enzyme activity (B) GR activity and (C) GPx activity in p53-proficient and p53-deficient HCT116 
cells after 24 h incubation. 10 µM auranofin (AU) (6 h) served as TrxR positive control. TrxR activity was 
determined by the DTNB reduction assay. 100 µM 2-AAPA (20 min) served as GR positive control. Total GR 
activity was determined by NADPH consumption in regeneration of GSH. 10 mM mercaptosuccinate (MS) 
(5,5h) served as GPx positive control. Total GPx activity was determined indirectly by GR coupled assay with 
reduction of GSH. Mean values ± SD of three independent experiments are shown. Statistically significant 
differences between single and combined treatment with cadmium chloride as tested by independent sample t-
test (Mann Whitney U test): * = p < 0.05, ** = p < 0.01. Statistically significant differences from the negative 
control and positive control tested by ANOVA with Dunnett’s T3 Post-Hoc test: * = p < 0.05, ** = p < 0.01, 
*** = p < 0.001. 
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Neither catalase activity (see appendix Figure A1A) nor SOD activity was significantly decreased 
(see appendix Figure A1B) following cadmium exposure. Sodium selenite decreased catalase activity 
in both cell lines in the absence of cadmium, but not significantly (see appendix Figure A1A). Gene 
expression data showed, however, that catalase mRNA levels tended to be decreased upon sodium 
selenite exposure. Total SOD activity was not significantly changed following exposure to sodium 
selenite (see appendix Figure A1B). The catalase enzyme contains four heme groups per tetramer, 
whereby the N triangle of the His 74 imidazole residue is the functional catalytic site (Casalino et al. 
2002). This essential enzyme protects against oxidative stress by detoxifying hydrogen peroxides to 
water and oxygen. The mechanisms suggested for decreased catalase activity are interactions 
between cadmium and the catalytic subunit of the enzyme, as well as iron deficiency due to cadmium 
exposure (Cuypers et al. 2010). Reduced enzyme activity is linked to pH-sensitive reduction of 
nitrogen in the imidazole residue of His 74. At physiological pH, this nitrogen is unprotonated, 
making it possible for cadmium to interact with the active site. Casalino et al. showed that cadmium-
induced inhibition of liver mitochondrial MnSOD activity was completely restored when adding 
Mn2+ ions, suggesting that the activity-reducing effect on this enzyme was probably due to the 
substitution of cadmium by manganese (Casalino et al. 2002). However, reduced activity of the 
enzyme did not seem to be due to the replacement of zinc by cadmium, nor to the peroxides 
formed. Ikediobo et al. demonstrated that cadmium exposure in CRL-1439 normal rat liver cells led 
to loss of SOD, catalase, GR and GPx enzyme activities after 4 h (Ikediobi et al. 2004). However, the 
concentrations chosen were very high and possibly toxic concentrations (100-300 µM). SOD and 
GPx activities increased after 8 h exposure, while catalase and GR were significantly decreased. One 
possible underlying mechanism of cadmium-induced effects on GPx activities might be selenium 
depletion arising from the formation of Cd-Se-Cys complex at the active site of GPx. It is well 
established that cadmium is able to form covalent attachments with various cellular thiols (e.g. GSH, 
MTs as well as proteins). The impact of total SOD activity as well as catalase activity following 
cadmium exposure has been intensively studied, resulting in descriptions of increases and decreases 
of their activities depending on exposure conditions and target system studied (Cuypers et al. 2010).  
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5.4 Cell cycle distribution and apoptosis 
Different types of DNA lesions occur due to DNA damage, leading to changes of the course of cell 
cycle, a complicated, interacting network of various regulatory factors involved in the control of cell 
growth and genomic stability. Repair of DNA damage is often connected with the cell cycle arrest to 
ensure sufficient time for recovering to the original undamaged condition. If repair is not possible, 
another controlled mechanism, programmed cell death, is induced. In addition to the analysis of 
transcript levels of genes associated with apoptosis, examination of involvement of apoptosis in the 
observed cytotoxic effects of sodium selenite, several parameters were investigated, including 
increase of sub-diploid cells (sub-G1 fraction), cell viability, mitochondrial membrane potential, and 
translocation of AIF. 
The obtained gene expression profiles showed induction of several p53 target genes, such as the cell 
cycle inhibitors CDKN1A and CDKN2B as well as pro-apoptotic genes PUMA, NOXA, DR5 and BAX 
after treatment with sodium selenite, which indicates that sodium selenite induced genotoxic stress, 
cell cycle arrest and induction of apoptosis. Therefore, cell cycle distribution and cell viability was 
examined from the same sample using increasing concentrations of sodium selenite in combination 
with 10 µM cadmium chloride for 24 h. Floaters and attached cells were combined for the analysis. 
The cell cycle phases were analyzed by flow cytometry and DNA staining with DAPI. Figure A3 in the 
appendix illustrates how the single phases are distributed according to DNA content: Cells in the 
G2/M phase contain double DNA content compared to cells in the G1 or G0 phases, while cells in S-
phase have DNA contents between those cells in G1 and G2/M phase. Classification of cell viability 
was analyzed by simultaneous three color staining with propidium iodide (PI) and FITC-conjugated 
Annexin-V, which indicate membrane integrity and phosphatidylserine (PS) exposure, respectively, in 
addition to DiIC1(5), which determines mitochondrial membrane potential by accumulating in 
mitochondria with active membrane potential (see appendix Figure A4). 
5.4.1 Impact of sodium selenite in combination with cadmium 
chloride on cell cycle distribution and sub-G1 fraction  
The impact of sodium selenite on cell cycle distribution was dependent on the p53 status of the 
HCT116 cells (Figure 5.18). The effects induced by 7 µM sodium selenite in p53-proficient cells 
treated for 24 h were significantly different from the untreated control. Cells in the G1 phase 
declined from 45.2 % in untreated cells to 33.3% in treated cells, increased from 22.3 % to 30.6 % in 
the S phase, declined from 31.7 % to 25.1 % at G2/M phase, and increased from 0.4 % to 11.3 % sub-
G1 fraction, characteristic of apoptotic cells. Even though the G1 phase arrest was not observed, the 
sub-G1 fraction of sub-diploid cells was significantly increased in the higher tested concentrations of 
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sodium selenite and accompanied by S phase arrest (Figure 5.18A), suggesting that the cells are 
arrested in G1 phase but have already initiated programmed cell death. Lower concentrations than 6 
µM sodium selenite did not produce such effects. These results clearly showed that sodium selenite 
could significantly affect the cell cycle distribution of HCT116 cells and induce apoptosis. However, 
these effects were abolished in the presence of cadmium chloride (Figure 5.18B). Results from the 
flow cytometry showed that p53-deficient HCT116 cells treated for 24 h by sodium selenite had a 
similar cell cycle distribution as untreated cells, whereby cells in the G1 phase comprised about 47 % 
of the total cell population, S phase 24 %, and G2/M phase 28 %. Moreover, no increased sub-G1 
fraction was observed (Figure 5.18C). Cao and co-workers performed cell cycle analysis and gene 
expression profiling with different doses of sodium selenite, which inhibited cell proliferation in 
NB4 cells (Cao et al. 2006). They showed an increased G0/G1 cell cycle arrest in addition to 
enhanced sub-G1 peak, accompanied with up-regulation of pro-apoptotic genes, such as BAX and 
CASP8. Exposure to 500 µM selenomethionine affected the cell cycle by depleting S phase, 
independent of p53, as well as a concomitant G2 phase arrest, independent of cadmium (data not 
shown).  
In human DU145 prostate cancer cells, expressing mutant p53, S phase arrest was detected after 
sodium selenite incubation. This arrest was independent from p53, and p21 also did not play a role 
(Jiang et al. 2002). Our working group has previously shown that sodium selenite induced p21 first of 
all p53 dependently at the protein level (Klaus 2009). Data on cell cycle analysis in colon cancer cell 
lines focusing on the influence of sodium selenite have been studied. Cytotoxic levels of sodium 
selenite led to arrest in the S- and G1 phases and induction of p21 at mRNA level in HAT-29 cells, 
which express mutant p53 (Zeng and Davis 2003). The expression of cell cycle control genes in p53-
deficient cells presented in this current work was increased, but whether the induction of p21 
compared to the p53-proficient cell line was enhanced at the protein level needs to be investigated.  
Based on the transcriptional activation of p53 target genes, CDKN1A and CDKN2B, we expected to 
see an effect on the cell cycle. In principle, activation of kinase inhibitors can serve as a protective 
mechanism following genotoxic stress. CDKN1A encodes for the cyclin-dependent kinase inhibitor, 
p21, which following its activation leads to cell cycle arrest in the G1/S, as well as G2/M phases and 
to cellular senescence (Abbas and Dutta 2009). p21 belongs to the so-called stress response gene 
family. The protein p21 is activated by p53 and binds to cyclin-CdK complex. As a downstream gene 
of p53, p21 is a part of p53-mediated apoptotic signaling. CDKN2B encodes the cyclin-dependent 
kinase inhibitor p15, which like p21 induces G1 phase cell arrest. A p53-dependent prevention of cell 
cycle arrest upon co-exposure to cadmium was also expected in regard to the observed reduced 
cytotoxicity and deregulated gene expression. Meplan and co-workers investigated the impact of 
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cadmium on p53 conformation, DNA-binding and transcriptional activity (Meplan et al. 1999). They 
showed that sub-toxic concentrations of cadmium (10-30 µM) disturbed the folding of p53 and 
abolished binding of DNA to the protein. Moreover, cadmium impaired the induction of p53 by a 
DNA-damaging agent and down-regulated the transcriptional activity. Cell cycle arrest in response to 
γ-irradiation was prevented in the presence of cadmium.  
Figure 5.18: Impact of sodium selenite in combination with cadmium on cell cycle distribution. 
p53-proficient HCT116 cells (A, B) and p53-deficient HCT116 cells (C, D) were treated with sodium selenite 
(3 µM-7 µM) in combination with cadmium chloride (10 µM) for 24 h incubation. Cell cycle distribution was 
determined by flow cytometry using the DNA dye 4’, 6-diamidino-2-phenylindole (DAPI). Mean values ± SD of 
least three independent experiments are shown. Statistic significant differences between single and combined 
treatment with cadmium chloride as tested by independent sample t-test (Mann Whitney U test): ** = p< 0.01. 
Statistically significant differences from the corresponding negative control tested by ANOVA with Dunnett’s 
T3 Post-Hoc test: °° = p < 0.01, °°° = p < 0.001.  
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5.4.2 Flow cytometric analysis of cell viability 
HCT116 cells with different p53 status were incubated with increasing amounts of sodium selenite 
for 24 h with or without cadmium chloride (Figure 5.19 and Figure 5.20). At the end of treatment, 
trypsin-detached cells as well as floaters in the incubation medium were stained simultaneously by 
three dyes: the nucleic acid dye PI, phosphatidylserine marker FITC-conjugated Annexin-V, and 
mitochondrial membrane potential dye DiIC1(5). Cells that are AnnexinV-positive and PI-negative 
are in early apoptosis, as PS translocation has already occurred, although the plasma membrane 
remains intact. By gating the stained cells into sub-populations according to staining patterns, the 
degree of cell viability could be determined. Cells that are positive for both Annexin-V and PI are 
either in the late stages of apoptosis or are already dead, as PS translocation has occurred, and the 
loss of plasma membrane integrity is visible.  
Figure 5.19A shows that sodium selenite caused loss of membrane integrity and PS translocation, as 
well as increased loss of mitochondrial membrane potential in a dose-dependent manner, indicating 
induction of apoptotic as well as necrotic cell death. These staining patterns were strongly 
suppressed in p53-deficient cells (Figure 5.20) and by co-exposure to cadmium chloride (Figure 
5.19B). However, this method cannot discriminate between late apoptotic and primary necrotic cells, 
since both of these groups of cells are Annexin V-positive/PI-positive, whereas late apoptotic cells 
exhibit same staining patterns due to a loss of plasma membrane integrity. In addition, reliable 
apoptotic quantification in adherent cell cultures by flow cytometry is difficult and unreliable given 
the fact that during the process of cell harvesting and manipulation before and during flow cytometry 
assays many apoptotic cells undergo secondary necrosis (Oropesa-Avila et al. 2014). 
According to the gene expression data, the pro-apoptotic BAX gene was induced in p53 dependent 
manner, but suppressed by the presence of cadmium. Bax is an initiator in mitochondrial apoptotic 
pathway. Direct activation of Bax mediates mitochondrial membrane permeabilization, releasing 
cytochrome C into the cytoplasm to mitochondria, which triggers subsequent activation of executer 
caspases and leads to apoptosis (Zhang et al. 2000). Sodium selenite induced p53-mediated activation 
of Bax transcription, which can translocate into the mitochondria, and trigger loss of mitochondrial 
membrane integrity. Sodium selenite induced apoptosis by producing superoxide to activate p53, 
whose activation in turn synergistically enhanced superoxide production and apoptosis induced by 
sodium selenite (Zhao et al. 2006). Inorganic selenium sensitizes prostate cancer cells TRAIL-induced 
apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway (Hu et al. 
2006).  
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Figure 5.19: Impact of sodium selenite in combination with cadmium on cell viability of p53-
proficient HCT116 cells determined by flow cytometric analysis. Cells were treated with sodium 
selenite (3 µM-7 µM) alone (A, B) in combination with cadmium chloride (10 µM) (C, D) for 24 h incubation. 
Necrotic cells: propidium iodide (PI) positive/annexin positive, apoptotic cells: PI negative/annexin positive, 
viable cells: PI negative/annexin negative. Mitochondrial membrane potential (MMP); MMP+: active MMP, MMP-: 
decreased MMP. Mean values ± SD of three independent experiments are shown. Statistically significant 
differences between single and combined treatment with cadmium chloride as tested by independent sample t-
test (Mann Whitney U test): * = p < 0.05, ** = p < 0.01. 
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Figure 5.20: Impact of sodium selenite in combination with cadmium on cell viability of p53-
deficient HCT116 cells determined by flow cytometric analysis. Cells were treated with sodium 
selenite (3 µM-7 µM) alone (A, B) in combination with cadmium chloride (10 µM) (C, D) for 24 h incubation. 
Necrotic cells = propidium iodide (PI) positive/annexin positive, apoptotic cells = PI negative/annexin positive, 
viable cells = PI negative/annexin negative. Mitochondrial membrane potential (MMP); MMP + = active MMP, 
MMP - = decreased MMP. Mean values ± SD of three independent experiments are shown.   
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5.4.3 AIF translocation 
Apoptosis-inducing factor (AIF) is released into the cytosol in mitochondria-mediated apoptosis and 
further translocated to the cell nuclei, where it accumulates and in turn induces apoptosis. We 
observed that sodium selenite induced nuclear translocation of AIF to 130 %, which was significant 
compared to negative control cells (Figure 5.21A). The sodium selenite-induced AIF translocation 
was significantly decreased by cadmium. No translocation of AIF was also seen in p53-deficient 
HCT116 cells (data not shown). The apoptosis-inducer staurosporine (STS) (400 nM) served as the 
positive control and increased the AIF fluorescence signal to 146 %. With regard to 
selenomethionine, no nuclear translocation of AIF could be detected (data not shown). Detection of 
AIF by the means of immunofluorescence microscopy normally exhibits a punctuated cytoplasmic 
staining pattern with some preference for the perinuclear area, which is typical for mitochondrial 
localization (Daugas et al. 2000). This pattern was seen in the untreated HCT116 cells in both cell 
lines. After treatment with STS and sodium selenite, apoptotic cells, in which DNA condensation 
took place, were visible, with an increase in the fluorescence signal intensity within the cell nuclei.  
Apoptotic cells are characterized by various morphological, molecular and biochemical properties, 
e.g. cell shrinkage, membrane “blubbing”, chromatin condensation and DNA fragmentation. 
Detection of several parameters of apoptosis is essential for identifying definitely apoptotic cells 
(Rahman et al. 2002). In this present work, sodium selenite affected the normal cell cycle distribution 
and generated a detectable fraction of late apoptotic cells with subdiploid DNA, which was not found 
after co-exposure to cadmium chloride. The amount of AIF located in the nuclei was increased in 
p53-proficient HCT116 cells, while co-exposure to cadmium or selenomethionine alone did not 
produce apoptotic outcomes. 
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Figure 5.21: Impact of sodium selenite on nuclear AIF translocation in combination with 
cadmium chloride as well as impact of selenomethionine on nuclear AIF translocation. p53-
proficient HCT116 cells were incubated for (A) 24 h with sodium selenite alone and in combination with 
cadmium chloride (15 µM, 2 h pretreatment). (B) Shown are representative immunofluorometric images from 
three experiments. Scale bar = 32 µM, magnification of the pictures = 63x. The nuclear translocation of AIF 
was visualized by indirect immunofluorescence microscopy The DNA dye 4’, 6-diamidino-2-phenylindole 
(DAPI) was used to stain the nuclei. Staurosporine (STS) 400 nM was used as positive control. Mean values ± 
SD of three experiments are shown. Statistically significant differences between single and combined treatment 
with cadmium chloride as tested by independent sample t-test (Mann-Whitney U): * = p < 0.05. Statistically 
significant differences between the positive control and the corresponding negative control tested by 
independent sample t-test (Mann-Whitney U): ** = p < 0.01.  
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5.5 Bioavailability 
To investigate if the observed cytotoxic effects by the two selenocompounds are associated to 
bioavailability, the total cellular uptake of selenium was quantified. Bioavailability is characterized as 
the relationship between the applied and the resorbed amount of a substance. Previous work in this 
working group showed that cellular uptake of sodium selenite in HCT116 cells was p53 dependent, 
but not selenomethionine (Klaus 2009). Therefore, the question concerning a possible interaction of 
cadmium chloride with the uptake of sodium selenite in a p53 dependent matter was raised. Could 
cadmium co-exposure affect the bioavailability of sodium selenite by inhibiting the cellular uptake of 
the element, and thus reduce the cytotoxic effects observed after sodium selenite exposure? With 
regard to selenomethionine, would cadmium exert no influence on the fully-reduced 
selenomethionine due to its presumably p53 independent cellular uptake?  
The basal contents of selenium in untreated cells were 1.4 µM and 2.3 µM in the p53-proficient and 
the p53-deficient cells, respectively (Figure 5.22A). Under standard cell culture conditions, cells are 
grown under selenium deficient conditions. Previous investigations showed that the content of 
selenium in the cell culture growth medium was 2 nM (Klaus 2009). Exposure to 7 µM sodium 
selenite reached 44.4 µM intracellular selenium concentration in the p53-proficient cells and 40.5 µM 
intracellular selenium concentrations in the p53-deficient cells (Figure 5.22A). The uptake of selenium 
as sodium selenite was, however, significantly higher in the p53-proficient HCT116 cells than in the 
p53-deficient cell line at lower tested concentrations, confirming the observation previously seen in 
our working group.  
To address the question whether cadmium co-exposure could decrease the uptake of sodium 
selenite, cells were co-incubated with sodium selenite and cadmium chloride for 24 h. Cadmium 
exposure alone did not significantly change the basal content of selenium in either cell line. 
Unexpectedly, simultaneous exposure to cadmium chloride led to a dramatically increased content of 
intracellular selenium over the whole concentration range in both cell lines (Figure 5.22B). These 
results show that cadmium chloride improves the bioavailability of sodium selenite independently of 
the cellular p53 status. Indeed, there was a significant higher absolute uptake of selenium in the p53-
proficient HCT116 cells in the lower concentration range of sodium selenite than in the p53-deficient 
cells. In the p53-proficient cells, from 5 µM sodium selenite, the uptake of selenium reached a plateau 
around 700 µM in the simultaneous presence of cadmium chloride. In the p53-deficient cell line, a 
concentration-dependent increase of intracellular selenium was observed, reaching a concentration 
of 886 µM intracellular selenium when co-exposed to 7 µM sodium selenite and 10 µM cadmium 
chloride for 24 h. 
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Figure 5.22: Cellular uptake of sodium selenite in p53-proficient- and p53-deficient HCT116. Cells 
were incubated with (A) sodium selenite (3 µM-7 µM) without cadmium chloride, (B) or in combination with 
cadmium chloride (10 µM) for 24 h. The total cellular selenium content was determined by graphite furnace 
atomic absorption spectroscopy (GF-AAS). Mean values ± SD of three independent experiments are shown. 
Statistically significant differences between the cell lines as tested by independent sample t-test (Mann Whitney 
U test): * = p < 0.05, ** = p < 0.01, *** = p < 0.001. 
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The intracellular selenium concentration after 24 h exposure to selenomethionine produced a 
different picture compared to sodium selenite exposure. After incubation with 10 µM 
selenomethionine in the p53-proficient HCT cells, 79.1 µM intracellular selenium was measured 
(Figure 5.23), which exerted no cytotoxic effects. In contrast, exposure to 7 µM sodium selenite 
increased the intracellular concentration to only 44.4 µM selenium (Figure 5.22A), however, which 
was sufficient to strongly induce cell death. 
 
Figure 5.23: Cellular uptake of selenomethionine in p53-proficient and p53-deficient 
HCT116 cells. Cells were incubated with selenomethionine (10 µM-1000 µM) without cadmium chloride or 
in combination with 10 µM cadmium chloride for 24 h. The total cellular selenium content was determined by 
graphite furnace atomic absorption spectroscopy (GF-AAS). Mean values ± SD of at least two independent 
experiments are shown. Statistically significant differences between single and combined treatment with 
cadmium chloride as tested by independent sample t-test (Mann Whitney U test): *** = p < 0.001. 
 
Increasing the selenomethionine incubation concentration from 10 to 100 µM resulted in an 
approximately 10-fold increase in the intracellular selenium level. Further increasing the 
selenomethionine incubation concentration to 500 µM raised the intracellular content of selenium by 
36-fold to about 2900 µM. Raising the incubation concentration of selenium to 1000 µM further 
enhanced the intracellular selenium content almost by 64-fold (5100 µM). Compared to basal levels, 
with increasing selenomethionine concentrations, a nearly linear uptake of selenium was observed 
(correlation coefficient >0.99). Simultaneous exposure to selenomethionine (up to 500 µM) and 10 
µM cadmium chloride, no difference in the intracellular level of selenium was found compared to 
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selenomethionine exposure in the absence of cadmium chloride. However, at 1000 µM 
selenomethionine in the presence of cadmium, the intracellular level of selenium reached about 
3700 µM compared to 5100 µM without co-exposure in the proficient cell line. Selenomethionine 
and other selenoamino acids appear to be effectively transported by various intestinal amino acid 
transporters (Nickel et al. 2009), which do not seem to be affected by the presence of cadmium. 
What could explain the strongly enhanced uptake of selenium after exposure to sodium selenite in 
the presence of cadmium? Several studies have shown that selenium uptake in the form of selenite 
increases after extracellular thiol-assisted reduction (Ganyc and Self 2008; Olm et al. 2009; Tarze et 
al. 2007). Tarze et al. (2007) demonstrated that millimolar tolerance to selenite in yeast can be 
reduced to the micromolar range in the presence of excessive thiols in the growth medium through 
high-affinity uptake of a more reduced form of selenite. All assayed thiols were shown to drastically 
enhance selenite toxicity, resulting in entry of selenium inside the cell possibly under the form of 
hydrogen selenide. Ganyc and Self (2007) used a human keratinocyte model to determine whether 
reduction of selenite to the more reduced form, selenide, would affect uptake. They showed a high-
affinity uptake of selenium even in the nanomolar range of selenite through the addition of 
extracellular thiols. Selenium uptake was prevented in keratinocytes by an anion channel blocker in 
the presence and absence of GSH, suggesting that both selenite and selenide were taken up through 
these pathways but with different affinities. Olm et al. (2009) showed that selenite cytotoxicity is 
determined by its cellular uptake and not by intrinsic cellular differences. Selenite uptake and 
consequently its cytotoxic effects were dependent on the extracellular redox state. By oxidizing or 
reducing compounds the extracellular state was modulated, and thus able to sensitize or desensitize 
cells towards selenite. The sensitivity of malignant cells to selenite was decreased by extracellular 
glutamate, while higher extracellular cysteine concentrations facilitated the reduction of selenite to 
hydrogen selenide, which was rapidly taken up into the cells and thus highly cytotoxic. This study by 
Olm demonstrated that high extracellular cysteine levels in the selenite-sensitive cells must be linked 
with high system xc--activity. The transporter system xc- consists of two protein components: the 
4F2 heavy chain, necessary for membrane location of the heterodimer and the xCT protein, 
responsible for transport activity. The system transports one molecule of cystine, the oxidized form 
of cysteine, into cells and releases one molecule of glutamate into the extracellular space (Conrad 
and Sato 2012). Importantly, xCT expression can be triggered in response to increased oxidative 
stress to stimulate GSH biosynthesis. In this way, the supply of cysteine for protein synthesis and 
GSH biosynthesis is ensured by this transporter system. The system is unaffected by the highly 
specific and irreversible inhibitor of γ-glutamylcysteine synthetase, BSO, suggesting that this 
transporter system may independently of GSH sustain a redox cycle across the plasma membrane. 
The features of this redox cycle are cystine uptake, intracellular reduction to cysteine and secretion 
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of the surplus cysteine into the extracellular space (Conrad and Sato 2012). The xc- antiporter 
expression has been shown to be regulated by ARE and is therefore an Nrf2 target gene associated 
with other phase II proteins, in addition to MRPs and enzymes regulating intracellular redox 
homeostasis (Sasaki et al. 2002). The role of the xc- exchanger among the ARE-regulated proteins is 
to facilitate uptake of cystine, increasing intracellular cysteine availability and thereby enhancing GSH 
levels in the cellular defense against oxidative stress. The reductive microenvironment is dependent 
on cystine uptake via system xc-, intracellular reduction of NADPH-dependent redox protein 
systems and secretion of cysteine to the extracellular environment by MRPs. The gene induction of 
xCT gene and the activity of system xc- is induced by various stimuli, including electrophilic agents 
and heavy metals like cadmium (Sasaki et al. 2002). Bannai et al. (1991) showed that cadmium caused 
an increase of cellular GSH due to the enhanced uptake of cystine, a protective mechanism related to 
the induced cellular stress. We demonstrated in this work that cadmium increased the intracellular 
GSH levels, in addition to activating Nrf2 target genes. Thus, it is likely that cadmium could cause an 
enhancement of extracellular cysteine concentration, which could lead to an extracellular reduction 
of the present sodium selenite to a more reduced form of selenite, possibly hydrogen selenide. This 
form of selenium is then taken up more efficiently than selenite, which would explain the enhanced 
uptake of selenium in sodium selenite-treated cells in the presence of cadmium chloride. 
We determined therefore the total extracellular thiol content after exposure to increasing 
concentrations of sodium selenite with or without cadmium chloride for 24 h in p53-proficient 
HCT116 cells (Figure 5.24). The data showed that the extracellular thiol content was decreased by 
raising sodium selenite concentrations, which may indicate that sodium selenite is reduced by the 
present cysteine in the culture media, and thus enhanced the uptake of sodium selenite. Cadmium 
alone did not increase the extracellular thiol content as might expected due to the presumed 
increased GSH biosynthesis and cystin/cysteine cycle, however, the simultaneous incubation of 
sodium selenite and cadmium chloride did not deplete the thiol levels in the extracellular space, like 
observed by sodium selenite exposure only. Upon co-exposure, the transport of cysteine across the 
cell membrane into the extracellular compartment might perhaps provide an increased supply of 
cysteine in order to sustain a reductive extracellular environment. In this way, sodium selenite 
molecules could be reduced without depleting the present thiols. The extracellular thiol content in 
untreated, p53-deficient HCT116 cells was more than half the basal levels in the p53-proficient cell 
line (data not shown). These observations might explain the reason why the uptake of selenium 
following sodium selenite incubation is higher in the p53-proficient cells than in the p53-deficient cells 
due to the potential thiol-assisted reduction of sodium selenite, and thereby increasing the 
bioavailability of the element. 
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Figure 5.24: Impact of sodium selenite in combination with cadmium on extracellular thiol 
content. p53-proficient HCT116 cells were treated with sodium selenite (3 µM-7 µM) in combination with 10 
µM cadmium chloride for 24 h incubation. The total extracellular thiol content was determined by the thiol 
reagent 5.5'-dithiobis-(2-nitrobenzoic acid) (DTNB) using L-cysteine as standard. Mean values ± SD of three 
independent experiments are shown. Statistically significant differences between single and combined treatment 
with cadmium chloride as tested by independent sample t-test (Mann Whitney U test): *** = p < 0.001. 
Preliminary data have shown that pre-incubation of thiols (GSH, L-Cysteine) and sodium selenite 
(3 µM) before addition to the culture media for further 24 h co-incubation (with no presence of 
cadmium chloride), increased cytotoxicity by reducing colony-forming ability, and thereby confirming 
the assumption that thiol-assisted reduction of sodium selenite occurs in the extracellular 
compartment of HCT116 cells. However, the presumed enhanced uptake of intracellular selenium 
following thiol-treated sodium selenite incubation has not been demonstrated by us so far. 
The cytotoxic effects of sodium selenite were significantly reduced when the cells were co-exposed 
to cadmium chloride. This appeared to involve an inactivation of p53 and thereby an inhibition of 
sodium selenite-induced and p53-mediated effects. The high intracellular concentration of selenium 
after sodium selenite exposure in combination with cadmium chloride did not cause cell death, as we 
would have expected. The more reduced form of sodium selenite that is absorbed could be 
elemental selenium and thereby induce less cytotoxic effects. However, elemental selenium has a 
much lower bioavailability than hydrogen selenide (Tarze et al. 2007), which makes this explanation 
less plausible. Interactions between selenite and other elements have been reported for copper. 
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Zeng and Botnen showed that copper may interact with sodium selenite extracellularly in cultured 
HT-29 cells (Zeng and Botnen 2004). Their results indicated that copper might specifically interact 
with inorganic, but not organic forms of selenium by strongly suppressing selenite-induced cell cycle 
arrest. Selenite-catalyzed generation of superoxide has been shown to be inhibited by copper in 
another study (Davis and Spallholz 1996). However, simultaneous incubation with copper and 
selenite in culture media significantly reduced intracellular selenium content, providing direct 
evidence that copper ions can interact with selenite extracellularly and block selenite from getting 
through the cell membrane (Zeng and Botnen 2004). A possible mechanism behind inhibition by 
cadmium of sodium selenite-induced cytotoxicity might be the complexation of cadmium ions by 
selenite molecules. Metal ions, including cadmium ions protect cells against selenium toxicity by 
formation of insoluble colloids with selenide in yeast cells, believed to provide cross-protection 
against the toxicities of both metals and selenocompounds (Dauplais et al. 2013). This explanation 
needs, however, further investigations.  
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6 Summary and conclusions 
Selenium is an essential trace element, which presents a very narrow range between deficient, 
essential and toxic doses. Dietary intake of this essential trace element is not just provided by 
consumption of foods, such as dairy products, bread and cereals, fish and meat, but also by 
consumption of selenium-containing dietary supplements. During the last decades, selenium has 
raised significant expectations of the prevention of chronic diseases, such as several forms of cancer, 
due to the potential of selenoproteins to protect against oxidative stress (Stranges et al. 2010). Thus, 
selenium is marketed as a dietary supplement for optimal health and is therefore commonly added to 
multivitamin-mineral supplements consumed in many Western countries. However, optimum 
selenium dietary requirements are still a matter of debate, and concerns have been brought up about 
potential toxicities from long-term intake of selenium supplementation (Vinceti et al. 2014). Most 
beneficial effects from selenium supplementation are limited to initially inadequate selenium status, 
which means that care should be taken when using supplements because high selenium intake could 
lead to toxic effects (Roman et al. 2014). Despite the lack of definitive evidence on the efficacy of 
selenium for disease prevention, the use of selenium-enriched foods, fertilizers, and supplements has 
increased considerably in the US and other Western countries in recent years (Stranges et al. 2010). 
The indiscriminate use of selenium supplements in individuals and populations with adequate to high 
selenium status cannot be justified, posing a potential health risk (Rayman and Stranges 2013). 
A central role in the maintenance of genomic stability belongs to the tumor suppressor protein p53. 
An appropriate cellular response to DNA damage is important; otherwise errors could lead to 
incorrect replication which can then manifest in mutations. Mutations in p53 are closely associated 
with cancer development, and more than 50 % of human primary tumors possess a mutated p53 
(Greenblatt et al. 1994). The tumor suppressor protein p53 is intrinsically sensitive to oxidative 
stress, but also to transition metals, e.g. zinc and toxic metals (Hartwig 2001). Furthermore, ROS 
play important regulatory roles in the p53 signaling pathways as well as the fine-tuning of p53 itself 
(Meplan et al. 2000). Moreover, superoxide is produced by several selenocompounds e.g. sodium 
selenite, which are able to interact with thiols, which could subsequently activate p53 (Zhao et al. 
2006). In fact, pro-oxidant effects have been proposed to be one of the mechanisms where selenium 
provides anticancer effects. On the other hand, as an oxidizing agent, sodium selenite is capable of 
compromising genetic stability by inducing DNA damage through the generation of ROS (Drake 
2006). Structural and functional changes of the p53 protein may also be induced by toxic metal 
compounds, which are already shown for cadmium compounds (Meplan et al. 1999; Schwerdtle et al. 
2010). One possible explanation is the interaction with the zinc-binding structure of the tumor 
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suppressor protein due to high affinity to sulfhydryl groups, also known as thiol reactivity (Hartwig 
2013).  
Because cadmium affects multiple cellular functions, our studies aimed to elucidate the impact of 
cadmium on cellular effects induced by two different selenocompounds. With respect to sodium 
selenite, pronounced cytotoxic effects over a narrow concentration range were seen in p53-
proficient cells. In contrast, in combination with cadmium, the colony-forming ability was increased, 
implying an inhibition of sodium selenite-induced cell death. The p53-deficient HCT116 cells were 
still viable after both treatment conditions, indicating that this effect was restricted to p53-proficient 
cells, and displaying p53 dependence of the cellular response to sodium selenite. Subsequently, the 
genomic integrity may be endangered upon sodium selenite exposure, underlining the importance of 
p53 as a tumor suppressor. In the case of selenomethionine exposure, whose concentration was 
100-fold higher than for sodium selenite, there was no observed p53 dependence or effect of 
cadmium on the acute toxicity determined by cell number. However, the presence of cadmium 
resulted in a significant reduction on long-term toxicity estimated by colony-forming ability in all 
tested concentrations of selenomethionine in p53-proficient cells, but not in the p53-deficient cells. 
Taken together, cadmium mitigated the cytotoxicity of high sodium selenite concentrations, while it 
enhanced the cytotoxicity of selenomethionine in a p53-dependent manner. 
Underlying mechanisms in cadmium carcinogenicity are complex and not yet completely understood 
(Hartwig 2010). Despite the inability of cadmium to directly generate free radicals under 
physiological conditions, lipid peroxidation and removal of iron from cell membranes have long been 
considered to be primary mechanisms for cadmium toxicity (Casalino et al. 1997; Eneman et al. 
2000). “Free” redox active metals directly enhance hydroxyl radical production via the Fenton 
reaction, followed by reduction of the oxidized metal achieved by the Haber-Weiss reaction with 
superoxide radicals as substrate (Winterbourn 1979). Although cadmium exposure increased the 
intracellular GSH levels in our cell culture model rather than depleting total GSH and did not 
increase the formation of superoxide, the gene expression profile analysis of cadmium indicated that 
the oxidative stress response was activated. Stress-responsive gene transcripts were strongly 
upregulated, such as HMOX-1, HSPA1A, MT1A, MT2X as well as Nrf2 target genes in phase I and 
phase II metabolism. The cadmium-induced up-regulation of cytoprotective enzymes, activation of 
GSH synthesis and MT expression is presumably a cellular attempt to initiate an acute response 
towards cadmium detoxification. This detoxification mechanism effectively suppresses the toxic 
action of cadmium ions in the cell. The induction of MT and GSH activity suppresses the action of 
free Cd2+ by converting it to a stable, chelated form, thus preventing the associated adverse effects of 
cadmium, such as impaired cell growth (Delalande et al. 2010). The high basal level of GSH in the 
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examined cells might also be a specific reason why inhibition of cellular GPx activity could not be 
observed. Enhanced cellular levels of GSH, increased availability of enzymes involved in GSH-
mediated detoxification and removal of cadmium and its toxic by-products could potentially prevent 
their interaction with key cellular targets and reduce toxicity and carcinogenesis (Eneman et al. 2000). 
Sodium selenite induced oxidative stress by generating superoxide production accompanied by 
depletion of GSH, which subsequently induced pro-apoptotic signaling in a p53-dependent manner. 
The intracellular GSH levels were, however, enhanced after exposure to sodium selenite in 
combination with cadmium chloride. The sodium selenite concentration, which decreased the GSH 
content in the absence of cadmium, also lowered the cadmium-induced glutathione increase to 
control levels. In addition to inactivating p53, cadmium appeared to attenuate the sodium selenite-
induced GSH depletion, and thereby also superoxide production as well as pro-apoptotic signaling of 
p53. The dependence of sodium selenite-induced apoptosis on p53-mediated ROS generation was 
found by another studies (Zhao et al. 2006), showing that sodium selenite induced apoptosis by 
producing superoxide, which then activated p53. In turn, the activation of p53 synergistically 
enhanced superoxide production and apoptosis induced by sodium selenite. These results suggest 
that superoxide may be a mediator for p53 phosphorylation/activation following sodium selenite 
exposure (Zhao et al. 2006). Generation of ROS is a key event in sodium selenite-induced apoptosis 
in different cancer cells, and sodium selenite-induced generation of ROS is blocked by antioxidants 
(NAC, catalase, SOD) protecting cells from sodium selenite-induced apoptosis (Jiang et al. 2002; Li et 
al. 2007; Shen et al. 1999; Stewart et al. 1997; Wang et al. 2002). DNA strand breaks result in 
stabilization of p53 and an initiation of p53-dependent signal transduction (Nelson and Kastan 1994). 
Sodium selenite induces DNA-strand breaks via generation of ROS, such as H2O2 and superoxide 
(Drake 2006; Kim et al. 2001; Li et al. 2007). Studies by several working groups have shown that 
sodium selenite-induced apoptosis involves the rapid induction of single-stranded DNA breaks in a 
variety of cell types (Jiang et al. 2004; Lu et al. 1994; Lu et al. 1995). These results suggest that even 
though ROS are important for initiating signals which activate p53, the p53 functional activity may 
play an important role for sustaining the ROS generation induced by sodium selenite, leading to an 
acceleration of apoptosis. Up-regulation of p53-induced ROS-generating enzymes could eventually 
contribute to the oxidative stress and consequently apoptosis (Liu et al. 2008). Assuming that the 
transcription factor p53 is unfolded by cadmium chloride exposure, protective cellular mechanisms 
could be disturbed, resulting in accumulation of sodium selenite-induced DNA damage. In the p53-
proficient HCT116 cells, accumulation of selenium was correlated to the onset of cytotoxicity 
following exposure to sodium selenite. Cell cycle arrest was only induced at comparably high 
concentrations. As expected, the data presented here indicate that attenuating p53 activity by 
cadmium chloride or using p53-deficient cells led to a lower sensitivity towards sodium selenite-
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induced apoptosis. The role of p53 as a critical downstream mediator of ROS signaling and DNA 
damage by sodium selenite treatment was supported by the significant attenuation of overall death in 
the p53-deficient cells.  
Previous work in our working group examined the induction of DNA-strand breaks and Fpg-sensitive 
base modification via different selenium compounds in relation to p53 status (Klaus 2009). A 45 h-
exposure to sodium selenite led to a strikingly different accumulation of oxidative damage in the 
HCT116 cell lines. The p53-deficient HCT116 cells accumulated high levels of DNA-strand breaks 
already at non-cytotoxic concentrations of sodium selenite, while p53-proficient cells exhibited 
marginal DNA damage even in the cytotoxic range. Fpg-sensitive lesions were first observed at 5 µM 
sodium selenite in the p53-deficient cells. Exposure to 8 µM sodium selenite resulted in comparable 
high levels of DNA damage in both cell lines. Appearance of DNA damage was independent of p53 
status following exposure to selenomethionine. At 500 µM selenomethionine, the level of single-
stranded DNA breaks was raised. The impact of sodium selenite exposure in combination with 
cadmium chloride on the induction of oxidative DNA damage was also investigated, however, only 
over a 24 h period. The degree of DNA damage caused by sodium selenite was higher in the 
presence of cadmium chloride than induced in the absence of the heavy metal cadmium (Klaus 2009). 
Cadmium chloride alone generated a similar number of DNA-strand breaks as the co-exposure to 
sodium selenite and cadmium chloride, indicating that the formed oxidative damage was induced by 
cadmium chloride with no additive effects by sodium selenite. Cadmium itself induced similar levels of 
DNA damage without highly reducing colony-forming ability, suggesting possible impairment of 
p53 functions. Inactivation of p53 by cadmium chloride due to conformational changes in its zinc-
binding domain could possibly explain the observed effects, since divalent metal ions, such as 
cadmium could unfold the zinc-binding DNA binding domain, via a possible displacement of zinc ions 
by cadmium ions (Meplan et al. 1999; Schwerdtle et al. 2010). Inhibition of p53-mediated processes 
through cadmium represents a possible underlying mechanism in its cancerogenic potential.  
Cadmium is also suggested to activate the nuclear translocation of Nrf2 to prevent apoptosis, 
possibly through induction of ROS or by increasing Nrf2 stability by direct binding of Cd2+ to 
cysteine residues on Keap1 (Chen and Shaikh 2009). Sodium selenite has been shown to activate 
Nrf2 via superoxide production, which consequently leads to apoptosis (Park et al. 2012). Chen and 
co-workers suggested that p53 controls a biphasic Nrf2 response, depending on the level of ROS and 
thereby the expression of p53 (Chen et al. 2012). Nrf2 is proposed to act as another key player in 
p53’s tumor suppression. Since cadmium has been shown to activate Nrf2 while inactivating p53, 
what is the proposed cross-link between p53 and Nrf2 responding to high levels of ROS production 
from sodium selenite exposure? In this work, we attempted to answer this question in p53-proficient 
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and p53-deficient HCT116 cells exposed to sodium selenite exposure with or without cadmium co-
exposure by using antibody-coupled immunofluorescence microscopy, which detects Nrf2’s nuclear 
location and by live-cell imaging followed by stable transfection with GFP-Nrf2 in HeLaS3 cells 
(Furukawa and Xiong 2005; Ott 2014). However, the Nrf2 activation methods did not provide 
optimal confirmation from positive control substances (e.g. sulphoraphane), and the stable GFP-
Nrf2 transfected cells only showed a cytoplasmic green signal, which was highly dependent on cell 
cycle stage, making it very difficult to distinguish a potential nuclear translocation signal. Therefore, a 
possible Nrf2 activation by sodium selenite and cadmium chloride dependent on p53 status was only 
investigated at the transcriptional level by gene expression analysis. 
Previous work in this working group showed that cellular uptake of sodium selenite, but not the 
uptake of selenomethionine in HCT116 cells, was p53-dependent (Klaus 2009). Therefore, the 
question of a potential interaction of cadmium chloride concerning the uptake of sodium selenite in a 
p53-dependent matter was raised. It would be possible that cadmium co-exposure affected the 
bioavailability of sodium selenite by inhibiting the cellular uptake of the element, and in this way 
reduce the cytotoxic effects observed after sodium selenite exposure. Unexpectedly, simultaneous 
exposure to cadmium chloride led to a dramatically increased content of intracellular selenium over 
the whole concentration range in both cell lines. The results show overall that cadmium chloride 
improves the bioavailability of sodium selenite independent on the cellular p53 status. With 
simultaneous exposure to selenomethionine and cadmium chloride, no difference in the intracellular 
level of selenium was found compared to selenomethionine exposure in the absence of cadmium 
chloride. Most selenium compounds can be converted to one or more metabolites: hydrogen 
selenide, methylselenol and selenomethionine. Hydrogen selenide can redox cycle, deplete GSH and 
produce ROS such as superoxide and hydrogen peroxide (Jackson and Combs, Jr. 2008). Different 
chemical forms of selenium are metabolized differently in vivo, activate distinct molecular mechanisms 
and exhibit varying degrees of anti-carcinogenicity in different cancer types (Jiang et al. 2002; Li et al. 
2007; Meuillet et al. 2004). Olm and co-workers demonstrated that the extracellular environment is 
a key factor specific to sodium selenite cytotoxicity, and that sodium selenite uptake depends on 
extracellular reduction. Extracellular reduction is mediated by cysteine, and the efficacy is determined 
by the uptake of cystine by the xc--antiporter and secretion of cysteine by multidrug resistance 
proteins (Olm et al. 2009). A major mechanism of sodium selenite cytotoxicity is thought to be the 
generation of oxidative stress through intracellular redox cycling of the selenium metabolite selenide 
with oxygen and cellular thiols, producing superoxide and cellular disulfides. The induction of 
oxidative stress and consequent apoptosis has been demonstrated in numerous cancer cell lines 
(Nilsonne et al. 2006; Rudolf et al. 2008; Zou et al. 2008). This occurs mainly in malignant cells. A 
cancer-specific, high-affinity selenium uptake mechanism could possibly explain cancer-specific sodium 
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selenite cytotoxicity (Olm et al. 2009). The xc--antiporter expression is regulated by ARE and is 
thereby an Nrf2 target gene and associated with other phase II proteins, in addition to MRPs and 
enzymes regulating intracellular redox homeostasis. The gene induction of xCT gene and the activity 
of system xc- is induced by various stimuli, including electrophilic agents and heavy metals such as 
cadmium (Sasaki et al. 2002). Bannai et al. (1991) showed that cadmium caused an increase of cellular 
GSH due to the enhanced uptake of cystine, a protective mechanism related to the induced cellular 
stress. The reductive microenvironment is dependent on cystine uptake via system xc-, intracellular 
reduction of NADPH dependent redox protein systems and secretion of cysteine to the extracellular 
environment by MRPs. In this work, we demonstrated that cadmium increased the intracellular GSH 
levels in addition to activating Nrf2 target genes, and therefore possibly the xCT gene. Thus, it is 
likely that cadmium would cause an enhancement of extracellular cysteine concentration, which 
could lead to an extracellular reduction of the present sodium selenite to a more reduced form of 
selenite, possibly hydrogen selenide. This form of selenium could then be taken up more efficiently 
than selenite, which would explain the enhanced uptake of selenium in sodium selenite treated cells 
in the presence of cadmium chloride. The cytotoxic effects of sodium selenite were significantly 
reduced when the cells were co-exposed to cadmium chloride, suggested to involve an inactivation 
of p53 and thereby an inhibition of sodium selenite-induced, p53-mediated effects. Cytotoxic effects 
were clearly attenuated despite the dramatically higher intracellular concentration of selenium after 
sodium selenite exposure in combination with cadmium chloride. It is also possible that the absorbed 
form of selenium could be another form than hydrogen selenide, and accumulates in the cell without 
acting as cytotoxic as sodium selenite and hydrogen selenide. Another possible mechanism behind 
cadmium’s inhibition of sodium selenite-induced cytotoxicity might be a complexation of cadmium 
ions with selenite molecules. Metal ions, including cadmium ions protect cells against selenium 
toxicity by formation of insoluble colloids with selenide in yeast cells, believed to provide cross-
protection against the toxicities of both metals and selenocompounds (Dauplais et al. 2013). 
Extracellular interactions between sodium selenite and copper have been reported (Zeng and Botnen 
2004). The authors suggested that copper interacts specifically with inorganic, but not organic forms 
of selenium by strongly suppressing selenite-induced cell cycle arrest. Generation of superoxide by 
sodium selenite has shown to be inhibited by copper in another study (Davis and Spallholz 1996). In 
contrast to our results, which showed that cadmium enhances the bioavailability of selenium in the 
form of sodium selenite, they demonstrated that the extracellular interaction between copper and 
sodium selenite significantly reduced intracellular selenium content. Altogether, the observed 
increased bioavailability of selenium by cadmium following sodium selenite exposure needs further 
investigations. Taken together, Figure 6.1 provides a summary of the impact of cadmium on sodium 
selenite-induced cellular effects.  
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Figure 6.1: (A) Cellular uptake of sodium selenite and the following GSH-depletion and superoxide 
generation. Tumor suppressor protein p53 is thus activated, leading to cell cycle arrest and apoptosis, which 
provides protection against genotoxic DNA damage. Other redox-sensitive transcription factors are also 
activated. (B) In the presence of cadmium, oxidative stress occurs along with the conformational alteration of 
p53, causing the protein to function similar to a mutant p53. The conformational alteration induced by 
cadmium prevents cells to undergo normal p53-dependent responses to sodium selenite. This continued cell 
proliferation might allow the expansion of clones of genetic unstable cells increasing the risk of critical 
mutations. An improved bioavailability of sodium selenite was observed, hypothesized to be due to increased 
extracellular thiol-assisted reduction of sodium selenite as a result of enhanced cystine/cysteine redox cycling. 
Complexation by cadmium ions and selenite/selenide ions is also discussed, but further investigation is needed. 
DMT1: divalent metal transporter 1, MRP: multidrug resistance-related protein, xc-: xc--antiporter. 
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The comparison of sodium selenite and selenomethionine showed that sodium selenite exhibits 
higher cytotoxicity at much lower concentrations, while selenomethionine accumulates more 
strongly in the cell because of unspecific integration into proteins following incubation at higher 
concentration before cytotoxic effects occur. Selenomethionine induced DNA damage only at 
comparably high, cytotoxic concentrations independent of the p53 status (Klaus 2009). On the other 
hand, sodium selenite produced a p53-dependent response. Therefore, due to different chemical 
properties of selenocompounds and differing interactions with other metals, such as cadmium, it is 
important to be precise when discussing the respective selenium compounds instead of using 
“selenium” as a general term, particularly when it comes to dietary supplements. Which 
selenocompound is preferable for supplementation must be further discussed. Sodium selenite is 
critical due to its pro-oxidative and cytotoxic effects. On the other hand, a possible chronic toxicity 
through the strong accumulation of selenomethionine should not be underestimated. For this reason 
the Federal Institute of Risk Assessment (BfR) in Germany advised against supplementation with 
selenomethionine (BfR 2004).  
To the best of our knowledge, the inhibiting effect of cadmium on sodium selenite-induced apoptosis 
has not been described previously in literature. The data obtained with HCT116 colon cancer cells 
may help to explain sodium selenite and cadmium interaction when present in the gastrointestinal 
tract. The presented results of this work help to illustrate that indiscriminate consumption of 
selenium-containing dietary supplements may possibly be a risk for individuals at particularly high risk 
of cadmium exposure (e.g. vegetarians, children, females). Although smoking exposes the lung tissue 
by inhalation, the selenite-cadmium interaction could be an additional risk for smokers, as smokers 
are remarkably more exposed to cadmium due to the fact that a single cigarette contains 1-2 µg 
cadmium. Inactivation of tumor suppressive responses could lead to accumulation of mutations and 
eventually to increased genomic instability. However, conclusions from in vitro studies must be drawn 
with caution as they do not fully reflect in vivo situations. Until these effects are well understood, it is 
important to establish safe supplementation and exposure levels for selenium and its compounds, in 
order to maximize health benefits while avoiding potential chronic toxic effects. Additionally, the 
contamination of soil, plants and animals by cadmium must be reduced and controlled in order to 
achieve a minimum exposure for individuals at high risk.  
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7 Materials and methods 
7.1 Cell culture 
7.1.1 Cell lines 
As cell culture models for our investigations, adherent cell lines growing under sterile conditions, and 
cultivated at 37 °C in 5 % CO2 and 100 % humidity were used. The human colon cancer cell line 
HCT116 and the isogenic p53-deficient cell line (Bunz et al. 1998) were originally established by 
Prof. Vogelstein (John Hopkins University, Baltimore, USA) and kindly given as a gift from 
Prof. Schönfelder (Charité, Universitätsmedizin, Berlin). The cell lines were grown in DMEM with the 
addition of 10 % fetal bovine serum (FBS), 100 U/mL penicillin and 100 µg/mL streptomycin. Sub-
cultivation of the HCT116 cells followed every 2-3 days. Prior to sub-cultivation, all necessary 
solutions were preheated to 37 °C and cells were observed microscopically to inspect their 
morphology. To detach the cells, cells were first washed with PBS and then with 0.25 % 
trypsin/EDTA solution (~30 s) followed by 1,5-2 min in the incubator before fresh medium was 
added to detach the cells. To quantify the cell number, aliquots of the cell suspension were measured 
using an electronic cell number device (Counter coulter ®, Beckmann). Both HCT116 cell lines were 
measured in size range of 9-30 µM. Appropriate aliquots of the cell suspension were finally diluted in 
new cell culture dishes.  
7.1.2 Incubations 
Stock solutions of cadmium chloride (100 mM), sodium selenite (100 mM) and selenomethionine 
(100 mM) in bidistilled water were prepared, sterile-filtered and stored at 4 °C until use. Prior to the 
experiment the stock solutions were further diluted and defined aliquots were pipetted into the cell 
culture medium. The volume of the cell culture medium was determined before by using the scaling 
of a glass pipette. 
7.1.3 Colony-forming ability  
To determine colony-forming ability, cells were trypsinised after treatment with the respective 
compounds, counted, and 300 cells were seeded in 60 mm cell culture dishes in triplicate. Following 
9 days in the incubator, the medium was removed, plates were washed once with cold PBS and the 
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colonies were fixed with ice-cold 96 % ethanol. The colonies were subsequently stained with Giemsa, 
washed with distilled water and counted.   
7.2 Gene expression profiling 
Determination of relative gene expression was performed using high throughput-RT-
qPCR. 5 x 105 cells were seeded in 60 mm culture dishes to grow for 24 h. Cells were treated with 
selenocompounds in the presence or absence of cadmium chloride, or by cadmium chloride only. 
After incubation, the cells were detached with trypsin, harvested in PBS/FBS (10 % FBS) and 
centrifuged at 1300 rpm and 4 °C for 4 min. The cell pellet was washed again with 1 ml PBS, 
transferred to an Eppendorf tube and centrifuged at 1300 rpm and 4 °C for 3 min. The supernatant 
was removed, and the pellets were stored at -20 °C. 
RNA isolation was performed using NucleoSpin RNA II Kit (Macherey Nagel). This kit uses a silica-
based membrane which selectively binds RNA molecules longer than 200 nucleotides. mRNA are 
usually longer than 200 nucleotides, while other types of RNA, such as rRNA, 5S rRNA and tRNA 
are mostly less than 200 nucleotides in length and are therefore excluded.   
The pellets were thawed and resuspended in 100 µL sterile PBS. For cell lysis, 350 µL lysis buffer 
(RAI) and 3.5 µL mercaptoethanol were added and thoroughly mixed. The samples were aspirated 
five times by a needle (0.9 mm) and liquefied through shearing. After adding 350 µL of ethanol (70 %) 
and further mixing, the samples were transferred to the columns and centrifuged at 8600 x g for 
30 s. The columns were washed with 350 µL of membrane-desalting-buffer (MDB). After 1 min 
centrifugation at 12 900 x g, DNA was digested by the addition of 95 µl DNase solution (1:10 diluted 
with DNase reaction buffer) to the columns and incubation for 15 min at room temperature. After 
adding 200 µl wash buffer (RA2) to the columns, they were centrifuged for 30 s at 8600 x g. A 
washing step with 600 µl wash buffer (RA3) was followed by centrifugation for 30 s at 8600 x g. The 
washing step was repeated with another 250 µl at 18 000 x g for 2 min. 30 µl RNase free water was 
added to the columns, which were centrifuged at 18 000 x g, followed by a second centrifugation 
step with the 30 µL elute. The eluted RNA was stored at -80 °C. 
The isolated mRNA was quantified prior to cDNA synthesis by measuring the absorption of an 
undiluted aliquot (2 µl) in duplicate at 260 nm a using a multi-plate reader with NanoQuant plate 
(Infinite M200, Tecan). The ratio of the absorbance at 260 nm and 280 nm (maximum absorption of 
proteins) was also measured to determine the purity of the mRNA. A ratio of A260:A280 >1.8 
indicates high RNA purity. 
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RNA integrity of HCT116 cells was previously confirmed in the working group (Neumann 2014). By 
the means of gel electrophoresis, electrophoretic separation of ribosomal RNA, which represents a 
major part of total RNA (85-90 %), was performed. At high RNA quality the ribosomal RNA 
separates in two bands, 28 S and 18 S bands, producing a 28S/18S rRNA ratio of 2:1 in the electrical 
field. By densitometric quantification of the two bands with Aida software the 28S/18S rRNA ratio of 
2.2:1 was detected, confirming proper RNA integrity (Neumann 2014). An automated capillary 
electrophoresis by the means of Lab-on-Chip technology on a Bioanalyzer was performed to verify 
the confirmation from the agarosis gel electrophoresis results. In an electrogram, individual rRNA 
fractions, mRNA and fragmented RNA are visualized. A RNA integrity number (RIN) of 10 was 
detected, which represented intact, but not degraded or fragmented, RNA (Neumann 2014). 
cDNA synthesis was performed in duplicate using the qScript™ cDNA Synthesis Kit (BioRad). 1 µg 
RNA was mixed with 4 µL reaction mix and 1 µL iScript reverse transcriptase in PCR strip tubes in a 
total reaction volume of 20 µL with RNase free water. The reaction was initiated using a 
temperature program (1 cycle 25 °C for 5 min, 1 cycle 42 °C for 30 min, 1 cycle 85 °C for 5 min) 
conducted by a Thermocycler iCycler (BioRad).  
To guarantee sufficient cDNA amount for the RT-qPCR a pre-amplification of the samples was 
performed with the specific primer pairs. 2.5 µL TaqMan® PreAmp Master Mix (2x) was mixed with 
0.5 µM of 500 nM mix for each primer pair, 0.75 µL water and 1.25 µl of the sample were mixed 
together and preamplified in the thermo cycler (Temperature programme: 1 cycle 95 °C for 10 min, 
12 looped cycles at 95 °C for 15 s and 60 °C for 4 min). A non-template control (NTC) (water) and 
untranscribed RNA samples as –Reverse Transcriptase (-RT) control served as controls. After the 
preamplification an exonuclease digestion was also performed to remove residual, unbound primers. 
2 µL of an exonuclease solution (4 U/µL) was added to each sample and incubated at 37 °C (40 min). 
The exonuclease was inactivated by heating (80 °C for 15 min), and the entire sample set was diluted 
1:5 with TE buffer and stored at -20 °C. 
Before the RT-qPCR analysis 2.25 µl of each pre-amplified sample was combined with 2.5 µL SsoFast 
EvaGreen® Supermix (2 x with low ROX) and 0.25 µL DNA Binding Dye Sample Loading Reagent 
(20x). Another NTC was included. The primer pairs were diluted with DNA Suspension buffer (1x) 
and Assay Loading Reagent (2x), obtaining a primer concentration of 5 µM. The final primer 
concentration was accordingly 500 nM. The RT-qPCR analysis was performed on a Biomark™-RT-
qPCR instrument, allowing simultaneous analysis of 96 x 96 independent PCR reactions using a chip. 
The Dynamic Array of the chip was primed with a control liquid in Integrated Fluidic Circuits (IFC) 
Controller HX to fill the channels of the Dynamic Array. Afterwards, 5 µL of each sample and primer 
solutions were pipetted in the respective cavities and the chip was loaded with the solutions in the 
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IFC Controller HX. In the following RT-qPCR, amplification of each separate sample to each of the 
95 primer pairs took place (temperature program: 1 cycle 70 °C for 40 min, 1 cycle 60 °C for 30 s, 
1 cycle 95 °C for 1 min, 30 looped cycles at 96 °C for 5 s and 60 °C for 20 s, 1 cycle from 60 to 
95 °C for 3 min). 
The analysis of the obtained data was performed using Fluidigm Real Time PCR Analysis software. By 
using the passive reference dye, ROX, the correct loading of all reaction chambers was confirmed. 
The amplificates were quantified using the intercalating fluorescence dye EvaGreen, whereby the 
specificity of each PCR reaction was monitored by assessing the respective melting curves. The 
GenEx software (MultiD Analyses) was used to obtain Cq values. The samples were normalized to 
the reference genes ACTB, B2M, GAPDH, GUSB and HPRT.  
7.3 Detection of superoxide generation 
The superoxide indicator dihydroethidium (DHE), also called hydroethidine, exhibits blue-
fluorescence in the cytosol until oxidized to the fluorescent molecule ethidium bromide by O2•−, 
where it intercalates with DNA in the cell, staining its nucleus a bright fluorescent red. The oxidation 
of DHE is rapid when the oxidant is O2•−, but considerably slower in the presence of O2, H2O2, 
HOCl or ONOO−. Consequently, DHE is considered a good detector of intracellular superoxide 
(Carter et al. 1994).  
2.5 x 105 HCT116 cells were seeded out in 40 mm culture dishes for 42 h before 6 h incubation time 
with selenocompounds in the presence or absence of cadmium chloride. 15 min treatment with 
100 µM menadione was used as positive control. After treatment, cells were trypsinized and 1 ml 
fresh medium was added to each dish, then 500 µl was transferred to conical tubes (suitable for flow 
cytometer) and centrifuged at 1300 rpm for 3 min. After centrifugation, the medium supernatant was 
removed. Next, 400 µl of a mixture of DHE dye and PBS (1:100 from 1 mM DHE frozen aliquot; final 
concentration 10 µM DHE) was added to each tube, briefly vortexed and incubated at 37 °C for 
45 min. The stained samples were again centrifuged to remove the dye and resuspended with 300 µl 
PBS before being measured in the flow cytometer.  
Flow cytometry data were acquired with LSRII Fortessa (BD Sciences). Excitation for PE was at 
488 nm and the emission of 10 000 cells per sample was recorded at FL-1sensor (575/28 nm BP). 
Data analysis was performed with BD FACSDiva™ software and expressed as the percentage of the 
untreated control cells, which was set to 100 %. 
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7.4 Thiol determination 
7.4.1 Intracellular quantification of total GSH 
 Quantification of the total intracellular GSH content was performed by the recycling assay as 
described by Tietze (Tietze 1969). Here, Ellman’s reagent (5.5’-dithio-bis-(2-nitrobenzoic acid), 
DTNB) is reduced by GSH to the yellow-colored 5-thio-2-nitrobenzoic acid (TNB). Through 
addition of GR/NADPH, GSSG is reduced back to GSH in a redox cycle. The GR-driven GSSG 
recycling leads to a persistent increase in TNB, and quantified via absorbance at 412 nm.  
3.5 x 105 HCT116 cells were seeded out in 60 mm culture dishes for 24 h before the desired 
incubation time with selenocompounds in the presence or absence of cadmium chloride, or by 
cadmium chloride alone. After each treatment, cells were trypsinized to measure cell number as well 
as mean cell volume before transferring 2 ml of cell suspension in micro-reaction vessels. Cells were 
centrifuged at 640 g to pellets at 4 °C for 4 min, supernatant was removed and potassium phosphate 
puffer added giving a cell concentration of 2.5 x 105 cells per 120 µL solution.  
For cell lysis, cells were stored at -80 °C for at least 24 h. After thawing, sonification followed for 
5 min in an ultra sound bath before a second freeze/thaw/sonification cycle.  6.5 % 5-sulfo salicyl acid 
(5-SSA) solution (final concentration 1.3 %) was added for protein precipitation, followed by 10 min 
on ice after thoroughly mixing. The protein precipitate was separated from the supernatant at 
2000 x g at 4 °C, using the supernatant directly for the recycling assay.  
The measurement of the total GSH content was performed in 96 microwell plates in a microplate 
reader (Tecan). 20 µL supernatant was added per cavity as well as 40 µL phosphate potassium buffer 
and 100 µL DTNB/NADPH mixture (final concentrations in mixture 2 mM DTNB and 0.3 mM 
NADPH). The reaction was initiated by addition of 40 µL GR (4 U/mL). The formed TNB was 
measured in 30 s intervals for a 4 min reaction time (8 cycles). The total GSH content of the samples 
as well as an external control (20 µM GSSG) were determined using an external calibration curve 
(GSH 5-50 µM).  
To calculate the intracellular total GSH content, the extinction difference (ΔE) between cycle 1 and 
cycle 5 was determined (ΔE = ECycle 5 –ECycle1). Relative GSH content of the samples could be 
determined by the external calibration curve (E = ΔESample - ΔEBackground). The GSH data was 
normalized to the actual mean cell volumes in order to obtain molar intracellular concentrations.   
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7.4.2 Extracellular quantification of total thiols 
Quantification of the total extracellular thiol content was performed by using the thiol reagent 
DTNB, which is reduced by present thiols to the yellow-colored TNB. The conversion of DTNB to 
TNB was quantified via the absorbance at 412 nm.  
2.5 x 105 HCT116 cells were seeded out in 40 mm culture dishes for 24 h before the desired 
incubation time with selenocompounds in the presence or absence of cadmium chloride. Directly 
after addition of compounds, culture medium (200 µl) was transferred in micro reaction tubes 
(1.5 ml) in order to determine the thiol levels at 0 h incubation time, as well as after 24 h treatment. 
Detached cells and debris from culture medium was separated by centrifugation (2 min, 1500 rpm). 
A medium blank (growth medium only) was included for each time point to subtract the background 
from the samples. L-cysteine was used as standard. The calibration curve ranged from 7.8 µM to 
1000 µM cysteine, prepared by serial dilutions (1:2) starting from a stock solution of 2 mM cysteine, 
which was dissolved in 400 mM Tris-HCl (pH 8.0). 50 µl standard or incubated medium supernatant 
was transferred in 96 well plates (in triplicate). 150 µl buffer (400 mM Tris HCl pH (8.0) was added 
to each well followed by addition of 10 µl DTNB (10 mM) to the wells to initiate the thiol reaction, 
and the absorption measured at 412 nm. The untreated control was set to 100 %. 
7.5 Enzymatic activities of antioxidant enzymes 
1.7 x 106 HCT116 cells were seeded out in 100 mm culture dishes to grow for 24 h before 
incubation with selenocompounds in the presence or absence of cadmium chloride. After each 
treatment, cells were trypsinized to determine cell number before transferring 2 ml cell suspension 
in micro reaction vessels. Cells were centrifuged at 640 x g to pellets at 4 °C for 4 min, 
the supernatant was removed and 0.1 M potassium phosphate puffer (pH 7.0), including 1 % reduced 
Triton X-100 (Fluka) was added (final cell concentration of 3.0 x 106 cells/150 µL solution). For cell 
lysis, cells were centrifuged at 16600 x g for 10 min at 4°C. The supernatants were transferred into 
new micro reaction vessels and stored at -20°C until assay measurement. 
All the enzyme activity measurements were performed in 96 microwell plates with a microplate 
reader (Tecan).  
Thioredoxin Reductase (TrxR) Assay (DTNB reduction): 
The quantification of the intrinsic TrxR enzyme activity was modified after the method of Smith 
(Smith et al. 2001). The assay buffer used was 0.1 M KH2PO4 (pH 7.0). Rat liver TrxR (IMCO, 
Sweden) was stored at -20 °C in aliquots of 2.64 µM (50 µl in 50 mM TE, pH 7.5). 50 nM TrxR was 
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used as a positive assay control. Cellular samples treated with the gold compound auranofin (Sigma) 
was used to inhibit cellular TrxR activity, and served as a positive inhibition control. A specific TrxR 
inhibitor, aurothiomalate (Sigma) (final concentration 20 µM), was added to sample wells, allowing 
correction of non-thioredoxin reductase-independent DTNB reduction (e.g. presence of glutathione) 
(Smith et al. 1999). The difference between samples with or without the inhibitor aurothiomalate 
obtained the DTNB reduction due to TrxR activity. 120 to 160 µL assay buffer was added to all 
wells, depending on the activity in the lysates. 2.5 mM DTNB in assay buffer (final concentration 0.25 
mM) was added and the absorbance (412 nm) was measured for 8 cycles of 20 s intervals to obtain 
the background. Addition of 2 mM NADPH (final concentration 0.2 mM) initiated the reaction. The 
NADPH-dependent disappearance of DTNB, the conversion into TNB, was recorded at the 
absorbance at 412 nm using a kinetics program with 31 cycles of 20 s intervals obtaining the reaction 
rate. 
The TNB extinction coefficient is 13.6 mM-1 cm-1. The path length of the solution in the well (0.6 cm) 
was adjusted for the activity calculation. The change in absorbance per min (ΔA/min) was 
determined, and the A values plotted as a function of time to obtain the slope of the linear part of 
the curve (ΔA/min = (A2-A1)/(t2-t1). The background value was subtracted from the sample values, as 
well as the values from samples containing the TrxR specific inhibitor. One unit is defined as the 
NADPH-dependent production of 2 µmol of TNB from DTNB per min. TrxR activity (µmol/min) in 
samples was calculated using this equation: ((ΔA/min)/ 6.756 mM-1). The untreated control was set to 
100 %.   
Glutathione Reductase (GR) Assay (NADPH consumption): 
Quantification of the intrinsic GR enzyme activity was modified after the method of Carlberg and 
Mannervik (Carlberg and Mannervik 1985). The assay buffer used was 0.1 M KH2PO4 (pH 7.0). The 
isolated GR enzyme (Baker’s yeast) served as the positive assay control (0.25 U/mL, final 
concentration 5 mU per well). Cellular samples treated with the specific cellular GR inhibitor, 2-
AAPA (Sigma) was used as positive inhibitor control (Seefeldt et al. 2009). A stock solution of 
100 mM oxidized GSH (GSSG) was stored at -20°C. 90 µl assay buffer and 10 µL of sample, positive 
control or lysis buffer were added to each cavity. 100 µl of the GSSG-NADPH mixture prepared in 
assay buffer (final concentrations in mixture 1 mM GSSG/0.4 mM NADPH) was added to start the 
reaction. The absorbance (A) was measured immediately at 340 nm with a kinetics program with 
16 cycles of 20 s intervals.  
The NADPH extinction coefficient is 0.00622 µM-1 cm-1. The path length of the solution in the well 
(0,6 cm) was adjusted for the activity calculation. The change in absorbance per min (ΔA/min) was 
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determined, and the A values plotted as a function of time to obtain the slope of the linear part of 
the curve (ΔA/min = (A2-A1)/(t2-t1). The background value was subtracted from the test values. One 
unit is defined as the amount of enzyme which will cause the oxidation of 1 nmol of NADPH to 
NADP+ per min. GR activity (nmol/min) in the samples was calculated using this equation: 
((ΔA/min)/0.00373 µM-1)). The untreated control was set to 100 %.   
Glutathione Peroxidase (GPx) Assay (indirect GR-coupled): 
Quantification of the intrinsic GPx enzyme activity was modified after the method of Sharov (Sharov 
et al. 1999). The assay buffer used was 0.1 M KH2PO4 (pH 7.0) and isolated bovine erythrocytes GPx 
(Sigma) used as positive assay control (1U/mL). Bovine erythrocytes GPx was stored at -80 °C in 
aliquots of 100 U/mL (20 µl in 10 mM Na2HPO4+ in 1 mM DTT). Cellular samples treated with 
mercaptosuccinate (Sigma) was used to inhibit cellular GPx and served as a positive inhibitor control 
(Michiels and Remacle 1988). A reaction mix (RM) of 100 µL per cavity was prepared, including 
10 mM GSH (final concentration 1 mM), 6 U/ml GR (final concentration 0,6 U/mL), and 3.3 mM 
DETAPAC/0.166 M KH2PO4 (final concentration 1 mM DETAPAC). 20 to 60 µL of sample or 
positive control was added depending on the activity in the cell lysate. 1 mM NADPH (final 
concentration 0.1 mM) was added before addition of 12 mM tertbutyl hydroperoxide (t-BOOH, final 
concentration 1.2 mM) was used to initiate the reaction. The absorbance (A) was measured 
immediately at 340 nm with a kinetics program with 16 cycles of 20 s intervals, thus obtaining the 
reaction rate of the conversion to NADP+ from NADPH. 
The NADPH extinction coefficient is 0.00622 µM-1 cm-1. The path length of the solution in the well 
(0.6 cm) was adjusted for the activity calculation. The change in absorbance per min (ΔA/min) was 
determined, and the A values plotted as a function of time to obtain the slope of the linear part of 
the curve (ΔA/min = (A2-A1)/(t2-t1). The background value was subtracted from the test values. One 
unit is defined as the amount of enzyme which will cause the oxidation of 1 nmol of NADPH to 
NADP+ per min. GPx activity (nmol/min) in samples was calculated using this equation: 
((ΔA/min)/0.00373 µM-1). The untreated control was set to 100 %.   
Catalase Assay: 
Quantification of the intrinsic catalase enzyme activity was modified after the method of Li and 
Schellhorn (Li and Schellhorn 2007). In this assay, 96 well UV micro plates were used to measure 
decomposition of H2O2 from the catalase present in the samples. Isolated catalase from bovine 
erythrocytes (Sigma), as well as cellular samples treated with sodium azide, served as positive 
controls (Sorg et al. 1997). 10 µL of sample or positive controls were pipetted into the cavities, 
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followed by 200 µL 5.25 mM H2O2 (final concentration 5 mM H2O2) to start the reaction. The 
decomposition of H2O2 was measured immediately at 240 nm using a kinetics program with 16 cycles 
of 20 s intervals to obtain the reaction rate. 
The H2O2 extinction coefficient is 39.4 mM-1 cm-1. The path length of the solution in the well (0.6 cm) 
was adjusted for the activity calculation. The change in absorbance per min (ΔA/min) was 
determined, and the A values plotted as a function of time to obtain the slope of the linear part of 
the curve (ΔA/min = (A2-A1)/(t2-t1). The background value was subtracted from the sample values. 
One unit is defined as the amount of enzyme which will cause the decomposition of 1 µmol of 
H2O2 per min. Catalase activity (µmol/min) in samples was calculated using this equation: ((ΔA/min)/ 
23.64 mM-1). The untreated control was set to 100 %.   
Superoxide dismutase (SOD) Assay:  
This assay is based on the published assay from Peskin and Winterbourn (Peskin and Winterbourn 
2000). Cells were treated with the positive control sodium diethyl dithio carbamate (DDC). Assay 
buffer used in the assay and reaction mix was 0.1 M KH2PO4 (pH 8.0), including 0.1 mM DETAPAC 
and 0.1 mM hypoxanthine. The superoxide radical WST-1 (Dojindo) was kept in aliquots (10 mM in 
water) at -20 °C, and added immediately before use in reaction mixture (final concentration 50 µM), 
including 10 U/mL catalase (final concentration 0.06 U/ml). As the samples had high SOD activity, the 
samples were diluted prior to the assay. 10 µl of diluted samples, lysis buffer (background) and SOD 
standard, as well as 200 µl reaction mixture were added to all wells. 20 µL 100 mU/ml xanthine-
oxidase (XO) (final concentration per well 8.7 mU/mL) was quickly added to initiate the reactions, 
the plate was covered and incubated for 20 min at 37 °C in the dark, and measured at 450 nm. One 
unit is defined as the amount of enzyme needed to exhibit 50 % dismutation of the superoxide 
radical. Relative SOD content of the samples could be determined by the external calibration curve 
from SOD standards (from bovine erythrocytes). 
7.6 Cell cycle distribution and apoptosis 
To examine if apoptosis is involved in the observed cytotoxic effects, several parameters were 
investigated. In addition to the analysis of transcript levels of genes associated with apoptosis (see 
section for gene expression profiling), cell death analysis and mitochondrial membrane potential were 
simultaneously detected by flow cytometry, as well as determination of concurrent increase of sub-
diploid cells (sub-G1 fraction) in the cell cycle distribution. Immunofluorescence microscope analysis 
of nuclear AIF translocation was also performed. 
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7.6.1 Single tube flow cytometric cell death analysis 
Cell death classification can be provided by staining cells with different dyes from one single tube 
(Munoz et al. 2013). The common markers AnnexinV-FITC and propidium iodide (PI) stain for 
phosphatidylserin (PS) exposure and plasma membrane damage, respectively. Mitochondrial 
membrane potential could be determined by the dye 1,1',3,3,3',3'-hexamethylindodicarbocyanine 
iodid (DiIC1(5)), which accumulates in mitochondria with active membrane potential. Morphological 
alterations in cell size and cell granularity are provided by scatter changes in forward scatter (FSC) 
and side scatter (SSC). Apoptotic cells are detected as a cell population with decreased FSC and 
increased SSC due to cellular shrinkage and an increased cytoplasmic granularity (Hagenhofer et al. 
1998).  
5.0 x 105 HCT116 cells were seeded out in 60 mm culture dishes for 24 h before another 24 h 
incubation time with selenocompounds in the presence or absence of cadmium chloride. After 
treatment, 150 µl incubation medium containing detached cells was transferred to conical FACS 
tubes for cell death classification. The rest of the incubation medium was transferred to conical tubes 
for a separate measurement of cell cycle distribution. Attached cells were trypsinized and collected 
in 1 ml fresh medium. 150 µl was transferred to respective tubes for the cell viability test, while the 
remaining cell suspension was transferred to the respective tube for cell cycle measurement. 200 µl 
fresh master mix (containing 200 µl Ringers solution (calcium-containing puffer), 5 µl PI (50 µg/µl), 
1 µl AnnexinV-FITC and 1 µl DilC1(5) (3 µM)) for each tube was added and briefly vortexed 
followed by 30 min incubation in the dark at 4 °C. The samples were immediately measured in the 
flow cytometer.  
Flow cytometry data were acquired with LSRII Fortessa (BD Sciences). Excitation for FITC and PI 
was at 488 nm, the FITC fluorescence was recorded on the FL-1 sensor (530/30 nm BP), the PI 
fluorescence on the FL-3 sensor (695/40 nm BP). FITC signal (X axis) was set up against the PI signal 
(Y axis), allowing gating of PI negative/Annexin V negative (viable), PI negative/Annexin V positive 
(apoptotic), PI positive/Annexin V positive (necrotic) cell populations. DilC1(5) fluorescence was 
excited at 640 nm and recorded with the FL-2 sensor (670/14 nm BP). The DilC1(5) signal was 
displayed as a histogram, and a decreased signal compared to the viable cell population was 
interpreted as apoptotic or already dead cells. The dyes were compensated in advance to reduce 
fluorescence overlap. 10 000 cells per sample were recorded and analyzed. Data analysis was 
performed with BD FACSDiva™ software. 
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7.6.2 Cell cycle distribution and sub-G1 fraction 
Flow cytometry allows the investigation of DNA content in cells. Specific markers of DNA, such as 
4’, 6-diamidino-2-phenylindole (DAPI), can be used. DAPI binds preferentially to AT-rich regions of 
the minor grooves of DNA, resulting in a 20-fold fluorescence enhancement (Karlsson et al. 2003; 
Kubista et al. 1987). The absorbed amount of dye is proportional to the DNA content. By excitation 
of the dye, the emitted fluorescent signal can be examined and quantified. The distribution of cells 
can be separated into cell cycle phases, based on the DNA content. Cells containing less DNA than a 
cell in the G1-phase are cells in late apoptosis due to DNA fragmentation and can be detected due to 
their appearance as the so-called sub-G1 fraction in the histogram.  
During the 30 min incubation time for cell viability test (see 7.6.1), the cell samples for cell cycle 
analysis were centrifuged at 1300 rpm for 3 min at 4 ° C. The pellet was resuspended in 1 ml cold 
PBS and fixed with dropwise addition of another 3 ml of ice-cold ethanol (96 %) while vortexing. The 
samples were stored at -20 °C until the day of measurement. On the day of measurement the 
samples were centrifuged, and the supernatant removed followed by resuspension of 250 µL DAPI 
staining solution (CyStainDNA, Partec, Münster, Germany). Samples were incubated for 30 min at 
4 °C before measurement. 30 000 cells per sample were examined and analyzed by LSRII and the 
Diva software.  
7.6.3 AIF translocation 
Apoptosis is triggered by two possible pathways. The first pathway is receptor-mediated, and the 
second one is mediated by the mitochondria. Cytochrome C and apoptosis inducing factor (AIF) are 
anchored at the inner mitochondrial membrane. The mitochondria-mediated apoptotic pathway is 
triggered through certain apoptotic stimuli, and thereby cytochrome C and AIF can detach from the 
membrane and be released into cytosol. From the cytosol, AIF is further translocated to the cell 
nuclei, where it accumulates and in turn induces chromatin condensation as well as DNA 
fragmentation (Norberg et al. 2010). By means of a specific primary antibody against AIF detected by 
a red fluorescence-coupled secondary antibody, the localization of the AIF was examined. The nuclei 
were stained with DAPI, a fluorescent dye that binds to A-T rich regions in DNA.  
1.5 x 105 cells were seeded and grown on sterile cover slips (12 mm Ø) placed in 60 mm culture 
dishes. After 24 h, cells were incubated with sodium selenite, selenomethionine or staurosporine for 
24 h. In combination with cadmium, cells were co-incubated with cadmium chloride for 26 h. At the 
end of the incubation, the medium was removed from the culture dishes. The cells were washed 
twice in ice-cold PBS-UVC solution, ice-cold methanol was quickly added to fix the cells for 10 min 
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according to Chen et al. (Chen et al. 2008). The cover slips covered with cells were taken from the 
dishes and coated with blocking solution (5 % FBS in PBS/UVC) for at least 30 min to block unspecific 
binding sites. After removing the blocking solution, 70 µl of the primary antibody (anti-AIF-antibody 
H300 (rabbit), diluted 1:300 in blocking solution) were applied and incubated for 1 h at 37 °C to 
reduce background signal. Afterwards, the cover slips were washed several times with PBS followed 
by another blocking step for 10 min. Next, the cells were incubated with 70 µl of the secondary 
antibody (anti-rabbit-antibody Cy3, diluted 1:300 in blocking solution) under the same conditions as 
for the primary antibody. Finally, after another three washing steps, coverslips were placed on 
microscope slides with a drop of Vectashield mounting medium containing DAPI. Labeled AIF 
location was visualized and recorded using an Axio Imager.M1 fluorescence microscope with an 
AxioCam MRm camera (Zeiss). The red AIF fluorescence signal intensity of at least 100 cells per 
slide (15-30 pictures) was analyzed by the AxioVision 4.8 software (Zeiss). Only signals in DAPI- 
stained nuclei were quantified. The untreated control was set to 100 %. 
7.7 Bioavailability 
To investigate if the observed different cytotoxic effects following exposure to selenocompounds in 
combination of cadmium chloride are associated with bioavailability, the uptake of total selenium was 
quantified by graphite furnace atomic absorption spectroscopy (GF-AAS).  
1.0 x 106 HCT116 cells were seeded out for 24 h. To assess cellular uptake of sodium selenite and 
selenomethionine in combination with cadmium chloride, logarithmically growing HCT116 cells were 
treated for 24 h with the respective selenocompound in the presence of cadmium chloride (10 µM) 
or by cadmium chloride alone. After treatment, cells were trypsinized, collected in 5 ml 5 % FBS in 
PBS and centrifuged (1250 rpm, 5 min, 4 °C) before determination of cell number and mean cell 
volumes. Next, the pellets were washed twice with ice-cold PBS and stored at -20 °C. For the cell 
disruption, the pellets were resuspended in a 1:1 mixture of HNO3 (69 %) and H2O2 (30 %) 
(suprapure quality) (so-called nitrohydrochloric acid) before incinerated in a thermo mixer at 65 °C 
for 1 h and stepwise by 10 °C per hour until reaching 95 °C for about 7 h. The ash was collected in 
1 ml double-distilled water. Next, selenium was determined by GF-AAS (Perkin-Elmer, PinAAcle 
900 T). The measurements and signal analysis were performed using Software AA Winlab32. The 
peak areas were quantified. Argon was used as protective gas. For the AAS measurements, 20 µl of 
sample or dilution was applied together with 5 µl Pd/Mg modifier in the graphite furnace, and 
analyzed by optimized temperature program for Se (Table 7.1). The wave length for analysis of Se 
was 196.03 nm. We used a 5-point calibration curve in the range of 2-20 µg Se/l in a dilution of a 
selenium atom spectroscopy standard solution (cSe = 1 g/l; Roth) with 0.2 % HNO3. The blank limit 
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for Se was 0.53 µg/l, the limit of detection was 1.05 µg/land the quantification limit was 1.58 µg/l. 
External recovery using the AAS standard solution (10 µg Se/l) for each test series was determined in 
order to verify a constant measuring performance of the GF-AAS. The external recovery of Se was 
in average 102.4 % ± 10.7 %. It is thereby assumed that the determination of Se by GF-AAS identified 
correct measurement data. Additionally, for each cell disruption procedure by nitrohydrochloric acid, 
another external recovery with 10 µg Se/l was performed. This external standard yielded in average 
89.1 % ± 11.8 %, by which a marginal loss of selenium might have occurred during the cell disruption 
and ashing. 
Table 7.1: Temperature program of the AAS analysis of Se  
Se Temp (°C) Ramp (sec) Hold (sec) Internal Flow 
(ml/min) 
Drying 110 1 30 250 
Drying 130 15 30 250 
Pyrolysis 1200 10 20 250 
Atomisation 1800 0 5 0 
Clean-out 2450 1 3 250 
 
7.8 Statistical analysis 
Besides descriptive statistics, data were analyzed by the Levene's test for equality of variances. 
Differences between the mean values compared to the untreated control were examined by one-way 
factorial analysis of variance (ANOVA). In the case of equal variance post hoc Dunnett’s T-test was 
used. In the case of unequal variance, Dunnett’s T3 Post-Hoc test was used. Identification of 
statistical significant differences (p<0.05) between the treatments in the different cell lines or with 
the respective selenocompounds alone and in combination with cadmium in the HCT116 cells was 
revealed by using a non-parametric independent samples t-test. The Mann-Whitney U test was 
chosen to compare differences between two not normally distributed and independent groups with 
the dependent continuous variable. Data from at least two sets of independent experiments are 
shown as arithmetic mean ± SD.  
Statistical analysis was performed with SPSS (PASW Statistics 19; IBM, Armonk, USA) and Microsoft 
Excel 2010 (Microsoft Deutschland GmbH, Unterschleisheim, Germany). 
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9 Appendix 
9.1 List of Abbreviations 
ActD  Actinomycin D  
AIF  Apoptosis inducing factor  
AP Apurinic/apyrimidinic 
ARE Antioxidant response element 
ATM  Aurothiomalate  
ATP  Adenosine triphosphate  
Bax  Bcl-2-associated protein  
BER  Base excision repair  
BfR Bundesinstitut für Risikobewertung, The German Federal Institute for risk assessment 
BH Bcl-2 homology 
Bp Base pairs 
Caspase  Cysteinyl-aspartate specific protease  
CDK  Cyclin-dependent kinase  
CDKI Cyclin-dependent kinase inhibitor 
cDNA  Complementary DNA  
CONTAM EFSA Panel on Contaminants in the Food Chain 
Cq quantification cycle  
Cys Cysteine 
DAPI  4`, 6-Diamidino-2-phenylindol  
DiIC1(5) 1,1',3,3,3',3'-hexamethylindodicarbocyanine iodid  
DIO Deiodinase 
DMEM  Dulbeccos Modified Eagle Medium  
DMSO  Dimethyl sulphoxide  
DMT1 Divalent metal transporter 1 
DNA  Deoxyribonucleic acid  
dsDNA  Double stranded DNA 
DTNB 5.5'-dithiobis-(2-nitrobenzoic acid)  
EDTA  Diethylenediamine tetraacetic acid  
EFSA European Food Safety Authority 
FBS  Fetal bovine serum  
FITC  Fluoresceinisothiocyanat 
FSC Forward scatter 
GAPDH  Glycerinaldehyde-3-phophate dehydrogenase  
GF-AAS Graphite furnace atomic absorption spectroscopy 
GPx  Glutathione peroxidase  
GRE  Glucocortoid responsive element 
GSH  Glutathione (reduced form)  
GSSG  Glutathione disulfid (oxidized form)  
GST Glutathione-S-transferase 
HCT116  Human colon cancer cell line  
His Histidine 
HPRT  Hypoxanthine phosphoribosyltransferase 1  
IARC  International Agency for Research on Cancer  
IFC Integrated fluidic circuit 
IL  Interleukin  
kDa  Kilo dalton  
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Keap1 Kelch-like ECH-associated protein 1 
MAPK Mitogen-activated protein kinase 
MDB  Membrane desalting buffer  
MDR1 Multidrug-resistance protein 1 
MMR  Mismatch repair  
MRE Metal response element 
mRNA  Messenger RNA  
MRP Multidrug resistance related protein 
MT  Metallothionein  
MTF-1 Metal-regulatory transcription factor 1 
MTT  [3 – (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide 
NER  Nucleotide excision repair  
NF-kB nuclear factor kappa-light-chain-enhancer of activated B cells 
NF-κB  Nuclear factor kappa B  
NPC Nutritional Prevention of Cancer Trial 
Nrf2 Nuclear factor-E2-related factor 2 
NTC No template control 
PARP  Poly (ADP-ribose)-polymerase  
PBS  Phosphate buffered saline  
PCR  Polymerase chain reaction  
PI Propidium iodide 
PS Phosphatidylserine  
RIN  RNA integrity number  
RNA  Ribonucleic acid  
ROS  Reactive oxygen species  
RT-PCR  Reverse transcriptase polymerase chain reaction  
SD  Standard deviation  
SELECT  Selenium and Vitamin E Cancer Prevention Trial  
Sepp Selenoprotein P 
SOD Superoxide dismutase 
SPS2 Selenophosphate syntethase 2 
SSC Side scatter 
Sub-G1-fraction Cells containing subdiploid DNA 
TNB 5-thio-2-nitrobenzoic acid  
TNF  Tumor Necrosis Factor  
TRAIL Tumor necrosis factor-related apoptosis-inducing ligand 
TrxR Thioredoxin reductase 
WHO  World Health Organization  
WST-1 Water-soluble tetrazolium-1 
ZnT Zinc export protein 
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9.2 Applied chemicals 
Chemical Manufacture (Location) 
1,1',3,3,3',3'-hexamethylindodicarbocyanine iodide 
(DilC1(5)) 
Invitrogen (Darmstadt, DE) 
1.4-Dithiothreitol (DTT), (≥99% p.a.) Roth (Karlsruhe, DE) 
2-acetylamino-3-[4-(2-acetylamino-2-
carboxyethylsulfanylthiocarbonylamino)phenylthiocarba
moylsulfanyl]propionic acid (2-AAPA) (≥95 %) 
Sigma-Aldrich (Steinheim, DE) 
2-mercaptoethanol Serva (Heidelberg, DE) 
5.5'-dithiobis-(2-nitrobenzoic acid) (DTNB) (≥99 % p.a.) Roth (Karlsruhe, DE) 
5-sulfo salicyl acid (SSA) (≥99 %) Roth (Karlsruhe, DE) 
Annexin-V (FITC conjugated) Biolegend (London, UK) 
Anti-AIF-antibody (H300) (rabbit polyclonal)    Santa Cruz Biotechnology (Heidelberg, DE) 
Anti-rabbit-antibody (Cy3) (goat) Jackson Immuno Research Laboratories 
Assay Loading Reagent 2x Fluidigm (San Francisco, USA) 
Auranofin Sigma-Aldrich (Steinheim, DE) 
Cadmium chloride (99.9 %) (CdCl2) Sigma-Aldrich (Steinheim, DE) 
Catalase (bovine liver) Sigma-Aldrich (Steinheim, DE) 
Coulter Isoton II Diluent Beckman Coulter (Krefeld, DE) 
D, L-Buthionine-[S, R]-Sulfoximine (BSO) (≥97 %) Sigma-Aldrich (Steinheim, DE) 
DAPI staining solution (Cystain DNA/Protein) Partec (Münster, DE) 
Diethylenetriaminepentaacetic acid (DETAPAC) Sigma-Aldrich (Steinheim, DE) 
Dihydroethidium Sigma-Aldrich (Steinheim, DE) 
Dimethylsulfoxid (DMSO) Sigma-Aldrich (Steinheim, DE)  
Dipotassium phosphate (K2HPO4)  Roth (Karlsruhe, DE) 
Disodium hydrogen phosphate (Na2HPO4) Roth (Karlsruhe, DE) 
DNA Away Molecular BioProducts (San Diego, USA) 
DNA Binding Dye Sample Loading Reagent (20x) Fluidigm (San Francisco, USA) 
DNA suspension buffer Teknova (Hollister, USA) 
Dulbecco’s Modified Eagel’s Medium (DMEM) Sigma-Aldrich (Steinheim, DE) 
Ethanol, 96 %, denatured Sigma-Aldrich (Steinheim, DE) 
Ethylenediaminetetraacetic acid (EDTA, ≥99 %) Roth (Karlsruhe, DE) 
Exonuclease 1 (20 U/µl)  New England BioLabs (Frankfurt am Main, DE) 
Exonuclease reaction buffer New England BioLabs (Frankfurt am Main, DE) 
FACS-Flow BD (Heidelberg, DE) 
Fetal bovine serum (FBS) Gibco, Invitrogen (Darmstadt, DE) 
Giemsa (Azure Eosin Methylene Blue) solution Roth (Karlsruhe, DE) 
Glutathione peroxidase (bovine erythrocytes) Sigma-Aldrich (Steinheim, DE) 
Glutathione reductase (Baker’s yeast, S. cerevisiae) Sigma-Aldrich (Steinheim, DE) 
Hydrogen chloride (HCl, 0.1 N, 4 N) Roth (Karlsruhe, DE) 
Hydrogen peroxide (H2O2, 30 %), suprapure Merck (Darmstadt, DE) 
Hypoxanthine Sigma-Aldrich (Steinheim, DE) 
L (+)-Selenomethionine (99 %) Acros Organics (Geel, BE) 
L-Cysteine (≥98 %) Roth (Karlsruhe, DE) 
L-Glutathione, oxidized (≥98 %) Sigma-Aldrich (Steinheim, DE) 
L-Glutathione, reduced (≥98 %) Sigma-Aldrich (Steinheim, DE) 
Magnesium Matrix modifier Merck (Darmstadt, DE) 
Menadione Sigma-Aldrich (Steinheim, DE) 
Mercaptosuccinate Sigma-Aldrich (Steinheim, DE) 
Methanol Roth (Karlsruhe, DE) 
Monopotassium phosphate (KH2PO4) Roth (Karlsruhe, DE) 
Nicotinamide adenine dinucleotide phosphate Roth (Karlsruhe, DE) 
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(NADPH) tetrasodium salt (≥97 %) 
Nitric acid (HNO3, 65 %) Merck (Darmstadt, DE) 
NucleoSpin RNA II (RNA Isolation Kit) Macherey-Nagel (Düren, DE) 
Palladium Modifier Merck (Darmstadt, DE) 
PCR Certified Water Teknova (Hollister, USA) 
Penicillin (5.000 U/ ml) ‐ Streptomycin (5 mg/l) solution Sigma-Aldrich (Steinheim, DE) 
Potassium chloride (KCl) Merck (Darmstadt, DE) 
Potassium dihydrogen phosphate (KH2PO4, ≥99 %) Merck (Darmstadt, DE) 
Primer  Eurofins (Hamburg, DE) 
Primer (Gene Expression Design) Fluidigm (San Francisco, USA) 
Propidium iodide (1 mg/ml) Sigma-Aldrich (Steinheim, DE) 
qScript™ cDNA Synthesis Kit Quanta Biosciences via VWR (Dresden, DE) 
RNase Away Molecular BioProducts (San Diego, USA) 
Single Element AAS Standard solution selenium (1g/L) Roth (Karlsruhe, DE) 
Sodium aurothiomalate Sigma-Aldrich (Steinheim, DE) 
Sodium azide (NaN3) Sigma-Aldrich (Steinheim, DE) 
Sodium chloride (NaCl) AppliChem (Darmstadt, DE) 
Sodium diethyl dithio carbamate (DDC) trihydrate 
(≥98 %) 
Alfa Aesar (Karlsruhe, DE) 
Sodium hydroxide (NaOH 0.1 N, 4 N) Roth (Karlsruhe, DE) 
Sodium selenite (Na2SeO3, 99 %) Sigma-Aldrich (Steinheim, DE) 
SsoFast EvaGreen® Supermix with low ROX BioRad (München, DE) 
Staurosporine Sigma-Aldrich (Steinheim, DE) 
Superoxide dismutase (bovine erythrocytes) Sigma-Aldrich (Steinheim, DE) 
TaqMan® PreAmp Master-Mix 2x Life Technologies (Darmstadt, DE) 
TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) Teknova (Hollister, USA) 
Tertbutyl hydroperoxide (t-BOOH) Fluka (buchs, CH) 
Thioredoxin reductase (rat liver) IMCO (Solna, SE) 
Tris -(hydroxymethyl)-aminomethan Roth (Karlsruhe, DE) 
Triton™ X-100 (reduced form, Fluka) Sigma-Aldrich (Steinheim, DE) 
Trypsin (10x) Sigma-Aldrich (Steinheim, DE) 
Vectashield Mounting Medium (DAPI) Vector Laboratories (Burlingame, USA) 
WST-1 Dojindo (Kumamoto, JP) 
Xanthine-oxidase (from bovine milk) Sigma-Aldrich (Steinheim, DE) 
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9.3 Applied solutions and buffers 
Culture medium for HCT116 cells DMEM 
 10 % FBS 
 100 U pencillin/ml, 10 µg streptomycin/ml 
  
PBS (pH 7.4) 100 mM NaCl, 4.5 mM KCl 
 7 mM Na2HPO4 , 3 mM KH2PO4 
  
PBS-EDTA  0,5 mM EDTA in PBS 
  
Trypsin solution (1x) 0.25 % trypsin in PBS-EDTA 
  
Potassium phosphate buffer (pH 7.4)  Solution A:                  Solution B: 
(total intracellular GSH determination) 0.1 M K2HPO4                    0.1 M KH2PO4 
 1 mM EDTA               1 mM EDTA 
 Solution B is added to solution A to set pH 7.4 
  
Tris-HCl 400 mM (pH 8.0)  
(total extracellular thiol determination) 
400 mM Tris, pH 8.0 set with 1 N HCl 
  
Potassium phosphate buffer (0.1 M) (pH 7.0)   
(enzyme activity assays) 
0.1 M KH2PO4  
  
PBS-UVC (pH 7.4) (indirect immunofluorescence) 137.1 mM NaCl, 2.15 mM KCl 
 8.5 mM Na2HPO4, 2.35 mM KH2PO4 
  
Blocking solution 5 % FBS in PBS-UVC, 2 % FBS in PBS-UVC 
9.4 Applied materials 
Material Manufacturer (Location) 
96 well plates, transparent  TPP (Trasadingen, CH) 
96 well plates, UV-star Greiner BioOne (Frickenhausen, DE) 
Accuvette cups Beckmann Coulter (Krefeld, DE) 
Cell culture dishes (40, 60, 100 mm) TPP (Trasadingen, CH) 
Cell culture flasks (25 cm2) TPP (Trasadingen, CH) 
Centrifuge tubes, 15 and 50 ml Sarstedt (Nümbrecht, DE) 
Cover glass, 12 mm Roth (Karlsruhe, DE) 
Cover slides, 75 x 25 mM VWR (Darmstadt, DE) 
Cryo tubes with screw cap Roth (Karlsruhe, DE) 
Glass pipettes (1, 2, 5, 10, 20 ml)  Roth (Karlsruhe, DE) 
Micro tubes, 1.5 and 2 ml Sarstedt (Nümbrecht, DE) 
Needles 0.4 x 20 mm Terumo (Eschborn, DE) 
PCR reaction tubes Sarstedt (Nümbrecht, DE) 
Pipette tips for multipette (1, 5 ml) Eppendorf (Hamburg, DE) 
Pipette tips, 0.1-10 µl Sarstedt (Nümbrecht, DE) 
Pipette tips, 100-1000 µl Brand (Wertheim, DE) 
Pipette tips, 10-200 µl Roth (Karlsruhe, DE) 
Pipette tips, 500-5000 µl Eppendorf (Hamburg, DE) 
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9.5 Applied instruments and software 
Instrument Manufacturer (Location) 
Atom absorption spectrometer PinAacle 900T Perkin Elmer (Rodgau, DE) 
Autoclave D-150 Systec (Linden, DE) 
Axio Imager Z2 Carl Zeiss (Oberkochen, DE) 
Biofreezer Herafreeze top Thermo Scientific (Langenselbold, DE) 
Biofuge pico Heraeus (Hanau, DE) 
Biomark HD System Fluidigm (San Francisco, USA) 
Centrifuge 5810R Eppendorf (Hamburg, DE) 
Colony Counter BZG-30 WTW (Weilheim, DE) 
Coulter counter Z2 Beckman Coulter, Inc (Krefeld, DE) 
Drying cabinet Heraeus T6 Heraeus (Hanau, DE) 
Galaxy Mini Centrifuge VWR (Darmstadt, DE) 
Gas burner Gas Profi 1 SCS micro  Roth (Karlsruhe, DE) 
Hera Cell 150 incubator Heraeus (Hanau, DE) 
HERAsafeKS (Sterile bench) Thermo Scientific (Langenselbold, DE) 
iCycler BioRad (München, DE) 
IFC Controlle HX Fluidigm (San Francisco, USA) 
Infinite M200 Tecan (Crailsheim, DE) 
LSRII Fortessa BD Sciences (Heidelberg, DE) 
Megafuge 1.0 Heraeus (Hanau, DE) 
Microscope Axiovert 40C Carl Zeiss (Oberkochen, DE) 
Mini Rocker MR-1 PeqLab (Erlangen, DE) 
Multichannel pipette (1-10 µl) Mettler-Toledo (Gießen, DE) 
Multipette®  Eppendorf (Hamburg, DE) 
NanoQuant plate Tecan (Crailsheim, DE) 
PCR Workstation Pro  PeqLab (Erlangen, DE) 
pH meter 3210 WTW (Weilsheim, DE) 
Pipetus Akku Hirschmann (Eberstadt, DE) 
Professional laboratory dish washer G7883  Miele (Gütersloh, DE) 
Real-Time System CFX96 BioRad (Hercules, USA) 
Refrigerators and freezers  Bosch (Stuttgart, DE) 
Software AA Winlab32 Perkin Elmer (Rodgau, DE) 
Software BD FACSDiva™ BD Sciences (Heidelberg, DE) 
Software Data Collection Fluidigm (San Francisco, USA) 
Software GenEx MultiD (Göteborg, SE) 
Software IBM Statistics 19 SPSS Statistics (Chicago, USA) 
Software Real-Time PCR Genetic Analysis Fluidigm (San Francisco, USA) 
Software Tecan i-Control Tecan (Crailsheim, DE) 
Software ZEN Carl Zeiss (Oberkochen, DE) 
Thermomixer MKR 13 HLC BioTech (Bovenden, DE) 
Thermomixer SH 26 CAT (Staufen, DE) 
Ultra precision scale Sartorius (Göttingen, DE) 
Ultra sound bath Sonifier 250 Branson (Danbury, USA) 
Ultrapure water purification system Milli-Q Millipore (Darmstadt, DE) 
Vortex Genie 2T Scientific Industries (New York, USA) 
Water bath Memmert (Schwabach, DE) 
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9.6 Supplementary data 
9.6.1 Gene expression analysis 
Table A1: The 95 genes of the assay setup classified in various signaling pathways  
Reference 
genes 
Redox-
sensitive 
transcription 
factors 
DNA damage 
response Apoptosis 
Cell cycle 
control 
Oxidative 
stress response 
Xenobiotic 
metabolism 
ACTB AXIN2 APEX1 APAF1 CCND1 CAT ABCB1 
B2M  BTRC ATM BAX CDKN1A  FTH1 ABCC1 
GAPDH JUN ATR BBC3 CDKN1B G6PD ADH1B 
GUSB KEAP1 BRCA1  BCL2 CDKN2B GCLC ALDH1A1 
HPRT1 MAP3K5 BRCA2 BCL2L1 E2F1 GPX1 CYP1A1 
 MDM2 DDB1 PMAIP1 EGFR GPX2 EPHX1 
 NFE2L2 DDB2 TNFRSF10B IL8 GSR GSTP1 
 NFKB1 DDIT3 XIAP MYC HMOX1 NAT1 
 NFKB2 ERCC1  PLK3 HSPA1A NQO1 
 NFKBIA ERCC2  PPM1D MT1X SULT1A1 
 TP53 ERCC4  SIRT2 MT2A UGT1A  
 SLC30A1 ERCC5   PRDX1  
 VEGFA GADD45A   SEPP1  
  LIG1   SOD1  
  LIG3   SOD2  
  MGMT   TFRC  
  MLH1   TXN1  
  MSH2   TXNRD1  
  OGG1     
  PARP1     
  PCNA     
  POLB     
  POLD1     
  RAD50     
  RAD51     
  RRM2B     
  XPA     
  XPC     
  XRCC5     
 
Table A2: Forward and reverse primer sequences of the 95 genes for the RT-qPCR analysis 
Gene Forward Primer (5`3´) Reverse Primer (5´3´) 
ABCB1 AACACCACTGGAGCATTGAC ACAGCAAGCCTGGAACCTA 
ABCC1 CCTGTTCTCGGAAACCATCC AAGGTGATCCTCGACAGGAA 
ACTB CCAACCGCGAGAAGATGAC TAGCACAGCCTGGATAGCAA 
ADH1  CCCTCAAGACTACAAGAAA CAGTCAGTAGCAGCATAG 
ALDH1A1 CTTATCAGCAGGAGTGTT GACCTCTGTATATTCATGGA 
APAF1 AAATCTGGGCTTCTGATG CTCTTGTCTCTGGTTGTAA 
APEX1 GGATTAGATTGGGTAAAGGA CCTATGCCGTAAGAAACT 
ATM TACCAAGCAGCATGGAGGAA GATTCATGGTAACTGGTTCCTTCTAC 
ATR CATTCCAAAGCGCCACTGAA CGCTGCTCAATGTCAAGAACA 
AXIN2 CTTGAATGAAGAAGAGGAGT CCTGTATCCACTGTCAAC 
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B2M CGCTACTCTCTCTTTCTG CAGTGTAGTACAAGAGATAGA 
BAX GGGTTGTCGCCCTTTTCTAC TCTTGGATCCAGCCCAACA 
BBC3 GACCTCAACGCACAGTAC GTATGCTACATGGTGCAG 
BCL2 TGACAGAGGATCATGCTGTACTTA TCCAATTCCTTTCGGATCTTTATTTCA 
BCL2L1 AAGCGTAGACAAGGAGAT TCCCATAGAGTTCCACAA 
BRCA1 AGTATGGGCTACAGAAAC CACAGTTCCAAGGTTAGA 
BRCA2  ATGCAGCAGACCCAGCTTA TCCATGGCCTTCCTAATTTCCA 
BTRC CTGCTATGAAGACTGAGAA TTCCACTTGATCTGACTC 
CAT AGAAGTGCGGAGATTCAACAC CCTCATTCAGCACGTTCACA 
CCND1 AGAGGCGGAGGAGAACAAA AGGGCGGATTGGAAATGAAC 
CDKN1A  CAGCATGACAGATTTCTAC CACACAAACTGAGACTAAG 
CDKN1B AGGAAGCGACCTGCAACC TTGGGGAACCGTCTGAAACA 
CDKN2B  TTACGGCCAACGGTGGATTA GGCATGCCCTTGTTCTCC 
CYP1A1 TTTGAGAAGGGCCACATC CCAGGAGATAGCAGTTGT 
DDB1 ATCATCATTGGACAGGAG AGGTATCTTGAGCCATTAG 
DDB2 ACACTCTGGATTCTTACC ACTGGTTGGTATTGAGAG 
DDIT3 TTAAGTCTAAGGCACTGAG GGTGTGGTGATGTATGAA 
E2F1 AGCTCATTGCCAAGAAGTCCAA TCCTGGGTCAACCCCTCAA 
EGFR GAACCCCGAGGGCAAATACA CACGAGCCGTGATCTGTCA 
EPHX1 GAGATCCACGACTTACAC AATTCATTCCGCCAGTAG 
ERCC1 GCCGACTGCACATTGATCC TCCGCTGGTTTCTGCTCATA 
ERCC2 TGAGAAGGTGATTGAAGAG GGCATCAAATTCCTCATAGA 
ERCC4 CTTCTGGAATCTCTGAGAGCAA GAGGTGCTGGAGTCAAGAAA 
ERCC5 TTGATGGGGATGCTCCACTA TGGAGTCACTGGACGCTAA 
FTH1 TTACCTGTCCATGTCTTAC CATCACAGTCTGGTTTCT 
G6PD GCCGTCACCAAGAACATTCA CTCCCGAAGGGCTTCTCC 
GADD45A GCTCCTGCTCTTGGAGAC CAGGATCCTTCCATTGAGATGAA 
GAPDH ACACCATGGGGAAGGTGAAG GTGACCAGGCGCCCAATA 
GCLC TGGATGCCATGGGATTTGGAA CTCAGATATACTGCAGGCTTGGAA 
GPX1 CACCCTCTCTTCGCCTTCC GAGCTTGGGGTCGGTCATAA 
GPX2 AGGAGAACTGTCAGAATG GGGTCATCATAAGGGTAG 
GSR CGTGAATGTTGGATGTGTA GGACTTGGTGAGATTGTT 
GSTP1 CTCCGCTGCAAATACATC CACAATGAAGGTCTTGCC 
GUSB CATCGATGACATCACCGTCAC ACAGGTTACTGCCCTTGACA 
HMOX1 CAGTCAGGCAGAGGGTGATA GCTCCTGCAACTCCTCAAA 
HPRT1 GCTTTCCTTGGTCAGGCAGTA ACTTCGTGGGGTCCTTTTCAC 
HSPA1A TCCTGTGTTTGCAATGTTGAA CTGCATGTAGAAACCGGAAAA 
IL8 CACTCCATAAGGCACAAA GCACTGACATCTAAGTTCT 
JUN GGTAGCAGATAAGTGTTGA CAGTTAGAGAGAAGGTGAAA 
KEAP1 CTTCGCTGAGCAGATTGG GTAGAACCGTCGCTGTTC 
LIG1 TGGGAAGTACCCGGACATCA GCTTCGGTGTCCAGGATGAA 
LIG3 TCCAGGACTTCCTTCGGAAA CAGCAGCAGCTTCACTGTTA 
MAP3K5 ATCATTCGGAAGGCGGTACA ACTCTCAGATGCAAGGCTGAA 
MDM2 CCATGATCTACAGGAACTTGGTA GACACCTGTTCTCACTCACA 
MGMT TGTGAAATTCGGAGAAGTGA GAGGATGGGGACAGGATT 
MLH1 TACTTCACCCAGACTTTG GCATAGACCTTATCACTACT 
MSH2 CCAGCAGCAAAGAAGTGCTA TGTTTCACCTTGGACAGGAAC 
MT1X TTCTCCTTGCCTCGAAAT GGTTGCTCTATTTACATCTG 
MT2A AACCTGTCCCGACTCTAG GAAGTCGCGTTCTTTACA 
MYC ACTGGAACTTACAACACC GTAGTCGAGGTCATAGTTC 
NAT1 GCAATCTGTCTTCTGGAT CAATGGATGTTAAGGTTCTC 
NFE2L2 CCTGAGTTACAGTGTCTTAA GTGGACTACAGTTACCTAC 
NFKB1 TCAGAATGGCAGAAGATG CCATCTGTGGTTGAAATAC 
NFKB2 TGACTTTGAGGGACTGTA ATCTCTGTGGCTAGATGC 
NFKBIA ACTTTCGAGGAAATACCC GATAGAGGCTAAGTGTAGAC 
NQO1 TCGGACCTCTATGCCATGAAC AAAGTTCGCAGGGTCCTTCA 
OGG1 ATCAAGTATGGACACTGAC CACACCTTGGAATTTCTG 
PARP1 TTCTGGAGGACGACAAGGAA GTTGCTACCGATCACCGTAC 
PCNA TCTGAGGGCTTCGACACCTA CATTGCCGGCGCATTTTAGTA 
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PLK3 ACTGTCCAGGTGAACTTC GAAGCGAGGTAAGTACAAG 
PMAIP1 TGTGTAGTTGGCATCTCC CTGAGTTGAGTAGCACAC 
POLB AAGTACAATGCTTACAGAAAAG GTATCATCCTGCCGAATC 
POLD1 TTACAACATCCAGAACTTCG GCTTGGACTGGAATGAAG 
PPM1D AGCCAGAACTTCCCAAGGAAA ACTACACGATTCACCCCAGAC 
PRDX1 GCTGATAGGAAGATGTCT GTGAAGTCAAGAGGGTAA 
RAD50 TCCCTCCTGGAACCAAAGGAA AGACGAATCTGGGCTCTCACA 
RAD51 GGGAAGACCCAGATCTGTCA ATGTACATGGCCTTTCCTTCAC 
RRM2B AGAATGTTCACTCAGAGATG GCCAGAATATAGCAGCAA 
SEPP1 CCAATGCTAAACTCCAATG GAGAAGAGATTCCTTGATGA 
SIRT2 GCTATTTCAAGAAACATCCG TATTCGCTCCAGGGTATC 
SLC30A1 GGTTCAGTGATTGTAGTAGT GCAGATTCCTTAAGTAATGG 
SOD1 GAGTTTGGAGATAATACAGC CAACATGCCTCTCTTCAT 
SOD2 AGGATCCACTGCAAGGAACA GTGCTCCCACACATCAATCC 
SULT1A GAGACTCTGAAAGACACA AACATAGACCACCTTGAC 
TFRC GTTGATAAGAACGGTAGACT CTGCTCTGACAATCACTAT 
TNFRSF10B GTGATTCAGGTGAAGTGG TCTTTGTGGACACATTCG 
TP53 TTCGAGATGTTCCGAGAG AGAAGTGGAGAATGTCAGT 
TXN TAAGAAGGGACAAAAGGTG AGCTATTCAGACATGAGAC 
TXNRD1 GCATCCCTGGTGACAAAGAA CCAACAACCAGGGTCTTACC 
UGT1A  CTCAGAAATTCCAGAGAAGA GTGTTGTTCGCAAGATTC 
VEGFA TACATCTTCAAGCCATCC CTGTAGGAAGCTCATCTC 
XIAP ACACCATCACTAACTAGAAG TCTGACTTGACTCATCTTG 
XPA ACATCATTCACAATGGGGTGATA ACCCCAAACTTCAAGAGACC 
XPC TAAAGGGGTCCATGAGGACACA CTGGCTGGCTGCAGATGTTA 
XRCC5 CAGTATCAGAACATCACAGT CAATATGCCTCTTCTCAAAC 
 
Table A3: Overview of the investigated genes and their encoded proteins 
Gene Coding protein 
ABCB1 ATP-binding cassette, Multidrug resistance protein 1, ABCB1 = MDR1 
ABCC1 ATP-binding cassette, Multidrug resistance-associated protein 1, ABCC1 = MRP1 
ACTB Actin, cytoplasmic 1 
ADH1  Alcohol dehydrogenase 1B 
ALDH1A1 Aldehyde dehydrogenase 1 
APAF1 Apoptotic peptidase activating factor 1 
APEX1 APEX nuclease (multifunctional DNA repair enzyme) 1 
ATM ATM serine/threonine kinase 
ATR ATR serine/threonine kinase 
AXIN2 Axin 2 
B2M Beta-2-microglobulin 
BAX BCL2-associated X protein 
BBC3 BCL2 binding component 3 
BCL2 B-cell CLL/lymphoma 2  
BCL2L1 BCL2-like 1 
BRCA1 breast cancer 1 susceptibility protein 
BRCA2  breast cancer 2 susceptibility protein 
BTRC beta-transducin repeat containing E3 ubiquitin protein ligase 
CAT catalase 
CCND1 cyclin D1, G1/S specific 
CDKN1A  cyclin-dependent kinase inhibitor 1A (p21, Cip1) 
CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1) 
CDKN2B  cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 
CYP1A1 cytochrome P450 family 1 
DDB1 damage-specific DNA binding protein 1, XPE = DDB1 
DDB2 damage-specific DNA binding protein 2 
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DDIT3 DNA-damage-inducible transcript 3 
E2F1 E2F transcription factor 1 
EGFR epidermal growth factor receptor 
EPHX1 epoxide hydrolase 1 
ERCC1 excision repair cross-complementing rodent repair deficiency, complementation group 1 
ERCC2 excision repair cross-complementing rodent repair deficiency, complementation group 2, 
XPD = ERCC2 
ERCC4 excision repair cross-complementing rodent repair deficiency, complementation group 4, 
XPF = ERCC4 
ERCC5 excision repair cross-complementing rodent repair deficiency, complementation group 5, 
XPG = ERCC5 
FTH1 Ferritin, heavy chain 
G6PD glucose-6-phosphate dehydrogenase 
GADD45A growth arrest and DNA-damage-inducible protein, alpha 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GCLC glutamate-cysteine ligase (catalytic subunit)  
GPX1 glutathione peroxidase 1 
GPX2 glutathione peroxidase 2 (gastrointestinal) 
GSR glutathione reductase 
GSTP1 glutathione S-transferase pi 1 
GUSB glucuronidase, beta 
HMOX1 heme oxygenase 1 
HPRT1 hypoxanthine phosphoribosyltransferase 1 
HSPA1A heat shock 70kDa protein 1A 
IL8 interleukin 8 
JUN Jun Proto-Oncogene (AP-1) 
KEAP1 kelch-like ECH-associated protein 1 
LIG1 DNA ligase I 
LIG3 DNA ligase III 
MAP3K5 mitogen-activated protein kinase kinase kinase 5 
MDM2 E3 ubiquitin protein ligase MDM2 (proto-oncogene)  
MGMT O-6-methylguanine-DNA methyltransferase 
MLH1 DNA mismatch repair protein, mutL homolog 1 
MSH2 DNA mismatch repair protein, mutS homolog 2 
MT1X metallothionein 1X 
MT2A metallothionein 2A 
MYC MYC  proto-oncogene protein 
NAT1 arylamine N-acetyltransferase 1 
NFE2L2 NF-E2-related factor 2, nuclear factor, erythroid 2-like 2 (Nrf2) 
NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105 subunit 
NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p100 subunit 
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 
NQO1 NAD(P)H dehydrogenase, quinone 1; 
OGG1 8-oxoguanine DNA glycosylase, HOGG1 = OGG1, 
PARP1 poly (ADP-ribose) polymerase 1   
PCNA proliferating cell nuclear antigen  
PLK3 serine/threonine kinase, polo-like kinase 3 
PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 
POLB DNA polymerase beta   
POLD1 DNA polymerase delta 1 (catalytic subunit) 
PPM1D protein phosphatase 1D (Mg2+/Mn2+ dependent) 
PRDX1 peroxiredoxin 1 
RAD50 DNA repair protein RAD50 (homolog (S. cerevisiae)) 
RAD51 DNA repair protein RAD51 (recombinase)  
RRM2B ribonucleotide reductase M2 B (TP53 inducible) 
SEPP1 selenoprotein P 1 (plasma) 
SIRT2 NAD dependent protein deacetylase sirtuin 2 
SLC30A1 solute carrier family 30 1 (zinc transporter = ZNT1) 
SOD1 superoxide dismutase 1 
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SOD2 superoxide dismutase 2 
SULT1A sulfotransferase 1A (cytosolic)  
TFRC transferrin receptor 1 
TNFRSF10B tumor necrosis factor receptor superfamily member 10b 
TP53 tumor protein p53 
TXN thioredoxin  
TXNRD1 thioredoxin reductase 1 
UGT1A  UDP glucuronosyltransferase 1A 
VEGFA vascular endothelial growth factor A  
XIAP E3 ubiquitin protein ligase X-linked inhibitor of apoptosis 
XPA DNA repair protein xeroderma pigmentosum, complementation group A 
XPC DNA repair protein xeroderma pigmentosum, complementation group C 
XRCC5 X-ray repair complementing defective repair in Chinese hamster cells 5  
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Table A4: mRNA levels in p53-proficient HCT 116 cells: Exposure to cadmium chloride (24h:1 µM-50 µM. 16h: 10 µM-50 µM; 8h 10 µM-50 µM) 
  CdCl2 (24 h)                    CdCl2 (16 h)         CdCl2 (8 h)         
  1 µM      5 µM      10 µM     50 µM      10 µM      50 µM      10 µM      50 µM      
  Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
ABCB1 0.94 0.18 0.15 1.86 0.20 0.18 2.86 0.59 0.49 4.49 0.39 0.36 3.67 1.95 1.27 5.10 1.80 1.33 2.93 1.55 1.01 5.49 2.80 1.85 
ABCC1 1.09 0.02 0.02 1.15 0.09 0.08 1.03 0.20 0.17 1.11 0.24 0.20 1.19 0.27 0.22 1.00 0.21 0.17 1.21 0.17 0.15 1.41 0.17 0.15 
CAT 0.94 0.06 0.05 0.86 0.05 0.05 0.71 0.04 0.03 0.70 0.06 0.06 0.75 0.05 0.05 0.68 0.03 0.03 0.82 0.06 0.05 0.82 0.11 0.10 
EPHX1 1.19 0.07 0.07 1.19 0.04 0.04 1.09 0.06 0.05 1.10 0.05 0.05 1.12 0.07 0.07 0.99 0.06 0.06 1.17 0.14 0.13 1.17 0.35 0.27 
FTH1 1.24 0.14 0.13 2.71 0.46 0.40 3.02 0.72 0.58 3.26 0.40 0.36 2.74 0.48 0.41 1.89 4.43 1.32 2.67 1.72 1.05 2.18 0.29 0.25 
G6PD 1.31 0.14 0.12 1.57 0.10 0.09 1.53 0.07 0.07 1.57 0.10 0.09 1.52 0.18 0.16 1.39 0.09 0.09 1.42 0.28 0.23 1.60 0.06 0.06 
GCLC 1.35 0.07 0.06 1.44 0.18 0.16 1.70 0.12 0.12 1.65 0.21 0.19 1.78 0.27 0.23 2.33 0.19 0.17 4.51 0.37 0.34 4.08 0.29 0.27 
GPX1 0.95 0.07 0.06 0.80 0.04 0.03 0.84 0.10 0.09 0.60 0.03 0.02 0.73 0.03 0.03 0.78 0.06 0.06 0.98 0.02 0.02 0.78 0.06 0.06 
GSR 1.39 0.23 0.20 1.68 0.09 0.09 2.03 0.21 0.19 1.99 0.18 0.17 2.06 0.23 0.20 2.45 0.17 0.16 2.31 0.11 0.11 2.36 0.14 0.13 
GSTP1 1.00 0.04 0.04 1.10 0.06 0.06 1.15 0.07 0.07 1.17 0.07 0.06 1.13 0.05 0.04 1.23 0.09 0.09 1.20 0.04 0.03 1.12 0.06 0.06 
KEAP1 1.20 0.20 0.17 1.14 0.20 0.17 0.89 0.21 0.17 0.79 0.10 0.09 0.84 0.13 0.11 0.61 0.12 0.10 0.90 0.11 0.10 1.00 0.19 0.16 
MT1X 5.09 1.79 1.33 16.50 4.63 3.62 19.24 3.45 2.93 19.00 2.17 1.94 28.47 3.51 3.12 32.80 4.01 3.57 37.92 5.41 4.73 30.18 2.88 2.63 
MT2A 3.93 0.23 0.22 6.58 0.45 0.42 7.41 0.16 0.16 7.32 1.29 1.10 7.89 0.78 0.71 7.11 4.13 2.61 8.45 0.85 0.78 6.90 0.75 0.68 
NAT1 1.16 0.13 0.12 1.57 0.11 0.10 1.84 0.13 0.12 1.97 0.12 0.11 1.57 0.10 0.09 1.55 0.04 0.04 0.92 0.16 0.14 0.91 0.13 0.11 
NFEL2L 0.98 0.12 0.11 0.95 0.11 0.10 0.90 0.16 0.14 0.86 0.16 0.13 0.90 0.10 0.09 0.87 0.08 0.07 1.00 0.23 0.19 1.08 0.07 0.07 
NQO1 1.18 0.03 0.03 1.53 0.04 0.04 1.31 0.12 0.11 1.50 0.06 0.06 1.56 0.10 0.09 1.40 0.04 0.04 1.62 0.10 0.10 1.80 0.08 0.08 
PRDX1 1.05 0.15 0.13 1.37 0.10 0.09 1.40 0.09 0.08 1.67 0.24 0.21 1.53 0.17 0.15 1.53 0.18 0.16 1.35 0.30 0.25 1.45 0.20 0.18 
SEPP1 1.04 0.09 0.08 0.79 0.04 0.04 0.68 0.06 0.06 0.54 0.12 0.10 0.45 0.03 0.03 0.37 0.02 0.02 0.57 0.14 0.11 0.52 0.34 0.20 
SLC30A1 1.52 0.58 0.42 2.47 1.80 1.04 3.33 1.64 1.10 2.54 1.79 1.05 2.69 0.24 0.22 3.20 0.75 0.61 10.34 1.13 1.02 8.13 0.29 0.28 
SOD1 0.96 0.05 0.04 0.98 0.05 0.05 1.31 0.22 0.18 1.26 0.13 0.12 1.18 0.10 0.09 1.55 0.11 0.10 1.38 0.20 0.17 1.19 0.04 0.04 
SOD2 0.92 0.03 0.03 0.99 0.06 0.06 0.98 0.09 0.08 1.03 0.05 0.05 0.97 0.04 0.04 0.93 0.04 0.03 0.87 0.06 0.06 0.92 0.02 0.02 
SULT1A 1.12 0.19 0.16 1.19 0.10 0.09 1.15 0.16 0.14 0.99 0.10 0.09 0.99 0.11 0.10 0.93 0.05 0.05 1.16 0.14 0.13 0.99 0.23 0.18 
TFRC 1.33 0.33 0.26 1.50 0.37 0.30 1.44 0.37 0.29 1.48 0.36 0.29 1.26 0.14 0.13 1.20 0.11 0.10 1.02 0.11 0.10 1.02 0.18 0.15 
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TXN 1.12 0.19 0.16 1.51 0.16 0.15 1.73 0.45 0.36 2.01 0.43 0.36 1.78 0.33 0.28 1.63 0.77 0.52 1.51 0.48 0.36 1.64 0.19 0.17 
TXNRD1 1.45 0.12 0.11 1.80 0.11 0.10 2.37 0.28 0.25 2.30 0.24 0.22 2.46 0.53 0.44 3.17 0.39 0.35 4.20 0.51 0.45 4.38 0.65 0.56 
HMOX1 1.35 0.06 0.06 22.99 13.63 8.56 42.72 16.08 11.68 66.43 17.53 13.87 62.23 29.42 19.97 79.10 17.14 14.08 108.78 8.68 8.04 161.69 12.51 11.61 
HSPA1A 0.99 0.28 0.22 66.16 39.07 24.56 173.96 55.85 42.27 273.36 32.47 29.02 160.00 164.67 81.15 244.11 263.94 126.82 58.80 73.09 32.59 150.06 235.80 91.70 
IL8 1.14 0.11 0.10 2.93 1.55 1.01 5.98 4.41 2.54 9.78 4.82 3.23 6.84 6.93 3.44 12.36 7.02 4.48 7.45 3.19 2.23 13.44 6.32 4.30 
NFKB1 1.09 0.22 0.19 1.03 0.18 0.15 0.82 0.15 0.12 0.76 0.10 0.09 0.86 0.09 0.08 0.67 0.07 0.06 0.88 0.10 0.09 1.01 0.10 0.09 
NFKBIA 1.33 0.20 0.17 1.41 0.18 0.16 1.30 0.23 0.20 0.99 0.13 0.12 0.93 0.13 0.11 0.57 0.62 0.30 1.02 0.28 0.22 0.72 0.57 0.32 
NFKB2 1.14 0.27 0.22 1.57 0.19 0.17 1.56 0.35 0.29 1.64 0.31 0.26 1.69 0.43 0.34 1.55 0.23 0.20 1.21 0.61 0.40 1.47 0.14 0.13 
CCND1 0.99 0.06 0.06 1.08 0.09 0.08 0.98 0.09 0.08 0.99 0.09 0.08 0.99 0.07 0.06 0.89 0.08 0.07 1.14 0.10 0.09 1.29 0.03 0.03 
CDKN1A1  1.08 0.11 0.10 1.10 0.07 0.07 1.14 0.21 0.18 1.08 0.07 0.07 1.16 0.10 0.09 1.19 0.07 0.06 1.30 0.31 0.25 1.11 0.14 0.12 
CDKN1B  0.97 0.09 0.08 0.89 0.10 0.09 0.74 0.16 0.13 0.60 0.09 0.08 0.64 0.14 0.11 0.45 0.07 0.06 0.50 0.14 0.11 0.43 0.21 0.14 
CDKN2B  1.01 0.19 0.16 0.96 0.08 0.07 0.99 0.19 0.16 0.99 0.32 0.24 1.11 0.39 0.29 0.95 0.31 0.24 1.21 0.44 0.32 1.51 0.21 0.19 
E2F1 1.28 0.06 0.06 0.92 0.04 0.04 0.93 0.17 0.14 0.69 0.04 0.04 0.70 0.15 0.12 0.71 0.17 0.14 0.69 0.04 0.04 0.50 0.15 0.11 
EGFR 1.15 0.08 0.08 0.85 0.01 0.01 0.90 0.13 0.11 0.69 0.03 0.03 0.90 0.22 0.18 0.92 0.10 0.09 1.56 0.63 0.45 1.50 0.25 0.21 
JUN  0.78 0.18 0.15 2.15 0.86 0.61 4.37 2.64 1.65 5.08 3.46 2.06 5.75 4.45 2.51 9.08 4.11 2.83 13.29 12.43 6.42 15.35 15.62 7.74 
MAP3K5  1.05 0.11 0.10 0.95 0.09 0.08 0.88 0.09 0.08 0.77 0.09 0.08 0.80 0.04 0.04 0.82 0.01 0.01 0.83 0.07 0.06 0.79 0.09 0.08 
MDM2 1.02 0.10 0.09 1.28 0.04 0.04 1.27 0.06 0.06 1.43 0.08 0.08 1.25 0.03 0.03 1.13 0.02 0.02 1.01 0.07 0.06 1.14 0.09 0.08 
MYC 1.17 0.17 0.15 0.97 0.14 0.12 0.88 0.20 0.16 0.70 0.10 0.09 0.77 0.10 0.09 0.71 0.11 0.10 1.45 0.07 0.06 1.06 0.47 0.33 
PLK3 1.22 0.39 0.30 1.17 0.19 0.17 1.15 0.36 0.28 0.94 0.13 0.11 0.98 0.14 0.12 0.87 0.33 0.24 1.64 0.47 0.37 1.44 0.08 0.07 
PPM1D 1.08 0.11 0.10 1.05 0.04 0.04 1.27 0.15 0.13 1.13 0.04 0.04 0.89 0.05 0.05 1.00 0.12 0.11 0.82 0.15 0.12 0.61 0.09 0.08 
SIRT2 1.27 0.15 0.14 1.16 0.06 0.06 1.43 0.12 0.11 1.40 0.16 0.14 1.09 0.18 0.15 1.39 0.33 0.26 0.95 0.16 0.14 0.86 0.04 0.04 
TP53 0.95 0.11 0.10 0.71 0.10 0.09 0.57 0.07 0.06 0.53 0.04 0.04 0.60 0.07 0.06 0.50 0.03 0.03 0.73 0.08 0.08 0.79 0.07 0.06 
VEGFA 1.28 0.18 0.16 1.56 0.02 0.02 1.69 0.20 0.18 1.45 0.11 0.10 1.53 0.08 0.07 0.97 1.62 0.61 1.74 0.28 0.24 1.53 0.13 0.12 
APEX1 1.08 0.09 0.09 1.05 0.18 0.15 0.86 0.13 0.11 0.86 0.22 0.18 0.91 0.19 0.16 0.82 0.15 0.13 1.00 0.20 0.17 0.93 0.29 0.22 
ATM 1.02 0.22 0.18 0.86 0.05 0.04 0.91 0.06 0.05 0.85 0.06 0.06 0.91 0.08 0.07 0.83 0.04 0.04 0.87 0.10 0.09 1.04 0.22 0.18 
ATR 0.97 0.04 0.04 0.88 0.03 0.03 0.96 0.17 0.14 0.80 0.15 0.13 0.85 0.20 0.16 0.94 0.17 0.14 0.98 0.19 0.16 0.76 0.05 0.05 
BRCA1 1.05 0.09 0.08 0.91 0.10 0.09 0.92 0.22 0.17 0.70 0.13 0.11 0.69 0.14 0.12 0.67 0.15 0.12 0.78 0.09 0.08 0.58 0.08 0.07 
BRCA2 1.03 0.05 0.04 0.95 0.03 0.03 0.94 0.09 0.09 0.78 0.12 0.11 0.77 0.20 0.16 0.71 0.16 0.13 0.70 0.14 0.12 0.64 0.11 0.09 
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DDB1 1.26 0.22 0.19 1.20 0.16 0.14 1.04 0.19 0.16 0.97 0.14 0.12 1.01 0.12 0.10 0.92 0.17 0.14 1.07 0.12 0.11 1.17 0.15 0.13 
DDB2 1.16 0.16 0.14 1.10 0.18 0.15 0.84 0.20 0.16 0.72 0.15 0.13 0.60 0.14 0.11 0.48 0.21 0.15 0.49 0.05 0.05 0.48 0.24 0.16 
ERCC1 0.92 0.02 0.02 0.95 0.05 0.05 1.12 0.12 0.11 1.13 0.09 0.08 1.09 0.25 0.21 1.39 0.27 0.22 1.19 0.25 0.21 1.25 0.38 0.29 
ERCC2 1.16 0.05 0.04 1.08 0.09 0.09 0.90 0.33 0.24 0.93 0.09 0.08 1.03 0.13 0.12 0.95 0.22 0.18 0.96 0.47 0.32 0.97 0.04 0.03 
ERCC4 0.87 0.14 0.12 0.84 0.09 0.08 0.71 0.14 0.12 0.66 0.10 0.09 0.72 0.12 0.10 0.54 0.06 0.05 0.56 0.05 0.04 0.54 0.07 0.07 
ERCC5 0.96 0.12 0.11 1.01 0.08 0.07 1.04 0.09 0.08 1.18 0.08 0.08 0.90 0.02 0.02 0.89 0.10 0.09 0.60 0.07 0.07 0.62 0.09 0.08 
LIG1 1.09 0.06 0.05 0.87 0.03 0.03 0.86 0.10 0.09 0.61 0.05 0.05 0.65 0.02 0.02 0.66 0.07 0.06 0.89 0.13 0.11 0.76 0.06 0.05 
LIG3 1.26 0.20 0.17 1.00 0.12 0.10 1.09 0.20 0.17 0.88 0.09 0.08 0.89 0.10 0.09 0.99 0.11 0.10 0.90 0.05 0.05 0.77 0.08 0.08 
MGMT 1.05 0.17 0.15 1.02 0.22 0.18 0.91 0.16 0.14 0.98 0.14 0.12 0.94 0.19 0.15 0.74 0.16 0.13 0.97 0.14 0.12 1.04 0.28 0.22 
MLH1 1.07 0.11 0.10 1.02 0.03 0.03 1.20 0.13 0.11 1.09 0.16 0.14 1.10 0.19 0.16 1.17 0.35 0.27 1.16 0.26 0.21 1.06 0.31 0.24 
MSH2 0.84 0.03 0.03 0.89 0.04 0.04 0.85 0.15 0.13 0.83 0.13 0.12 0.80 0.21 0.17 0.72 0.13 0.11 0.69 0.16 0.13 0.66 0.10 0.09 
OGG1 1.25 0.26 0.22 1.09 0.19 0.16 1.14 0.25 0.20 0.95 0.22 0.18 0.85 0.14 0.12 0.86 0.19 0.15 0.96 0.20 0.17 0.73 0.17 0.14 
PARP1 1.04 0.10 0.09 1.01 0.09 0.09 0.86 0.07 0.07 0.84 0.05 0.05 0.89 0.06 0.05 0.73 0.04 0.04 0.87 0.10 0.09 0.97 0.07 0.07 
PCNA 0.90 0.07 0.06 1.02 0.09 0.08 1.03 0.20 0.16 1.05 0.06 0.06 0.92 0.08 0.07 0.93 0.16 0.14 0.75 0.18 0.15 0.69 0.16 0.13 
POLB 0.94 0.09 0.08 1.01 0.13 0.11 1.08 0.19 0.16 1.11 0.20 0.17 1.05 0.17 0.15 1.08 0.14 0.13 1.00 0.20 0.16 0.95 0.08 0.07 
POLD1 1.21 0.13 0.12 0.95 0.10 0.09 0.93 0.20 0.17 0.69 0.10 0.09 0.78 0.09 0.08 0.76 0.15 0.12 1.01 0.43 0.30 0.80 0.04 0.04 
RAD50 1.05 0.04 0.04 0.85 0.04 0.04 0.92 0.11 0.10 0.71 0.07 0.06 0.77 0.10 0.09 0.80 0.08 0.08 0.89 0.10 0.09 0.76 0.06 0.06 
RAD51 0.96 0.02 0.02 1.04 0.04 0.04 0.94 0.05 0.05 0.93 0.07 0.06 0.93 0.10 0.09 0.89 0.14 0.12 1.01 0.06 0.06 0.89 0.14 0.12 
RRM2B 1.10 0.23 0.19 1.20 0.22 0.18 0.98 0.18 0.15 0.96 0.20 0.17 0.93 0.14 0.12 0.79 0.09 0.08 0.80 0.11 0.10 0.88 0.21 0.17 
XPA 0.94 0.03 0.03 0.94 0.01 0.01 0.93 0.16 0.14 0.96 0.08 0.07 0.90 0.15 0.13 0.81 0.09 0.08 0.86 0.21 0.17 0.91 0.12 0.11 
XPC 0.96 0.05 0.05 0.96 0.06 0.06 0.82 0.03 0.03 0.85 0.10 0.09 0.85 0.08 0.07 0.71 0.07 0.07 0.69 0.10 0.09 0.78 0.10 0.09 
XRCC5 1.05 0.12 0.11 1.02 0.08 0.07 0.95 0.04 0.04 0.98 0.06 0.06 0.98 0.04 0.04 0.89 0.04 0.04 0.95 0.06 0.05 1.04 0.04 0.04 
APAF1 1.05 0.20 0.17 0.97 0.09 0.08 0.85 0.16 0.13 0.70 0.06 0.06 0.76 0.08 0.07 0.58 0.16 0.12 0.85 0.12 0.10 0.70 0.09 0.08 
BAX 1.22 0.15 0.14 1.15 0.12 0.11 1.20 0.23 0.19 1.07 0.07 0.06 1.11 0.08 0.07 1.23 0.21 0.18 1.30 0.17 0.15 1.10 0.08 0.08 
BBC3  1.03 0.17 0.14 1.08 0.16 0.14 0.98 0.31 0.23 0.88 0.25 0.20 0.73 0.42 0.27 0.72 0.44 0.27 0.74 0.15 0.13 0.82 0.19 0.16 
BCL2 1.32 0.30 0.24 0.96 0.32 0.24 0.94 0.33 0.24 0.65 0.16 0.13 0.72 0.15 0.12 0.60 0.10 0.08 1.04 0.22 0.18 0.86 0.09 0.09 
BCL2L1 1.35 0.23 0.20 1.24 0.17 0.15 1.16 0.27 0.22 0.97 0.05 0.05 0.91 0.09 0.08 0.96 0.16 0.14 1.22 0.24 0.20 1.01 0.18 0.15 
PMAIP1  0.92 0.12 0.11 1.64 0.17 0.15 2.64 0.70 0.55 3.11 0.62 0.52 2.79 1.02 0.75 4.08 0.97 0.78 3.53 0.57 0.49 4.53 1.39 1.06 
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TNFRSF10B  1.12 0.11 0.10 1.34 0.18 0.16 1.35 0.31 0.25 1.50 0.37 0.30 1.70 0.80 0.55 1.76 0.64 0.47 1.71 0.69 0.49 2.21 0.77 0.57 
XIAP 1.21 0.23 0.19 1.29 0.08 0.07 1.56 0.14 0.13 1.61 0.11 0.10 1.49 0.19 0.17 1.72 0.16 0.15 1.26 0.16 0.14 1.45 0.15 0.13 
 
Table A5: mRNA levels in p53-proficient HCT 116 cells: Exposure to sodium selenite (24h:1 µM-5 µM. 8h 5 µM) in combination with 10 µM CdCl2. 
  Sodium selenite (24h)     
Sodium selenite (24h) + 10 µM CdCl2 
  
  Sodium selenite (8h) 
Sodium selenite (8h) + 
10 µM CdCl2 
  1 µM 3 µM 5 µM 1 µM 3 µM 5 µM 5 µM 5 µM 
 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD err- 
ABCB1 1.06 0.10 0.09 0.98 0.16 0.14 1.63 0.48 0.37 2.12 0.89 0.62 2.08 1.36 0.82 1.77 0.67 0.49 1.68 1.24 0.71 1.16 0.18 0.15 
ABCC1 1.06 0.10 0.09 1.17 0.07 0.06 1.21 0.38 0.29 1.13 0.03 0.03 1.17 0.02 0.02 1.25 0.15 0.14 0.93 0.14 0.12 1.03 0.04 0.04 
CAT 1.00 0.06 0.06 0.94 0.03 0.03 0.72 0.02 0.02 0.68 0.14 0.11 0.73 0.03 0.03 0.68 0.05 0.05 0.86 0.10 0.09 0.81 0.06 0.06 
EPHX1 1.09 0.15 0.13 1.78 0.20 0.18 2.35 0.23 0.21 1.19 0.05 0.05 1.05 0.02 0.02 0.94 0.07 0.07 1.49 0.10 0.09 1.15 0.08 0.07 
FTH1 1.08 0.33 0.25 4.11 4.06 2.04 4.86 5.42 2.56 2.24 0.27 0.24 4.19 2.65 1.62 4.17 1.41 1.06 2.48 1.95 1.09 2.52 1.31 0.86 
G6PD 1.09 0.08 0.07 2.11 0.54 0.43 2.16 1.06 0.71 1.65 0.24 0.21 2.18 0.11 0.10 2.30 0.37 0.32 1.43 0.12 0.11 1.40 0.14 0.13 
GCLC 1.08 0.10 0.09 4.35 1.76 1.25 5.00 2.14 1.50 1.61 0.71 0.49 2.81 0.18 0.17 2.60 0.08 0.08 4.27 0.77 0.66 3.25 0.38 0.34 
GPX1 1.10 0.05 0.05 1.10 0.18 0.15 1.56 0.04 0.04 0.77 0.24 0.18 0.89 0.06 0.05 0.69 0.09 0.08 1.18 0.16 0.14 1.01 0.08 0.08 
GSR 1.04 0.14 0.13 1.69 0.15 0.14 1.97 0.48 0.38 1.74 0.17 0.15 2.10 0.21 0.19 2.03 0.10 0.09 1.67 0.20 0.18 1.59 0.08 0.07 
GSTP1 1.02 0.00 0.00 1.04 0.03 0.03 1.05 0.10 0.09 1.12 0.08 0.07 1.22 0.03 0.03 1.19 0.14 0.12 1.09 0.05 0.05 1.09 0.06 0.06 
KEAP1 1.07 0.07 0.07 1.11 0.07 0.07 1.38 0.50 0.37 0.85 0.41 0.28 1.08 0.24 0.19 1.30 0.11 0.10 1.28 0.24 0.20 1.01 0.08 0.07 
MT1X 1.06 0.07 0.07 2.18 0.89 0.63 2.96 0.96 0.73 13.44 1.63 1.46 15.31 5.45 4.02 14.05 4.53 3.42 1.37 0.17 0.15 23.94 4.51 3.80 
MT2A 1.04 0.09 0.08 1.94 0.42 0.35 2.93 0.42 0.37 5.65 0.06 0.06 5.84 1.10 0.93 5.76 1.73 1.33 1.53 0.25 0.22 5.14 0.53 0.48 
NAT1 0.95 0.04 0.03 0.56 0.04 0.04 0.78 0.08 0.07 1.79 0.67 0.49 1.38 0.42 0.32 1.21 0.16 0.14 0.59 0.09 0.08 0.81 0.04 0.04 
NFEL2L 1.00 0.25 0.20 1.41 0.48 0.36 2.07 0.39 0.33 0.84 0.08 0.07 0.87 0.12 0.11 0.89 0.06 0.06 1.44 0.52 0.38 0.84 0.06 0.06 
NQO1 1.12 0.02 0.02 2.44 0.61 0.49 2.83 0.95 0.71 1.46 0.18 0.16 1.78 0.09 0.09 1.98 0.21 0.19 1.89 0.30 0.26 1.61 0.19 0.17 
PRDX1 1.03 0.09 0.08 1.01 0.02 0.02 1.05 0.02 0.02 1.38 0.29 0.24 1.34 0.20 0.17 1.30 0.14 0.13 1.10 0.06 0.05 1.10 0.04 0.04 
SEPP1 1.22 0.54 0.37 0.90 0.17 0.14 0.69 0.00 0.00 0.72 0.11 0.09 0.59 0.04 0.03 0.74 0.11 0.10 0.85 0.24 0.18 0.74 0.04 0.04 
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SLC30A1 0.98 0.08 0.07 1.45 0.57 0.41 2.06 0.97 0.66 3.00 0.32 0.29 3.87 0.27 0.26 2.91 0.52 0.44 1.86 0.85 0.58 3.11 0.65 0.54 
SOD1 1.04 0.03 0.03 0.90 0.03 0.03 0.79 0.14 0.12 1.13 0.04 0.04 1.13 0.12 0.11 0.96 0.02 0.02 1.00 0.08 0.07 1.01 0.14 0.13 
SOD2 1.01 0.08 0.07 0.86 0.07 0.06 1.09 0.10 0.09 0.93 0.06 0.06 0.87 0.10 0.09 0.88 0.05 0.05 0.95 0.14 0.12 0.86 0.03 0.03 
SULT1A 1.06 0.09 0.08 1.10 0.13 0.11 1.06 0.14 0.12 1.06 0.12 0.11 1.66 0.27 0.23 1.50 0.30 0.25 1.17 0.14 0.13 1.07 0.12 0.11 
TFRC 1.03 0.15 0.13 1.18 0.10 0.09 1.03 0.27 0.22 1.19 0.18 0.15 1.05 0.06 0.06 0.88 0.13 0.11 1.02 0.02 0.02 0.94 0.03 0.03 
TXN 1.04 0.20 0.17 1.29 0.02 0.02 1.83 0.16 0.14 1.53 0.61 0.44 1.36 0.12 0.11 1.43 0.05 0.05 1.29 0.13 0.12 1.14 0.05 0.05 
TXNRD1 1.18 0.19 0.16 4.19 1.89 1.30 5.63 3.27 2.07 2.07 0.68 0.51 4.07 0.61 0.53 3.60 0.50 0.44 4.85 2.31 1.57 3.67 0.54 0.47 
HMOX1 1.07 0.14 0.13 3.92 2.44 1.50 20.26 20.94 10.30 53.86 25.30 17.21 73.71 13.88 11.68 66.07 18.30 14.33 9.28 3.02 2.28 46.06 4.25 3.89 
HSPA1A 0.97 0.15 0.13 0.76 0.13 0.11 1.20 0.40 0.30 90.57 339.43 71.49 74.48 220.31 55.66 30.48 7.16 5.80 0.90 0.22 0.18 0.90 0.10 0.09 
IL8 0.95 0.04 0.04 13.17 16.57 7.34 83.89 15.65 13.19 4.15 2.43 1.53 5.50 0.47 0.44 6.41 2.00 1.53 154.53 419.84 112.96 2.54 0.34 0.30 
NFKB1 1.05 0.02 0.02 1.05 0.03 0.03 1.65 0.18 0.16 0.83 0.11 0.09 0.71 0.07 0.06 0.79 0.12 0.11 1.18 0.31 0.25 0.77 0.06 0.06 
NFKB1A 0.95 0.20 0.17 1.04 0.23 0.19 1.79 0.48 0.38 0.79 0.33 0.23 1.16 0.21 0.18 0.97 0.34 0.25 1.51 0.68 0.47 0.73 0.20 0.16 
NFKB2 1.06 0.01 0.01 1.37 0.08 0.08 3.72 1.14 0.87 1.67 0.22 0.20 1.81 0.15 0.14 2.40 0.54 0.44 1.95 1.13 0.71 1.10 0.09 0.08 
CCND1 1.04 0.10 0.09 1.14 0.04 0.04 1.65 0.21 0.19 1.05 0.09 0.09 1.17 0.12 0.11 1.34 0.17 0.15 0.97 0.09 0.08 1.07 0.05 0.05 
CDKN1A1  1.00 0.16 0.13 2.41 1.64 0.98 9.64 3.93 2.79 1.00 0.32 0.24 1.01 0.22 0.18 1.14 0.14 0.13 5.75 5.00 2.67 1.38 0.03 0.03 
CDKN1B  1.02 0.19 0.16 1.01 0.09 0.08 1.20 0.41 0.30 0.62 0.03 0.03 0.60 0.10 0.08 0.71 0.03 0.03 0.80 0.20 0.16 0.57 0.02 0.02 
CDKN2B  1.14 0.21 0.18 3.27 2.51 1.42 3.62 2.32 1.41 1.11 0.23 0.19 1.28 0.18 0.16 1.45 0.44 0.34 2.34 1.42 0.88 0.85 0.06 0.06 
E2F1 1.00 0.14 0.12 0.64 0.18 0.14 0.62 0.05 0.04 0.76 0.44 0.28 0.95 0.11 0.10 0.81 0.10 0.09 1.27 0.04 0.04 0.92 0.04 0.04 
EGFR 1.10 0.10 0.09 1.31 0.30 0.24 1.93 0.49 0.39 0.80 0.39 0.26 0.95 0.07 0.07 0.85 0.05 0.05 1.05 0.10 0.09 0.92 0.14 0.12 
JUN  0.98 0.48 0.32 4.16 1.91 1.31 9.49 2.73 2.12 3.39 1.89 1.21 5.92 0.30 0.28 4.11 1.04 0.83 4.93 0.52 0.47 2.60 0.21 0.19 
MAP3K5  1.04 0.11 0.10 1.04 0.13 0.11 1.00 0.07 0.07 0.74 0.17 0.14 0.76 0.03 0.03 0.72 0.08 0.07 0.69 0.12 0.10 0.72 0.08 0.07 
MDM2 1.04 0.12 0.11 1.40 0.35 0.28 4.82 2.22 1.52 1.20 0.07 0.07 1.23 0.04 0.04 1.52 0.13 0.12 3.17 2.93 1.52 1.45 0.12 0.11 
MYC 0.99 0.14 0.12 0.89 0.08 0.07 1.23 0.09 0.09 0.88 0.23 0.19 0.97 0.14 0.12 0.84 0.07 0.06 1.13 0.02 0.02 1.04 0.13 0.11 
PLK3 0.98 0.10 0.09 2.07 1.24 0.78 4.06 1.52 1.11 0.94 0.50 0.33 1.26 0.07 0.06 1.42 0.38 0.30 3.86 2.64 1.57 1.52 0.08 0.07 
PPM1D 1.01 0.11 0.10 1.21 0.46 0.33 3.23 1.28 0.92 0.90 0.28 0.21 1.09 0.08 0.08 1.03 0.09 0.08 2.51 1.95 1.10 1.10 0.08 0.07 
SIRT2 0.94 0.21 0.17 1.11 0.39 0.29 1.55 0.28 0.23 1.17 0.35 0.27 1.47 0.03 0.03 1.29 0.15 0.13 0.99 0.16 0.14 0.87 0.06 0.06 
TP53 1.06 0.14 0.12 1.65 0.14 0.13 1.92 0.50 0.40 0.59 0.06 0.06 0.71 0.01 0.01 0.89 0.05 0.05 1.29 0.18 0.16 0.92 0.04 0.04 
VEGFA 1.07 0.20 0.17 4.40 3.13 1.83 5.00 5.51 2.62 1.21 0.14 0.12 2.22 0.98 0.68 1.92 0.64 0.48 3.79 2.28 1.42 1.64 0.32 0.27 
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APEX1 1.00 0.02 0.02 0.94 0.05 0.05 1.03 0.02 0.02 0.89 0.10 0.09 0.82 0.09 0.08 0.85 0.11 0.10 0.91 0.07 0.07 0.92 0.05 0.05 
ATM 1.20 0.21 0.18 1.68 0.46 0.36 2.02 0.83 0.59 0.92 0.01 0.01 0.94 0.04 0.04 1.08 0.11 0.10 1.14 0.45 0.32 0.86 0.07 0.07 
ATR 0.98 0.09 0.08 0.88 0.14 0.12 0.85 0.09 0.08 0.76 0.13 0.11 0.83 0.03 0.03 0.72 0.08 0.07 0.83 0.09 0.08 0.89 0.12 0.10 
BRCA1 1.09 0.09 0.09 1.08 0.19 0.16 1.18 0.06 0.06 0.78 0.14 0.12 0.87 0.02 0.02 0.84 0.08 0.07 1.18 0.08 0.07 0.92 0.12 0.10 
BRCA2 1.09 0.05 0.05 0.80 0.12 0.11 0.77 0.05 0.04 0.82 0.02 0.02 0.74 0.02 0.02 0.72 0.16 0.13 1.03 0.16 0.14 0.84 0.08 0.07 
DDB1 1.04 0.10 0.09 1.05 0.05 0.04 1.08 0.25 0.21 1.06 0.21 0.18 1.19 0.09 0.08 1.05 0.16 0.14 0.93 0.08 0.08 1.00 0.03 0.03 
DDB2 1.02 0.19 0.16 1.00 0.26 0.20 2.59 0.64 0.52 0.74 0.06 0.05 0.68 0.02 0.02 0.70 0.03 0.03 1.98 1.28 0.78 0.78 0.02 0.02 
ERCC1 1.01 0.02 0.02 1.43 0.40 0.31 1.94 0.29 0.25 0.93 0.07 0.07 0.96 0.17 0.14 0.97 0.09 0.08 1.23 0.26 0.22 0.87 0.07 0.07 
ERCC2 1.01 0.01 0.01 0.79 0.07 0.06 0.67 0.04 0.03 1.04 0.41 0.30 0.99 0.12 0.11 0.92 0.18 0.15 0.76 0.17 0.14 0.87 0.05 0.05 
ERCC4 1.03 0.11 0.10 1.20 0.21 0.18 1.67 0.56 0.42 0.75 0.03 0.03 0.72 0.01 0.01 0.81 0.06 0.06 1.09 0.33 0.26 0.66 0.01 0.01 
ERCC5 1.05 0.17 0.15 1.19 0.24 0.20 1.75 0.57 0.43 0.89 0.08 0.08 0.85 0.14 0.12 0.93 0.06 0.06 0.96 0.24 0.19 0.67 0.01 0.01 
LIG1 1.05 0.19 0.16 0.74 0.10 0.09 0.74 0.04 0.04 0.66 0.44 0.26 0.89 0.12 0.10 0.74 0.09 0.08 1.05 0.04 0.04 1.00 0.07 0.07 
LIG3 1.06 0.13 0.12 1.07 0.14 0.12 1.05 0.22 0.18 0.92 0.31 0.23 1.05 0.09 0.09 1.00 0.03 0.03 0.91 0.06 0.05 0.94 0.07 0.07 
MGMT 1.03 0.17 0.14 0.85 0.10 0.09 0.71 0.03 0.03 0.86 0.09 0.08 0.71 0.05 0.05 0.71 0.10 0.08 0.91 0.08 0.07 0.83 0.05 0.05 
MLH1 1.07 0.19 0.16 1.70 0.37 0.31 2.27 0.81 0.60 0.98 0.20 0.16 1.18 0.05 0.05 1.14 0.09 0.08 1.86 0.47 0.38 1.04 0.21 0.18 
MSH2 1.03 0.06 0.06 0.67 0.16 0.13 0.70 0.03 0.03 0.83 0.01 0.01 0.84 0.02 0.02 0.83 0.07 0.07 0.87 0.06 0.05 0.82 0.04 0.04 
OGG1 1.00 0.12 0.11 0.81 0.08 0.07 0.77 0.05 0.05 0.93 0.23 0.18 0.85 0.04 0.04 0.83 0.08 0.07 0.85 0.02 0.02 0.90 0.07 0.06 
PARP1 1.06 0.00 0.00 0.82 0.10 0.09 0.64 0.12 0.10 0.83 0.17 0.14 0.83 0.03 0.03 0.83 0.08 0.07 0.88 0.12 0.10 0.85 0.04 0.04 
PCNA 1.00 0.30 0.23 0.61 0.11 0.09 1.18 0.09 0.08 0.97 0.23 0.19 0.93 0.11 0.10 0.96 0.17 0.14 1.18 0.35 0.27 0.93 0.02 0.02 
POLB 0.99 0.04 0.04 1.18 0.20 0.17 1.40 0.32 0.26 1.02 0.01 0.01 0.95 0.05 0.05 0.96 0.03 0.03 1.07 0.17 0.14 0.93 0.08 0.07 
POLD1 1.01 0.25 0.20 0.79 0.03 0.03 0.66 0.14 0.11 0.77 0.61 0.34 1.14 0.07 0.06 1.01 0.14 0.13 0.95 0.02 0.02 1.03 0.05 0.05 
RAD50 1.06 0.04 0.04 1.30 0.31 0.25 1.53 0.34 0.28 0.74 0.13 0.11 0.80 0.04 0.03 0.78 0.08 0.07 1.09 0.18 0.15 0.87 0.12 0.11 
RAD51 1.03 0.04 0.04 0.75 0.23 0.18 0.89 0.12 0.10 1.04 0.17 0.15 1.05 0.07 0.07 1.03 0.03 0.03 1.13 0.07 0.07 1.10 0.02 0.02 
RRM2B 1.01 0.03 0.03 1.32 0.34 0.27 2.60 0.94 0.69 0.82 0.21 0.16 0.91 0.04 0.03 1.07 0.07 0.06 1.56 0.55 0.41 0.99 0.05 0.04 
XPA 1.04 0.25 0.20 1.09 0.11 0.10 1.51 0.19 0.17 0.85 0.08 0.08 0.73 0.07 0.06 0.88 0.03 0.03 1.12 0.23 0.19 0.89 0.04 0.04 
XPC 1.06 0.16 0.14 1.20 0.16 0.14 2.89 1.34 0.91 0.82 0.05 0.05 0.77 0.02 0.01 0.97 0.07 0.06 1.85 1.13 0.70 0.97 0.10 0.09 
XRCC5 1.03 0.01 0.01 0.83 0.10 0.09 0.71 0.11 0.09 0.93 0.02 0.02 0.87 0.01 0.01 0.89 0.04 0.04 0.92 0.04 0.04 0.92 0.01 0.01 
APAF1 1.05 0.24 0.19 1.03 0.18 0.16 1.08 0.24 0.20 0.91 0.39 0.27 0.92 0.13 0.11 0.92 0.06 0.06 1.29 0.47 0.35 0.93 0.14 0.12 
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BAX 0.99 0.19 0.16 1.11 0.38 0.29 2.37 0.74 0.56 1.03 0.44 0.31 1.36 0.14 0.13 1.18 0.10 0.09 1.48 0.49 0.37 1.23 0.09 0.09 
BBC3  1.41 0.01 0.01 2.73 0.55 0.45 6.10 3.90 2.38 1.30 0.04 0.04 0.87 0.45 0.29 1.22 0.28 0.23 6.85 5.15 2.94 1.31 0.17 0.15 
BCL2 1.02 0.24 0.20 1.02 0.08 0.07 1.27 0.20 0.17 0.71 0.52 0.30 0.95 0.16 0.14 0.95 0.09 0.08 0.86 0.27 0.21 0.86 0.11 0.10 
BCL2L1 0.94 0.08 0.07 1.56 0.86 0.55 2.12 0.48 0.39 0.95 0.39 0.28 1.34 0.11 0.10 1.24 0.23 0.19 1.05 0.11 0.10 1.01 0.04 0.04 
PMAIP1  1.04 0.07 0.07 1.88 0.37 0.31 3.24 0.54 0.47 2.21 0.26 0.23 2.46 0.48 0.40 2.04 0.25 0.22 4.45 3.61 2.00 1.60 0.19 0.17 
TNFRSF10B  0.96 0.10 0.09 2.80 1.40 0.93 4.21 2.62 1.61 1.27 0.08 0.08 1.46 0.18 0.16 1.63 0.41 0.33 3.33 2.00 1.25 1.51 0.03 0.03 
XIAP 1.04 0.10 0.09 1.57 0.47 0.36 2.14 1.10 0.73 1.24 0.04 0.04 1.31 0.11 0.11 1.26 0.13 0.11 1.20 0.25 0.21 0.97 0.06 0.06 
 
Table A6: mRNA levels in p53-proficient HCT 116 cells: Exposure to selenomethionine (24h: 100 µM-500 µM. 8h 500 µM) in combination with 10 µM CdCl2. 
  Selenomethionine (24h)     
Selenomethionine 
(24h) + 10 µM CdCl2 
    Selenomethionine (8h) 
Selenomethionine 
(24h) + 10 µM CdCl2 
  100 µM 300 µM 500 µM 100 µM 300 µM 500 µM 500 µM 500 µM 
 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
Mean 
SD 
err+ 
SD 
err- 
ABCB1 0.81 0.03 0.03 0.53 0.03 0.03 0.55 0.07 0.06 2.01 1.03 0.68 2.53 2.04 1.13 3.24 3.97 1.78 1.13 0.61 0.40 1.29 0.71 0.46 
ABCC1 1.38 0.16 0.14 1.12 0.18 0.16 1.38 0.33 0.27 1.20 0.17 0.15 1.19 0.28 0.23 1.43 0.18 0.16 0.97 0.22 0.18 1.11 0.12 0.11 
CAT 0.94 0.00 0.00 0.95 0.05 0.05 1.05 0.12 0.10 0.64 0.09 0.08 0.69 0.05 0.05 0.63 0.07 0.07 0.96 0.10 0.09 0.92 0.05 0.05 
EPHX1 1.11 0.29 0.23 1.04 0.23 0.19 1.50 0.49 0.37 0.85 0.06 0.05 1.00 0.19 0.16 1.15 0.16 0.14 1.00 0.04 0.04 1.02 0.06 0.06 
FTH1 0.94 0.22 0.18 1.49 2.08 0.87 3.32 3.17 1.62 1.95 0.52 0.41 6.32 5.01 2.79 2.12 0.61 0.47 2.09 2.25 1.08 2.23 0.95 0.67 
G6PD 0.94 0.13 0.12 0.77 0.12 0.11 0.95 0.26 0.21 1.35 0.28 0.23 1.44 0.52 0.38 1.65 0.38 0.31 1.04 0.39 0.28 1.19 0.28 0.23 
GCLC 0.84 0.01 0.01 1.13 0.22 0.18 1.31 0.41 0.31 1.52 0.21 0.18 2.08 0.09 0.09 1.67 0.21 0.19 1.40 2.04 0.83 2.30 2.44 1.18 
GPX1 0.87 0.05 0.05 0.89 0.14 0.12 0.89 0.18 0.15 0.62 0.21 0.16 0.77 0.03 0.03 0.62 0.02 0.02 1.03 0.21 0.17 0.89 0.09 0.08 
GSR 1.04 0.02 0.02 1.07 0.10 0.09 0.99 0.22 0.18 1.62 0.07 0.07 1.64 0.16 0.15 1.47 0.03 0.03 1.25 0.70 0.45 1.45 0.38 0.30 
GSTP1 0.88 0.03 0.03 0.86 0.09 0.08 0.87 0.09 0.09 0.98 0.13 0.12 1.12 0.06 0.06 1.04 0.08 0.08 1.02 0.13 0.11 0.98 0.05 0.04 
KEAP1 0.90 0.11 0.10 0.66 0.06 0.06 0.73 0.19 0.15 0.62 0.05 0.04 0.46 0.01 0.01 0.48 0.11 0.09 0.66 0.27 0.19 0.69 0.07 0.06 
MT1X 0.98 0.01 0.01 1.32 0.44 0.33 1.66 0.80 0.54 17.89 4.44 3.55 51.48 35.65 21.06 47.38 46.51 23.47 4.32 22.00 3.61 11.47 60.24 9.64 
MT2A 1.07 0.38 0.28 1.24 0.47 0.34 1.66 0.71 0.49 5.45 0.79 0.69 12.19 5.26 3.67 11.07 8.66 4.86 2.31 3.66 1.41 3.46 5.38 2.11 
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NAT1 0.78 0.01 0.01 0.85 0.13 0.11 1.01 0.14 0.12 2.03 0.86 0.61 2.71 0.95 0.70 3.21 0.76 0.61 0.76 0.07 0.06 0.75 0.15 0.12 
NFEL2 1.15 0.16 0.14 0.98 0.25 0.20 1.32 0.38 0.30 0.74 0.04 0.04 0.81 0.11 0.09 0.91 0.15 0.13 1.06 0.16 0.14 1.04 0.13 0.12 
NQO1 0.94 0.02 0.02 0.85 0.15 0.12 1.07 0.28 0.22 1.37 0.08 0.08 1.33 0.22 0.19 1.28 0.05 0.05 1.29 0.67 0.44 1.49 0.58 0.42 
PRDX1 0.90 0.05 0.04 0.76 0.11 0.09 0.89 0.10 0.09 1.22 0.00 0.00 1.41 0.37 0.29 1.42 0.34 0.28 1.17 0.10 0.10 1.21 0.12 0.11 
SEPP1 0.68 0.10 0.09 0.60 0.04 0.04 0.61 0.01 0.01 0.43 0.05 0.05 0.38 0.15 0.11 0.50 0.20 0.14 0.67 0.25 0.18 0.69 0.08 0.07 
SLC30A1 0.96 0.02 0.02 1.14 0.24 0.20 1.32 0.41 0.31 3.57 0.21 0.20 5.19 0.51 0.47 4.39 0.13 0.13 2.28 4.52 1.52 4.48 7.91 2.86 
SOD1 0.85 0.02 0.02 0.85 0.11 0.09 0.84 0.06 0.05 0.98 0.10 0.09 1.32 0.41 0.31 1.27 0.51 0.36 1.01 0.14 0.12 0.98 0.07 0.07 
SOD2 1.02 0.02 0.02 0.92 0.20 0.17 1.17 0.26 0.21 0.93 0.03 0.03 0.92 0.18 0.15 0.95 0.16 0.14 0.98 0.13 0.11 0.97 0.06 0.06 
SULT1A 0.86 0.11 0.10 0.77 0.22 0.17 0.82 0.20 0.16 0.69 0.14 0.11 0.90 0.18 0.15 0.63 0.04 0.03 0.98 0.24 0.19 0.84 0.13 0.11 
TFRC 1.11 0.07 0.06 1.06 0.05 0.05 1.01 0.14 0.12 1.26 0.09 0.09 1.38 0.03 0.03 1.31 0.06 0.06 1.07 0.36 0.27 1.03 0.12 0.11 
TXN 0.97 0.09 0.08 0.87 0.17 0.15 1.10 0.16 0.14 1.42 0.24 0.20 1.65 0.46 0.36 1.82 0.62 0.46 1.12 0.21 0.18 1.20 0.17 0.15 
TXNRD1 1.04 0.05 0.04 1.54 0.17 0.15 1.55 0.29 0.24 2.18 0.01 0.01 3.33 0.80 0.64 2.77 0.45 0.39 1.90 2.90 1.15 2.80 2.26 1.25 
HMOX1 1.20 0.02 0.02 1.32 0.24 0.20 1.99 0.78 0.56 81.48 52.43 31.90 129.02 74.53 47.24 158.79 103.47 62.65 5.13 53.60 4.68 24.02 358.11 22.51 
HSPA1A 0.73 0.01 0.01 0.90 0.20 0.16 1.07 0.22 0.19 39.77 167.97 32.16 86.32 555.66 74.71 139.09 1295.40 125.61 1.88 4.21 1.30 3.39 8.99 2.46 
IL8 1.75 0.01 0.01 4.81 0.68 0.60 7.98 0.30 0.29 6.53 3.38 2.23 12.37 3.06 2.45 16.65 8.51 5.63 2.78 1.99 1.16 4.04 2.28 1.46 
NFKB1 1.03 0.14 0.13 0.90 0.09 0.08 1.05 0.13 0.12 0.71 0.11 0.10 0.59 0.04 0.04 0.59 0.15 0.12 0.96 0.13 0.12 0.92 0.05 0.05 
NFKB1A 0.81 0.09 0.08 0.93 0.39 0.28 1.24 0.54 0.37 0.53 0.38 0.22 0.67 0.16 0.13 0.39 0.21 0.14 0.95 0.06 0.06 0.81 0.23 0.18 
NFKB2 1.12 0.30 0.24 1.13 0.03 0.03 1.40 0.22 0.19 1.71 0.29 0.25 2.27 0.50 0.41 2.97 0.73 0.59 0.94 0.30 0.23 0.96 0.09 0.08 
CCND1 1.21 0.12 0.11 1.03 0.24 0.20 1.28 0.34 0.27 0.98 0.05 0.05 1.06 0.32 0.25 1.13 0.31 0.24 0.95 0.19 0.16 1.07 0.09 0.09 
CDKN1A1  0.91 0.05 0.05 0.96 0.20 0.17 1.18 0.42 0.31 0.86 0.11 0.09 1.31 0.40 0.31 1.47 0.39 0.31 0.81 0.11 0.10 0.75 0.07 0.06 
CDKN1B  0.87 0.03 0.03 0.62 0.21 0.15 0.83 0.25 0.19 0.45 0.02 0.02 0.42 0.13 0.10 0.49 0.06 0.06 0.69 0.22 0.16 0.62 0.29 0.20 
CDKN2B  2.06 0.37 0.31 2.39 1.06 0.73 4.19 2.63 1.62 1.48 0.11 0.11 3.33 1.36 0.96 4.88 1.91 1.37 1.65 0.50 0.39 1.75 0.18 0.17 
E2F1 0.97 0.02 0.02 1.06 0.15 0.13 0.68 0.13 0.11 0.65 0.13 0.11 0.58 0.01 0.01 0.45 0.07 0.06 0.95 0.31 0.23 0.78 0.24 0.19 
EGFR 1.12 0.07 0.07 1.72 0.18 0.16 1.85 0.39 0.32 0.96 0.07 0.07 1.62 0.32 0.27 1.69 0.13 0.12 1.07 0.37 0.27 1.11 0.12 0.11 
JUN  1.19 0.30 0.24 2.81 0.34 0.30 2.90 0.14 0.13 4.37 0.99 0.81 10.79 3.30 2.53 10.94 3.65 2.74 1.76 2.60 1.05 3.62 6.08 2.27 
MAP3K5  0.98 0.11 0.10 1.34 0.10 0.09 1.43 0.13 0.12 0.76 0.17 0.14 0.97 0.08 0.08 0.99 0.09 0.08 0.89 0.11 0.10 0.85 0.14 0.12 
MDM2 1.04 0.03 0.03 0.93 0.15 0.13 1.19 0.22 0.19 1.11 0.10 0.09 1.16 0.30 0.24 1.38 0.34 0.27 0.73 0.10 0.09 0.80 0.01 0.01 
MYC 0.98 0.07 0.06 0.80 0.10 0.09 0.70 0.07 0.07 0.65 0.34 0.22 0.52 0.04 0.04 0.35 0.10 0.08 0.96 0.37 0.27 0.94 0.09 0.08 
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PLK3 1.27 0.33 0.26 1.43 0.52 0.38 1.80 0.98 0.63 0.97 0.43 0.30 1.86 0.47 0.38 1.89 0.59 0.45 1.05 0.39 0.28 1.03 0.12 0.11 
PPM1D 0.86 0.09 0.08 0.99 0.15 0.13 1.00 0.23 0.19 0.83 0.21 0.17 1.10 0.23 0.19 0.91 0.13 0.11 0.80 0.09 0.08 0.72 0.19 0.15 
SIRT2 1.15 0.12 0.11 1.40 0.26 0.22 1.58 0.51 0.39 1.28 0.13 0.12 2.07 0.70 0.52 2.27 1.01 0.70 1.05 0.26 0.21 0.97 0.17 0.14 
TP53 1.22 0.14 0.13 1.26 0.26 0.22 1.76 0.45 0.36 0.66 0.00 0.00 0.82 0.13 0.11 1.02 0.06 0.06 1.03 0.13 0.12 1.00 0.14 0.12 
VEGFA 1.52 0.18 0.16 2.41 2.50 1.23 5.45 5.29 2.68 1.52 0.08 0.08 4.68 3.74 2.08 3.23 1.04 0.78 3.03 1.68 1.08 2.84 1.35 0.92 
APEX1 0.82 0.10 0.09 0.64 0.10 0.09 0.73 0.16 0.13 0.60 0.13 0.11 0.49 0.06 0.05 0.41 0.08 0.07 0.97 0.10 0.09 0.88 0.06 0.05 
ATM 0.93 0.06 0.06 0.88 0.23 0.18 0.98 0.32 0.24 0.81 0.15 0.13 1.03 0.54 0.36 1.28 0.64 0.43 0.77 0.10 0.09 0.81 0.05 0.05 
ATR 0.76 0.04 0.04 0.72 0.16 0.13 0.70 0.10 0.09 0.59 0.21 0.15 0.78 0.18 0.15 0.64 0.17 0.13 0.89 0.09 0.08 0.82 0.12 0.11 
BRCA1 1.02 0.03 0.03 1.22 0.13 0.12 0.85 0.06 0.05 0.68 0.18 0.14 0.67 0.04 0.03 0.53 0.07 0.06 0.91 0.10 0.09 0.81 0.28 0.21 
BRCA2 1.00 0.02 0.02 0.93 0.09 0.09 0.77 0.04 0.04 0.70 0.06 0.05 0.67 0.11 0.10 0.62 0.03 0.03 0.85 0.15 0.13 0.76 0.21 0.16 
DDB1 1.00 0.17 0.15 0.95 0.11 0.10 0.92 0.14 0.12 0.94 0.08 0.07 0.85 0.01 0.01 0.83 0.13 0.12 1.03 0.29 0.22 1.04 0.07 0.06 
DDB2 1.07 0.47 0.33 0.68 0.10 0.09 0.78 0.14 0.12 0.55 0.11 0.09 0.41 0.04 0.04 0.40 0.08 0.07 0.73 0.14 0.12 0.60 0.21 0.16 
ERCC1 1.04 0.08 0.08 1.27 0.38 0.29 1.73 0.56 0.42 1.06 0.06 0.06 2.05 0.89 0.62 2.29 1.23 0.80 1.02 0.08 0.08 1.01 0.04 0.03 
ERCC2 1.08 0.18 0.16 0.87 0.10 0.09 0.93 0.26 0.20 0.96 0.01 0.01 0.97 0.17 0.15 1.11 0.13 0.12 1.00 0.45 0.31 0.89 0.06 0.06 
ERCC4 0.83 0.00 0.00 0.73 0.20 0.16 1.01 0.37 0.27 0.54 0.02 0.02 0.65 0.20 0.15 0.74 0.22 0.17 0.65 0.25 0.18 0.60 0.19 0.14 
ERCC5 1.04 0.06 0.06 0.89 0.23 0.18 1.24 0.46 0.33 0.77 0.13 0.11 1.32 0.98 0.56 1.91 2.02 0.98 0.79 0.21 0.17 0.73 0.21 0.16 
LIG1 0.89 0.09 0.08 0.77 0.08 0.07 0.55 0.02 0.02 0.57 0.24 0.17 0.60 0.05 0.05 0.48 0.03 0.03 0.96 0.40 0.28 0.87 0.20 0.16 
LIG3 0.87 0.01 0.01 0.87 0.15 0.13 0.88 0.20 0.16 0.70 0.08 0.07 0.87 0.26 0.20 0.88 0.21 0.17 0.81 0.18 0.14 0.76 0.10 0.09 
MGMT 1.06 0.18 0.15 0.74 0.22 0.17 1.01 0.20 0.17 0.75 0.01 0.01 0.78 0.25 0.19 0.90 0.21 0.17 0.97 0.10 0.09 0.89 0.06 0.05 
MLH1 1.37 0.05 0.05 2.19 0.34 0.29 2.15 0.44 0.37 1.30 0.05 0.05 2.52 1.07 0.75 2.58 0.99 0.72 1.26 0.17 0.15 1.28 0.34 0.27 
MSH2 0.70 0.03 0.03 0.47 0.06 0.05 0.44 0.02 0.02 0.49 0.08 0.07 0.34 0.04 0.04 0.29 0.02 0.02 0.76 0.17 0.14 0.67 0.16 0.13 
OGG1 0.94 0.06 0.06 0.92 0.14 0.12 0.90 0.18 0.15 0.72 0.30 0.21 0.88 0.22 0.18 0.79 0.17 0.14 0.96 0.12 0.11 0.83 0.24 0.19 
PARP1 0.95 0.04 0.04 0.77 0.06 0.06 0.83 0.11 0.10 0.78 0.04 0.04 0.70 0.11 0.09 0.74 0.07 0.06 0.97 0.23 0.18 0.96 0.02 0.02 
PCNA 0.84 0.04 0.04 0.51 0.06 0.05 0.48 0.02 0.02 0.69 0.02 0.02 0.41 0.03 0.03 0.34 0.08 0.06 0.86 0.14 0.12 0.86 0.13 0.11 
POLB 0.96 0.01 0.01 1.00 0.31 0.24 1.37 0.40 0.31 0.99 0.05 0.05 1.24 0.34 0.27 1.34 0.31 0.25 1.16 0.13 0.12 1.11 0.11 0.10 
POLD1 0.94 0.06 0.05 0.87 0.07 0.07 0.65 0.07 0.06 0.68 0.22 0.17 0.82 0.19 0.16 0.69 0.11 0.10 1.00 0.69 0.41 0.95 0.16 0.13 
RAD50 0.90 0.08 0.07 0.98 0.20 0.17 1.02 0.21 0.18 0.65 0.11 0.10 0.86 0.12 0.10 0.78 0.09 0.08 0.92 0.03 0.03 0.89 0.18 0.15 
RAD51 0.99 0.03 0.03 0.99 0.12 0.11 0.75 0.12 0.11 0.89 0.21 0.17 0.60 0.19 0.15 0.49 0.22 0.15 1.15 0.18 0.15 1.10 0.04 0.04 
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RRM2B 0.90 0.04 0.03 0.93 0.13 0.11 1.23 0.33 0.26 0.74 0.01 0.01 0.67 0.06 0.05 0.73 0.14 0.12 0.83 0.14 0.12 0.84 0.12 0.10 
XPA 0.86 0.06 0.06 0.65 0.18 0.14 0.90 0.26 0.20 0.69 0.05 0.05 0.99 0.41 0.29 1.20 0.74 0.46 0.92 0.13 0.12 0.92 0.08 0.07 
XPC 0.94 0.12 0.11 0.74 0.14 0.12 0.99 0.33 0.25 0.73 0.08 0.07 0.82 0.19 0.15 1.08 0.27 0.21 0.67 0.14 0.12 0.68 0.05 0.05 
XRCC5 0.89 0.06 0.06 0.69 0.08 0.07 0.70 0.09 0.08 0.83 0.05 0.05 0.65 0.07 0.06 0.61 0.03 0.02 0.99 0.12 0.11 1.00 0.05 0.04 
APAF1 0.92 0.13 0.12 1.03 0.09 0.08 0.91 0.12 0.10 0.74 0.20 0.16 0.71 0.08 0.07 0.63 0.13 0.11 0.95 0.24 0.19 0.93 0.15 0.13 
BAX 0.82 0.01 0.01 0.81 0.23 0.18 0.86 0.30 0.22 0.89 0.29 0.22 1.23 0.58 0.40 1.18 0.55 0.37 0.88 0.33 0.24 0.86 0.04 0.04 
BBC3  1.19 0.00 0.00 1.45 0.20 0.18 1.47 0.34 0.28 1.10 0.02 0.02 1.14 0.33 0.26 1.82 0.62 0.46 0.94 0.16 0.14 0.97 0.10 0.09 
BCL2 0.86 0.12 0.10 0.94 0.07 0.06 0.77 0.10 0.09 0.57 0.36 0.22 0.56 0.16 0.13 0.55 0.05 0.05 0.89 0.32 0.24 0.99 0.17 0.15 
BCL2L1 1.28 0.37 0.29 1.39 0.35 0.28 1.58 0.54 0.40 0.93 0.40 0.28 1.32 0.19 0.17 1.19 0.04 0.04 1.12 0.52 0.35 1.08 0.14 0.12 
PMAIP1  1.38 0.09 0.08 1.87 0.22 0.20 2.10 0.29 0.26 3.16 0.11 0.11 4.01 0.95 0.77 4.12 0.67 0.58 1.85 0.84 0.58 2.47 1.02 0.72 
TNFRSF10B  1.31 0.29 0.24 1.79 0.34 0.28 2.74 1.10 0.78 1.59 0.82 0.54 3.03 0.83 0.65 3.94 1.33 0.99 1.22 0.58 0.39 1.48 0.33 0.27 
XIAP 1.02 0.07 0.06 1.31 0.30 0.25 1.64 0.43 0.34 1.49 0.35 0.29 2.02 0.67 0.50 2.19 0.56 0.45 1.04 0.16 0.14 1.10 0.15 0.13 
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Table A7: mRNA levels in p53-deficient HCT 116 cells: Exposure to cadmium chloride (24h: 5 µM-50 µM)  
  CdCl2 (24 h)      
  5 µM     10 µM     50 µM     
  Mean SD err+ SD err- Mean SD err+ SD err- Mean SD err+ SD err- 
ABCB1 1.19 0.04 0.04 1.80 0.30 0.26 3.11 0.30 0.28 
ABCC1 1.07 0.00 0.00 1.14 0.16 0.14 1.16 0.08 0.07 
CAT 0.93 0.05 0.05 0.89 0.04 0.04 0.82 0.04 0.04 
EPHX1 1.10 0.08 0.08 1.13 0.05 0.05 1.13 0.01 0.01 
FTH1 1.94 0.57 0.44 2.16 0.63 0.49 2.90 0.43 0.37 
G6PD 1.51 0.09 0.09 1.61 0.35 0.29 1.89 0.19 0.17 
GCLC 1.28 0.20 0.18 1.53 0.19 0.17 1.60 0.02 0.02 
GPX1 0.88 0.01 0.01 0.90 0.07 0.07 0.91 0.04 0.04 
GSR 1.23 0.16 0.14 1.45 0.03 0.03 1.57 0.00 0.00 
GSTP1 1.04 0.05 0.04 1.16 0.05 0.05 1.16 0.01 0.01 
KEAP1 1.15 0.04 0.04 1.15 0.24 0.20 1.08 0.09 0.08 
MT1X 18.18 3.23 2.75 19.75 5.28 4.17 25.06 2.36 2.15 
MT2A 4.94 0.57 0.51 5.22 0.49 0.45 5.69 0.23 0.23 
NAT1 1.18 0.17 0.15 1.42 0.31 0.26 1.92 0.09 0.08 
NFEL2L 0.91 0.06 0.05 0.93 0.05 0.05 0.96 0.02 0.02 
NQO1 1.63 0.04 0.04 1.62 0.26 0.22 1.76 0.11 0.10 
PRDX1 1.23 0.02 0.02 1.29 0.08 0.08 1.51 0.02 0.02 
SEPP1 0.86 0.03 0.03 0.73 0.04 0.04 0.66 0.02 0.02 
SLC30A1 3.73 0.58 0.50 3.78 0.49 0.43 3.79 0.26 0.24 
SOD1 1.04 0.09 0.08 1.13 0.15 0.13 1.24 0.10 0.09 
SOD2 1.01 0.02 0.02 1.01 0.06 0.05 1.07 0.06 0.05 
SULT1A 0.96 0.15 0.13 1.12 0.04 0.04 0.97 0.02 0.02 
TFRC 1.07 0.04 0.04 1.24 0.06 0.06 1.27 0.04 0.04 
TXN 1.18 0.01 0.01 1.31 0.03 0.03 1.53 0.03 0.03 
TXNRD1 1.61 0.36 0.29 1.88 0.32 0.27 2.53 0.06 0.06 
HMOX1 8.13 3.44 2.42 22.42 11.17 7.45 46.08 5.97 5.28 
HSPA1A 72.34 41.29 26.29 202.03 442.09 138.66 909.98 51.68 48.90 
IL8 1.25 0.20 0.17 1.93 0.41 0.34 2.80 0.19 0.18 
NFKB1 0.96 0.02 0.02 0.99 0.07 0.07 0.90 0.03 0.03 
NFKB1A 0.88 0.15 0.13 1.07 0.16 0.14 0.98 0.10 0.09 
NFKB2 1.31 0.05 0.04 1.47 0.40 0.32 1.68 0.06 0.06 
CCND1 1.00 0.06 0.06 1.07 0.07 0.07 1.18 0.07 0.07 
CDKN1A1  1.20 0.14 0.13 1.22 0.26 0.21 1.39 0.07 0.07 
CDKN1B  0.92 0.02 0.02 0.89 0.07 0.07 0.93 0.10 0.09 
CDKN2B  1.15 0.01 0.01 1.29 0.25 0.21 1.34 0.08 0.08 
E2F1 0.96 0.14 0.12 0.89 0.04 0.04 0.81 0.03 0.02 
EGFR 1.08 0.15 0.13 1.13 0.16 0.14 1.25 0.04 0.04 
JUN  1.50 0.39 0.31 2.03 1.08 0.70 3.55 0.13 0.13 
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MAP3K5  1.00 0.06 0.05 1.01 0.05 0.05 0.97 0.00 0.00 
MDM2 1.00 0.01 0.01 1.08 0.07 0.07 1.14 0.09 0.09 
MYC 0.87 0.05 0.05 0.88 0.03 0.03 0.76 0.00 0.00 
PLK3 1.14 0.09 0.08 1.16 0.14 0.12 1.06 0.01 0.01 
PPM1D 0.91 0.10 0.09 1.05 0.09 0.08 1.16 0.09 0.08 
SIRT2 1.22 0.18 0.16 1.27 0.28 0.23 1.57 0.03 0.03 
TP53 0.81 0.02 0.02 0.84 0.03 0.03 0.67 0.01 0.01 
VEGFA 1.16 0.14 0.13 1.28 0.20 0.18 1.43 0.10 0.09 
APEX1 0.94 0.01 0.01 0.94 0.07 0.07 0.79 0.02 0.02 
ATM 0.91 0.09 0.08 1.10 0.07 0.06 1.15 0.06 0.06 
ATR 1.03 0.12 0.10 1.00 0.12 0.11 0.98 0.07 0.06 
BRCA1 0.92 0.10 0.09 0.98 0.09 0.08 0.92 0.07 0.07 
BRCA2 0.95 0.08 0.07 1.04 0.04 0.04 1.01 0.00 0.00 
DDB1 1.02 0.05 0.05 1.13 0.08 0.08 1.09 0.01 0.01 
DDB2 0.90 0.02 0.02 0.87 0.09 0.08 0.72 0.05 0.04 
ERCC1 1.03 0.07 0.06 1.05 0.08 0.08 1.11 0.02 0.02 
ERCC2 1.21 0.10 0.09 1.17 0.22 0.19 1.17 0.05 0.04 
ERCC4 0.86 0.03 0.03 0.91 0.03 0.03 0.87 0.11 0.10 
ERCC5 0.98 0.06 0.05 1.13 0.10 0.09 1.32 0.13 0.12 
LIG1 0.91 0.09 0.08 0.94 0.03 0.03 0.88 0.02 0.02 
LIG3 1.01 0.09 0.09 1.02 0.04 0.04 1.08 0.02 0.02 
MGMT 0.92 0.11 0.10 0.99 0.05 0.04 0.94 0.01 0.01 
MLH1 1.09 0.25 0.20 1.30 0.09 0.09 1.35 0.01 0.01 
MSH2 0.93 0.03 0.03 0.90 0.02 0.02 0.88 0.04 0.04 
OGG1 1.07 0.11 0.10 1.09 0.09 0.08 1.13 0.09 0.08 
PARP1 0.98 0.04 0.03 0.93 0.10 0.09 0.91 0.09 0.08 
PCNA 0.93 0.01 0.01 0.93 0.06 0.06 0.95 0.03 0.03 
POLB 1.00 0.02 0.02 1.02 0.03 0.03 1.03 0.02 0.02 
POLD1 1.11 0.18 0.15 1.11 0.14 0.12 1.09 0.09 0.08 
RAD50 0.88 0.09 0.08 0.98 0.09 0.08 0.90 0.03 0.03 
RAD51 1.06 0.03 0.03 1.08 0.02 0.01 0.99 0.02 0.02 
RRM2B 0.99 0.01 0.01 0.99 0.07 0.07 0.91 0.03 0.03 
XPA 0.89 0.06 0.06 0.93 0.08 0.07 0.92 0.09 0.08 
XPC 0.95 0.01 0.01 1.00 0.10 0.09 1.03 0.14 0.12 
XRCC5 1.03 0.02 0.02 1.05 0.09 0.08 1.02 0.07 0.06 
APAF1 1.11 0.20 0.17 1.19 0.09 0.08 1.18 0.04 0.04 
BAX 1.00 0.10 0.09 1.07 0.04 0.04 1.03 0.05 0.04 
BBC3  0.94 0.04 0.04 1.32 0.10 0.09 1.16 0.19 0.17 
BCL2 0.99 0.12 0.11 0.96 0.03 0.03 0.86 0.04 0.03 
BCL2L1 1.23 0.21 0.18 1.14 0.14 0.13 1.29 0.10 0.09 
PMAIP1  1.28 0.14 0.13 1.48 0.32 0.26 1.88 0.08 0.08 
TNFRSF10B  1.01 0.04 0.04 1.10 0.13 0.12 1.10 0.10 0.09 
XIAP 1.13 0.10 0.09 1.23 0.13 0.12 1.40 0.03 0.03 
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Table A8: mRNA levels in p53-deficient HCT 116 cells: Exposure to sodium selenite (24h; 5 µM) or 
selenomethionine (24h; 500 µM) in combination with 10 µM CdCl2. 
 
        
 
Sodium selenite 5 µM (24h) 
Sodium selenite 5 µM +  
10 µM CdCl2 (24h) 
Selenomethionine 500 µM (24h) 
Selenomethionine 500 µM  + 
10 µM CdCl2  (24h) 
 
Mean SD err+ SD err- Mean SD err+ SD err- Mean SD err+ SD err- Mean SD err+ SD err- 
ABCB1 1.09 0.08 0.07 1.19 0.13 0.12 0.59 0.03 0.03 1.07 0.47 0.32 
ABCC1 1.12 0.07 0.06 1.02 0.11 0.10 1.35 0.19 0.17 1.08 0.16 0.14 
CAT 0.87 0.17 0.15 0.82 0.08 0.07 1.05 0.03 0.03 0.86 0.14 0.12 
EPHX1 1.49 0.20 0.18 1.15 0.10 0.10 1.55 0.19 0.17 1.24 0.15 0.13 
FTH1 4.65 2.47 1.61 2.17 3.15 1.29 3.65 2.92 1.62 3.96 3.50 1.86 
G6PD 1.65 0.26 0.23 1.74 0.76 0.53 0.80 0.13 0.11 1.10 0.49 0.34 
GCLC 3.66 3.51 1.79 2.75 0.28 0.25 1.47 0.26 0.22 2.23 0.41 0.35 
GPX1 1.10 0.07 0.07 0.89 0.08 0.07 1.09 0.22 0.18 0.74 0.11 0.10 
GSR 1.79 0.86 0.58 1.65 0.39 0.32 0.87 0.14 0.12 1.41 0.44 0.34 
GSTP1 1.03 0.05 0.05 1.06 0.08 0.07 0.99 0.08 0.07 1.13 0.14 0.12 
KEAP1 1.31 0.15 0.14 1.10 0.34 0.26 0.82 0.18 0.15 0.65 0.15 0.12 
MT1X 1.25 0.55 0.38 8.17 4.23 2.79 2.19 0.56 0.45 57.46 24.36 17.11 
MT2A 1.37 0.45 0.34 3.84 0.43 0.39 2.43 0.49 0.41 8.50 1.12 0.99 
NAT1 0.65 0.18 0.14 0.85 0.02 0.02 1.02 0.15 0.13 2.05 1.23 0.77 
NFEL2L 1.69 0.62 0.45 1.09 0.05 0.04 1.57 0.31 0.26 1.28 0.17 0.15 
NQO1 2.19 1.19 0.77 2.08 0.50 0.40 1.02 0.21 0.18 1.47 0.44 0.34 
PRDX1 1.01 0.04 0.04 1.22 0.09 0.08 0.89 0.06 0.06 1.27 0.23 0.20 
SEPP1 1.10 0.23 0.19 1.03 0.02 0.02 1.01 0.21 0.18 0.52 0.03 0.03 
SLC30A1 1.55 0.54 0.40 2.28 1.40 0.87 1.48 0.31 0.25 7.60 1.76 1.43 
SOD1 0.98 0.14 0.12 1.08 0.18 0.15 0.88 0.11 0.10 1.15 0.15 0.13 
SOD2 0.83 0.01 0.01 0.80 0.07 0.06 1.24 0.22 0.19 0.97 0.15 0.13 
SULT1A 1.04 0.09 0.09 0.96 0.19 0.16 1.03 0.28 0.22 0.60 0.23 0.17 
TFRC 0.93 0.24 0.19 0.82 0.05 0.05 0.92 0.01 0.01 0.92 0.22 0.18 
TXN 1.55 0.41 0.32 1.55 0.17 0.16 1.09 0.10 0.10 1.77 0.49 0.38 
TXNRD1 4.18 4.24 2.10 3.38 1.21 0.89 1.74 0.63 0.46 3.14 1.42 0.98 
HMOX1 8.47 17.22 5.68 21.78 15.90 9.19 2.79 0.59 0.49 67.93 29.17 20.41 
HSPA1A 0.94 0.07 0.06 24.33 14.38 9.04 1.19 0.11 0.10 98.75 385.45 78.61 
IL8 73.86 59.55 32.97 5.13 1.56 1.19 9.90 2.54 2.02 11.13 4.41 3.16 
NFKB1 1.06 0.11 0.10 0.68 0.05 0.05 1.00 0.11 0.10 0.68 0.08 0.07 
NFKB1A 1.35 0.62 0.43 0.67 0.08 0.07 1.30 0.35 0.27 0.75 0.30 0.22 
NFKB2 1.62 0.55 0.41 1.33 0.52 0.37 1.64 0.33 0.27 1.77 0.67 0.49 
CCND1 0.94 0.18 0.15 0.87 0.03 0.03 0.91 0.26 0.20 0.74 0.14 0.12 
CDKN1A1  2.69 2.80 1.37 1.59 0.55 0.41 3.02 1.16 0.84 3.44 1.47 1.03 
CDKN1B  1.19 0.07 0.07 0.76 0.03 0.03 0.91 0.27 0.21 0.53 0.15 0.12 
CDKN2B  1.11 0.15 0.13 0.94 0.09 0.08 1.99 0.44 0.36 1.80 0.45 0.36 
E2F1 0.71 0.24 0.18 0.75 0.09 0.08 0.74 0.16 0.13 0.50 0.11 0.09 
EGFR 1.31 0.44 0.33 0.97 0.11 0.10 1.91 0.47 0.38 1.74 0.56 0.43 
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JUN  3.68 1.42 1.03 1.94 1.08 0.69 2.81 0.51 0.43 4.53 1.73 1.25 
MAP3K5  0.82 0.12 0.11 0.79 0.07 0.06 1.03 0.11 0.10 0.78 0.10 0.09 
MDM2 1.31 0.19 0.16 1.08 0.07 0.07 1.39 0.16 0.14 1.13 0.22 0.19 
MYC 1.19 0.13 0.12 0.94 0.01 0.01 0.93 0.11 0.10 0.55 0.14 0.11 
PLK3 1.55 0.41 0.32 1.23 0.14 0.12 2.91 1.00 0.74 2.19 0.63 0.49 
PPM1D 1.01 0.20 0.17 0.91 0.11 0.10 1.04 0.21 0.17 0.99 0.26 0.21 
SIRT2 0.92 0.14 0.12 1.16 0.21 0.18 1.68 0.47 0.37 1.76 0.77 0.53 
TP53 1.84 0.31 0.26 1.21 0.06 0.06 2.51 0.14 0.13 1.45 0.12 0.11 
APEX1 0.85 0.04 0.04 0.84 0.05 0.04 0.80 0.07 0.07 0.63 0.04 0.04 
ATM 1.42 0.04 0.04 1.20 0.05 0.05 1.10 0.23 0.19 0.92 0.25 0.20 
ATR 0.87 0.10 0.09 0.90 0.22 0.18 0.83 0.20 0.16 0.79 0.06 0.06 
BRCA1 1.24 0.18 0.16 1.09 0.10 0.10 1.22 0.15 0.13 0.90 0.12 0.11 
BRCA2 1.12 0.11 0.10 1.00 0.08 0.08 1.15 0.13 0.12 0.82 0.13 0.12 
DDB1 0.99 0.25 0.20 0.93 0.06 0.06 1.01 0.10 0.09 0.95 0.15 0.13 
DDB2 0.87 0.27 0.20 0.77 0.07 0.06 1.23 0.03 0.03 0.80 0.03 0.03 
ERCC1 1.10 0.17 0.15 0.92 0.02 0.02 1.66 0.32 0.27 1.79 0.57 0.43 
ERCC2 0.66 0.32 0.21 0.77 0.11 0.09 0.94 0.10 0.09 0.87 0.25 0.20 
ERCC4 1.12 0.11 0.10 0.83 0.01 0.01 0.90 0.22 0.18 0.60 0.17 0.14 
ERCC5 1.17 0.07 0.06 1.02 0.02 0.02 1.35 0.22 0.19 1.21 0.40 0.30 
LIG1 0.89 0.13 0.11 0.87 0.09 0.08 0.74 0.23 0.17 0.58 0.12 0.10 
LIG3 0.95 0.17 0.14 0.92 0.05 0.04 0.82 0.16 0.13 0.66 0.15 0.12 
MGMT 0.93 0.18 0.15 0.83 0.15 0.13 1.19 0.08 0.08 0.91 0.02 0.02 
MLH1 1.56 0.30 0.25 1.35 0.13 0.12 2.32 0.50 0.41 2.30 0.46 0.38 
MSH2 0.86 0.10 0.09 0.85 0.06 0.05 0.43 0.04 0.04 0.33 0.02 0.02 
OGG1 0.76 0.10 0.09 0.89 0.04 0.04 1.10 0.32 0.25 1.00 0.27 0.21 
PARP1 0.81 0.15 0.13 0.73 0.04 0.04 0.80 0.07 0.07 0.62 0.06 0.06 
PCNA 0.78 0.22 0.17 0.88 0.17 0.14 0.55 0.05 0.05 0.46 0.07 0.06 
POLB 1.01 0.13 0.11 0.93 0.03 0.03 1.25 0.37 0.28 1.17 0.22 0.19 
POLD1 0.78 0.17 0.14 0.86 0.24 0.19 0.76 0.22 0.17 0.70 0.22 0.17 
RAD50 1.22 0.15 0.13 1.04 0.11 0.10 1.13 0.24 0.20 0.89 0.17 0.14 
RAD51 0.88 0.10 0.09 0.98 0.03 0.03 0.82 0.03 0.03 0.74 0.14 0.12 
RRM2B 1.12 0.10 0.09 0.90 0.06 0.05 1.37 0.17 0.15 0.96 0.14 0.12 
XPA 1.14 0.03 0.03 0.97 0.12 0.11 0.96 0.10 0.09 0.91 0.20 0.17 
XPC 1.15 0.16 0.14 0.91 0.10 0.09 1.18 0.09 0.08 0.92 0.15 0.13 
XRCC5 0.91 0.13 0.11 0.85 0.07 0.06 0.72 0.12 0.10 0.60 0.15 0.12 
APAF1 0.83 0.11 0.10 0.98 0.05 0.05 1.06 0.25 0.20 0.89 0.24 0.19 
BAX 0.94 0.28 0.22 0.97 0.06 0.06 1.22 0.39 0.30 1.02 0.33 0.25 
BBC3  5.75 2.63 1.81 2.33 0.70 0.54 5.66 0.87 0.75 4.02 1.64 1.17 
BCL2 1.00 0.21 0.18 0.94 0.11 0.10 0.78 0.29 0.21 0.54 0.17 0.13 
BCL2L1 1.11 0.36 0.27 1.10 0.24 0.20 2.08 0.31 0.27 1.88 0.37 0.31 
PMAIP1  1.96 0.52 0.41 1.53 0.18 0.16 2.13 0.63 0.48 2.85 0.62 0.51 
TNFRSF10B  2.63 1.04 0.74 1.55 0.14 0.13 3.51 0.25 0.23 3.05 0.49 0.43 
XIAP 1.40 0.42 0.33 1.07 0.24 0.19 1.71 0.49 0.38 1.78 0.73 0.52 
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9.6.2 Enzymatic activities of catalase and SOD 
 
 
Figure A1: Impact of sodium selenite in the combination with cadmium chloride on (A) CAT 
enzyme activity and (B) SOD enzyme activity in p53-proficient and p53-deficient HCT116 cells 
after 24 h incubation. 50 mM sodium azide (6 h) served as CAT positive control. CAT activity was 
determined by detection of decomposition of H2O2 at 240 nm. 50 mM diethyldithiocarbamate (DDC)(6 h) 
served as SOD positive control. Total SOD activity was determined by detection of superoxide radicals 
generated by xanthine oxidase and hypoxanthine, whereby SOD dismutates the superoxide radical (WST-1). 
Mean values ± SD of three independent experiments are shown. 
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9.6.3 ROS detection  
 
Figure A2: Example of histograms depicting increased PE signal and thereby oxidized DHE, indicating 
increased superoxide production in (A) untreated p53-proficient HCT116 control cells and (B) 15 min 100 µM 
menadione-treated cells. 
 
 
 
A
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9.6.4 Cell cycle distribution 
Figure A3: Cell cycle distribution depicted as histograms in (A) untreated p53-proficient HCT116 control 
cells, (B) sodium selenite treated cells (7 µM, 24 h) and (C) 24 h co-incubation with 10 µM cadmium chloride 
and 7 µM sodium selenite co-treated cells  
C  
A
  
B
  
C
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9.6.5 Cell death analysis   
Figure A4: Example of scatter plots of propidium iodide (PI) and Annexin V-FITC stained cell populations as 
well as histograms displaying changes in mitochondrial membrane potential in (A) untreated p53-proficient 
HCT116 control cells, (B) sodium selenite treated cells (7 µM, 24 h) and (C) with sodium selenite (7 µM) and 
cadmium chloride (10 µM) 24 h co-incubation  
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